dronabinol has been researched along with cannabidiol in 1164 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 154 (13.23) | 18.7374 |
| 1990's | 33 (2.84) | 18.2507 |
| 2000's | 94 (8.08) | 29.6817 |
| 2010's | 427 (36.68) | 24.3611 |
| 2020's | 456 (39.18) | 2.80 |
| Authors | Studies |
|---|---|
| Dewey, WL; Duffley, RP; Harris, LS; Jorapur, VS; Khalil, ZH; Martin, BR; Razdan, RK | 1 |
| Consroe, P; Fish, BS; Martin, AR | 1 |
| Bianchi, A; Cruciani, G; Fichera, M; Musumarra, G | 1 |
| Fowler, CJ; Lambert, DM | 1 |
| Drmota, T; Elebring, T; Greasley, PJ; Hermansson, NO; Hjorth, S; Larsson, N; Leonova, J; Nilsson, K; Ryberg, E; Sjögren, S | 1 |
| Flores, CM; Hutchinson, TL; Liu, Y; Lubin, ML; Neeper, MP; Qin, N | 1 |
| Appendino, G; Giana, A; Gibbons, S; Grassi, G; Pagani, A; Rahman, MM; Smith, E; Stavri, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Bradshaw, HB; Dunn, E; McHugh, D; Page, J | 1 |
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Chung, S; Dangott, LJ; Huang, H; Kier, AB; Landrock, D; Landrock, KK; Li, S; Martin, GG; McIntosh, AL; Schroeder, F | 1 |
| Dutour, R; Poirier, D | 1 |
| Ali, A; Banday, J; Bano, N; Bhat, AQ; Dar, MJ; Dar, MS; Nalli, Y; Rafia, B; Rasool, JU; Sarkar, AR; Vishwakarma, RA | 1 |
| Burstein, SH | 1 |
| Bisson, J; Chen, SN; Dahlin, JL; Friesen, JB; Graham, JG; Nelson, KM; Niemitz, M; Pauli, GF; Singh, G; Walters, MA | 1 |
| Anderson, LL; Arnold, JC; Bowen, MT; Cairns, EA; Fletcher, C; Heblinski, M; Krycer, JR; Martin, LJ; McGregor, IS | 1 |
| Combrinck, JM; de Sousa, ACC; Egan, TJ; Maepa, K | 1 |
| Smith, RN | 1 |
| Fairbairn, JW; Rowan, MG | 2 |
| Fairbairn, JW; Liebmann, JA; Rowan, MG | 1 |
| Harvey, DJ | 1 |
| Freidman, MA; Wrenn, JM | 1 |
| Dellarco, AJ; Harclerode, J; Jacobs, JA; Manfredi, RA | 1 |
| Butcher, RW; Kelly, LA | 1 |
| Gilbert, JC; Pertwee, RG; Wyllie, MG | 1 |
| Collins, FG; Haavik, CO | 1 |
| Bailey, K | 1 |
| Chesher, GB; Jackson, DM; Malor, R | 1 |
| Cameron, IL; Laurence, HL; Zimmerman, AM; Zimmerman, S | 1 |
| Carlini, EA; Mechoulam, R | 1 |
| Borys, HK; Chiu, P; Karler, R; Turkanis, SA | 1 |
| Ferraro, DP | 1 |
| Bruce, WR; Zimmerman, AM; Zimmerman, S | 1 |
| Hayden, DW; Rosenkrantz, H | 1 |
| Borys, HK; Karler, R | 2 |
| Musty, RE; Sands, R | 1 |
| Fairbairn, JW; Pickens, JT | 1 |
| Harvey, DJ; Martin, BR; Paton, WD | 3 |
| Friedman, MA | 1 |
| Segal, M | 1 |
| Cheney, DL; Costa, E; Moroni, F; Revuelta, AV | 1 |
| Neidig, PH; Nielsen, PJ; Stewart, J | 1 |
| Hanus, L | 1 |
| Dalton, WS; Forney, RB; Lemberger, L; Martz, R; Rodda, BE | 1 |
| Dalton, B; Forney, R; Lemberger, L; Martz, R; Rodda, B | 1 |
| Chao, FC; Forrest, IS; Green, DE; Loeffler, KO | 1 |
| Bhargava, HN | 1 |
| Consroe, P; Eisenstein, D; Martin, P | 1 |
| Erikson, DJ; Harakal, JJ; Knobloch, LC; Sofia, RD | 1 |
| Goldstein, H; Harclerode, J; Nyquist, SE | 1 |
| Fairbairn, JW; Rothschild, M; Rowan, MG | 1 |
| Fenselau, C; Head, K; Lyle, MA; Pallante, S | 1 |
| Adams, MD; Dewey, WL; Earnhardt, JT; Harris, LS; Martin, BR; Razdan, RK | 1 |
| Hollister, LE; Kanter, SL | 1 |
| Henriksson, BG; Järbe, TU; Ohlin, GC | 1 |
| Livne, A; Schurr, A | 2 |
| Bach, D; Goldman, R; Raz, A | 2 |
| Friedman, E; Moss, IR | 1 |
| Agurell, S; Ben-Zvi, Z; Lander, N; Martin, B; Mechoulam, R; Nordqvist, M | 1 |
| Knobloch, LC; Sofia, RD | 1 |
| Bueno, OF; Carlini, EA; Finkelfarb, E; Suzuki, JS | 1 |
| Billings, AA; Orlina, AR; Shapiro, CM; Telfer, M; Unger, PJ | 1 |
| Karler, R; Smiley, KA; Turkanis, SA | 1 |
| Agurell, S; Leander, K; Lindgren, JE; Ohlsson, A | 1 |
| Dvilanski, A; Levy, R; Livne, A; Nathan, I; Schurr, A | 1 |
| Karler, R; Turkanis, SA | 7 |
| Ten Ham, M; Van Klingeren, B | 1 |
| Gillespie, H; Hollister, LE | 1 |
| Hadley, KW; Holley, JH; Turner, CE | 1 |
| Clough, JM; King, LJ; Marks, V; Piall, EM; Teale, JD | 1 |
| Agurell, S; Rosell, S | 1 |
| Carchman, RA; Dewey, WL; Friedman, MA; Harris, LS; Munson, AE | 1 |
| De Jong, Y; Ham, MT | 1 |
| Cox, B; Lomax, P; Loskota, WJ; ten Ham, M | 1 |
| Chiu, P; Craven, C; Karler, R; Olsen, DM; Turkanis, SA | 1 |
| Levy, S; McCallum, NK | 1 |
| Goldman, R; Raz, A | 2 |
| Gershon, S; Hine, B; Torrelio, M | 2 |
| Carchman, RA; Harris, LS; Munson, AE | 1 |
| Gordon, R; Gordon, RJ; Sofia, D | 1 |
| Forney, RB; McCoy, DJ; Stone, CJ | 1 |
| Chesher, GB; Jackson, DM; Starmer, GA; Welburn, PJ | 1 |
| Levy, R; Livne, A | 1 |
| Fonseka, K; Widman, M | 1 |
| Berkery, D; Chang, MC; Schuel, H; Schuel, R; Zimmerman, AM; Zimmerman, S | 1 |
| Chang, MC; Schuel, H | 1 |
| Scuderi, P; Watson, RR; Watzl, B | 2 |
| Consroe, P; Kennedy, K; Schram, K | 1 |
| Browne, SE; Pertwee, RG; Ross, TM; Stretton, CD | 1 |
| Ali, SF; Bailey, JR; Newport, GD; Paule, MG; Scallet, AC; Slikker, W | 1 |
| Eldridge, JC; Landfield, PW | 1 |
| Bartke, A; Murphy, LL; Smith, MS; Steger, RW | 2 |
| Ou, DW; Papa, VM; Shen, ML | 1 |
| Compton, DR; Gilman, JW; Jorapur, VS; Little, PJ; Martin, BR; Razdan, RK; Saha, JK; Sard, HP | 1 |
| Archer, T; Hiltunen, AJ; Järbe, TU; Kamkar, MR | 1 |
| Bornheim, LM; Correia, MA | 1 |
| Howlett, AC; Scott, DK; Wilken, GH | 1 |
| Pontzer, NJ; Wilkison, DM | 1 |
| Hokin, LE; Nen, W; Reichman, M | 1 |
| Chiang, CN; Rapaka, RS | 1 |
| Mali, BD; Parulekar, PP | 1 |
| Bloom, AS; Harris, RA; Hillard, CJ | 1 |
| Chesher, GB; Jackson, DM | 1 |
| Burstein, S; Hunter, SA; Renzulli, L | 1 |
| Dvilansky, A; Nathan, I; Volfe, Z | 1 |
| Hosko, MJ; Pontzer, NJ; Wilkison, DM | 1 |
| Hiltunen, AJ; Järbe, TU | 2 |
| Hamajima, K; Narimatsu, S; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Agurell, S; Gillespie, H; Halldin, M; Hollister, L; Lindgren, JE; Ohlsson, A; Widman, M | 1 |
| Dalterio, S; DeAngelo, L; Mayfield, D; Michael, SD; Thomford, PJ | 1 |
| Hiltunen, AJ; Järbe, TU; Lander, N; Mechoulam, R | 1 |
| Dalterio, SL; deRooij, DG | 1 |
| Schuel, H; Schuel, R; Zimmerman, AM; Zimmerman, S | 1 |
| Chubb, CB; Gemmell, MA; Huberman, E; Maeda, S; Murison, G | 1 |
| Tjeerdema, RS | 1 |
| Agurell, S; Binder, M; Leander, K; Lindgren, JE | 1 |
| Karniol, IC; Teixeira, NA; Zuardi, AW | 1 |
| Jones, RT | 1 |
| Brown, RE; Colasanti, BK; Craig, CR | 1 |
| Nir, I; van Ree, JM; Veldhuis, HD | 1 |
| Niesink, RJ; Nir, I; van Ree, JM | 1 |
| Calder, LD; Karler, R; Turkanis, SA | 1 |
| Holmes, SD; Lipshultz, LI; Smith, RG | 1 |
| Aharon, M; Dvilansky, A; Lazarovitz, Z; Mazor, M; Nathan, I | 1 |
| Tilak, SK; Zimmerman, AM | 1 |
| Colasanti, BK; Lindamood, C | 1 |
| Alozie, SO; Dewey, WL; Harris, LS; Martin, BR | 1 |
| Esber, HJ; Rosenkrantz, H | 1 |
| Tansik, RL; White, HL | 1 |
| McBay, AJ | 1 |
| Raj, AY; Zimmerman, AM | 1 |
| Korczyn, AD; Maor, D; Treves, T | 1 |
| Balster, RL; Brady, KT | 1 |
| Bueno, OF; Finkelfarb, E; Karniol, IG; Musty, RE; Zuardi, AW | 1 |
| Fleischman, RW; Grant, RJ; Rosenkrantz, H | 1 |
| Franz, DN; Karler, R; Sangdee, C; Tramposch, A; Turkanis, SA | 1 |
| Pickens, JT | 1 |
| Bachman, J; Herning, RI; Hunt, CA; Jones, RT | 1 |
| Consroe, P; Fish, BS | 1 |
| Fu, TK; Matsuyama, SS | 1 |
| Hanlon, TH; Pirl, JN; Spikes, JJ | 1 |
| Bigot, MC; Camsonne, R; Debruyne, D; Moulin, M | 1 |
| Agurell, S; Carlsson, S; Gillespie, H; Hollister, L; Lindgren, JE; Ohlsson, A | 1 |
| Láng, A | 1 |
| Harris, RA; Stokes, JA | 1 |
| Colasanti, BK; Craig, CR; Lindamood, C | 1 |
| Finkelfarb, E; Karniol, IG; Shirakawa, I; Zuardi, AW | 1 |
| Becker, EL; Makryannis, A; Naccache, PH; Sha'afi, RI; Volpi, M | 1 |
| Borys, HK; Karler, R; Turkanis, SA | 1 |
| Burstein, S; Hunter, SA; Sedor, C; Shulman, S | 1 |
| Sieber, B | 1 |
| Baczynsky, WO; Zimmerman, AM | 2 |
| Bartke, A; Dalterio, SL; Mayfield, D | 1 |
| Carlen, PL; Kapur, BM; Kujtan, PW | 1 |
| Kita, M; Oguri, K; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Karniol, IG; Zuardi, AW | 1 |
| Latour, C; Nahas, G; Stüker, O; Trouvé, R | 1 |
| Harzer, K; Kächele, M | 1 |
| Bartke, A; Dalterio, S; Mayfield, D; Steger, R | 2 |
| Haque, SJ; Poddar, MK | 1 |
| Bloom, AS; Hillard, CJ | 1 |
| Hamajima, K; Narimatsu, S; Tateoka, Y; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Benet, LZ; Bornheim, LM; Kim, KY; Li, J; Perotti, BY | 1 |
| Abukhalaf, IK; Abusada, GA; Alford, DD; Kemp, PM; Manno, BR; Manno, JE | 1 |
| Das, SK; Dey, SK; Paria, BC | 1 |
| Tateoka, Y; Usami, N; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Chakraborty, I; Das, SK; Dey, SK; Paria, BC | 1 |
| Bornheim, LM; Correia, MA; Everhart, ET; Li, J | 1 |
| Bartke, A; Murphy, LL; Newton, SC | 1 |
| Charalambous, A; Compton, DR; Grzybowska, J; Lin, S; Makriyannis, A; Marciniak, G; Martin, BR; Semus, SF | 1 |
| Gohda, H; Matsunaga, T; Nagai, K; Narimatsu, S; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Funae, Y; Imaoka, S; Matsunaga, T; Narimatsu, S; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Matsunaga, T; Nagai, K; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Benet, LZ; Bornheim, LM; Jaeger, W | 1 |
| Axelrod, J; Grimaldi, M; Hampson, AJ; Wink, D | 1 |
| Dubroeucq, MC; Imperato, A; Jeantaud, B; Petitet, F; Reibaud, M | 1 |
| Brouhard, B; Srivastava, BI; Srivastava, MD | 1 |
| Cirimele, V; Jamey, C; Kintz, P; Ludes, B | 1 |
| Bonner, TI; Buckley, NE; Compton, DR; Járai, Z; Kunos, G; Lake, KD; Martin, BR; Mezey, E; Razdan, RK; Varga, K; Wagner, JA; Zimmer, A; Zimmer, AM | 1 |
| Lambert, P; Moerschbaecher, JM; Winsauer, PJ | 1 |
| Emrich, HM; Leweke, FM; Radwan, M; Schmidt, E; Schneider, U | 1 |
| Mauden, M; Pötsch, L; Skopp, G | 1 |
| Constans, J; Disdier, P | 1 |
| Peng, X | 1 |
| Smart, T | 1 |
| Gorter, R | 1 |
| DeLorenzo, RJ; Martin, BR; Wallace, MJ; Wiley, JL | 1 |
| Iida, O; Kojoma, M; Makino, Y; Satake, M; Sekita, S | 1 |
| Mechoulam, R; Parker, LA; Schlievert, C | 1 |
| Bagatta, M; Carboni, A; Crucitti, P; de Meijer, EP; Mandolino, G; Moliterni, VM; Ranalli, P | 1 |
| Russo, EB | 2 |
| Aram, J; House, H; Makela, P; Robson, P; Wade, DT | 1 |
| Burton, P; Kwiatkowska, M; Mechoulam, R; Parker, LA | 1 |
| Lichtman, AH; Mechoulam, R | 1 |
| Abou-Mohamed, G; Caldwell, RB; Caldwell, RW; El-Remessy, AB; Green, K; Khalil, IE; Liou, GI; Matragoon, S; Roon, P; Tsai, NJ | 1 |
| Metz, L; Page, S | 1 |
| Fox, P; Nunn, A; Sanders, H; Thompson, A; Vickery, J; Wright, D; Zajicek, J | 1 |
| Beckett, SR; Chapman, V; Finn, DP; Fone, KC; Kendall, DA; Madjd, A; Marsden, CA; Roe, CH | 1 |
| Hammell, DC; Ramsey, DR; Stinchcomb, AL; Valiveti, S | 1 |
| Szendrei, K | 1 |
| Miller, R; Newport, S; Notcutt, W; Phillips, C; Price, M; Sansom, C; Simmons, S | 1 |
| Nicholson, AN; Robson, PJ; Stone, BM; Turner, C | 1 |
| Burton, P; Mechoulam, R; Parker, LA; Sorge, RE; Yakiwchuk, C | 1 |
| Smith, PF | 1 |
| Gattlen, B; Hagen, U; Heinzel-Gutenbrunner, M; Jobin, P; Reif, M; Schnelle, M; Tschopp, F; Vaney, C | 1 |
| Berkley, KJ; Brady, CM; Dalton, C; DasGupta, R; Fowler, CJ; Wiseman, OJ | 1 |
| Bateman, C; House, H; Makela, P; Robson, P; Wade, DT | 1 |
| Berman, JS; Birch, R; Symonds, C | 1 |
| Fadda, P; Fratta, W; Pertwee, RG; Riedel, G; Robinson, L | 1 |
| Burstein, S; Zurier, RB | 1 |
| Abe, K; Egashira, N; Fujiwara, M; Hasebe, N; Hayakawa, K; Ikeda, T; Inui, K; Iwasaki, K; Mishima, K; Takamatsu, F; Yasuda, H | 1 |
| Atakan, Z; Martín-Santos, R; McGuire, P | 1 |
| Ashton, CH; Gallagher, P; Moore, PB; Young, AH | 1 |
| Jarho, P; Järvinen, K; Järvinen, T; Mannila, J; Tarvainen, M | 1 |
| Sibbald, B | 1 |
| Lee, MC; Menon, DK | 1 |
| Coleman, M; de Wit, H; ElSohly, MA; Gevins, A; Ilan, AB | 1 |
| Kwiatkowska, M; Mechoulam, R; Parker, LA | 1 |
| Guy, GW; Russo, E | 1 |
| Chung, BC; In, MK; Kim, JY; Paeng, KJ; Suh, SI | 1 |
| Grotenhermen, F | 2 |
| Blake, DR; Ho, M; Jubb, RW; McCabe, CS; Robson, P | 1 |
| Fronk, EM; Nadulski, T; Pragst, F; Roser, P; Schnelle, M; Stadelmann, AM; Weinberg, G | 1 |
| Christen, P; Ilias, Y; Mathieu, P; Rudaz, S; Veuthey, JL | 1 |
| Flau, K; Kathmann, M; Redmer, A; Schlicker, E; Tränkle, C | 1 |
| Adekanmi, O; Freeman, RM; Waterfield, AE; Waterfield, MR; Wright, D; Zajicek, J | 1 |
| Barnes, MP | 1 |
| Bridgen, DT; Lichtman, AH; Long, K; Martin, BR; Varvel, SA; Wiley, JL; Yang, R | 1 |
| Huestis, MA | 1 |
| Guy, G; Ware, M; Wright, S | 1 |
| Auchampach, JA; Carrier, EJ; Hillard, CJ | 1 |
| Nadulski, T; Pragst, F | 1 |
| Azuara-Blanco, A; Flint, M; House, H; Pertwee, RG; Robson, PJ; Tomida, I | 1 |
| D'Arcy, Y | 2 |
| Abe, K; Egashira, N; Fujioka, M; Fujiwara, M; Hasebe, N; Hayakawa, K; Hazekawa, M; Iwasaki, K; Liu, AX; Mishima, K; Nozako, M; Ogata, A | 1 |
| Battistin, L; Carbonare, MD; D'Arrigo, A; Facchinetti, F; Giudice, ED; Guiotto, A; Leon, A; Passarotto, M; Rinaldi, L | 1 |
| Collin, C; Davies, P; Mutiboko, IK; Ratcliffe, S | 1 |
| Drysdale, AJ; Pertwee, RG; Platt, B; Ryan, D | 1 |
| Abe, K; Egashira, N; Fujioka, M; Fujiwara, M; Hasebe, N; Hayakawa, K; Hazekawa, M; Irie, K; Iwasaki, K; Mishima, K; Nozako, M; Orito, K | 1 |
| Wallace, JM | 1 |
| Scully, C | 1 |
| Guy, GW; Robson, PJ; Russo, EB | 1 |
| Pertwee, RG | 2 |
| Gallinat, J; Juckel, G; Nadulski, T; Roser, P; Stadelmann, AM | 1 |
| Haines, D; Hoggart, B; Morlion, BJ; Nurmikko, TJ; Serpell, MG; Toomey, PJ | 1 |
| Egashira, N; Egawa, T; Fujiwara, M; Hayakawa, K; Hazekawa, M; Irie, K; Iwasaki, K; Kitamura, Y; Mishima, K; Nishimura, R; Orito, K; Sano, K; Uchida, N | 1 |
| Nurmikko, TJ; Rog, DJ; Young, CA | 1 |
| Gamage, TF; Marshall, EM; Martin, BR; Taylor, NL; Vann, RE; Warner, JA; Wiley, JL | 1 |
| Kalant, H | 1 |
| Curran, HV; Morgan, CJ | 1 |
| Connor, M; Napier, I; Ross, HR | 1 |
| Perez, J; Ribera, MV | 1 |
| Gallinat, J; Juckel, G; Nadulski, T; Rentzsch, J; Roser, P; Stadelmann, AM | 1 |
| Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, SJ; Crippa, JA; Fraccaro, V; Fusar-Poli, P; Martin-Santos, R; McGuire, PK; O'Carroll, C; Rubia, K; Seal, ML | 1 |
| Allen, JD; Arnold, JC; Holland, ML | 1 |
| Cluny, NL; Javid, FA; Naylor, RJ; Whittle, BA | 1 |
| di Forti, M; Luzi, S; Morrison, PD; Murray, RM; Powell, J | 1 |
| Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, SJ; Crippa, JA; Fusar-Poli, P; Martin-Santos, R; McGuire, PK; O'Carrol, C; Seal, M; Surguladze, SA; Zuardi, AW | 1 |
| Fuchs, D; Jenny, M; Pirich, E; Santer, E; Schennach, H | 1 |
| Gallinat, J; Gorynia, I; Juckel, G; Roser, P; Stadelmann, AM; Weinberg, G | 1 |
| Bereza, B; Desjardins, O; Einarson, TR; Iskedjian, M; Jaszewski, B; Piwko, C | 1 |
| Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, S; Crippa, JA; Fletcher, PC; Fusar-Poli, P; Giampietro, V; Martin-Santos, R; McGuire, P; Mechelli, A; Nosarti, C; O'Carroll, C; Seal, ML | 1 |
| Balducci, C; Cecinato, A; Nervegna, G | 1 |
| Jongejan, D; Malone, DT; Taylor, DA | 1 |
| Bari, M; Battistini, L; Bernardi, G; Buttari, F; Cencioni, MT; Centonze, D; Codecà, C; Fiore, S; Koch, G; Maccarrone, M; Mori, F; Rossi, S | 1 |
| Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, S; Crippa, JA; Fusar-Poli, P; Martin-Santos, R; McGuire, P; Mechelli, A; O'Carrol, C; Seal, ML; Zuardi, AW | 1 |
| Arnold, JC; Chesworth, R; Huang, XF; Karl, T; Long, LE; McGregor, IS | 1 |
| Emery, CJ; Gandhi, R; Selvarajah, D; Tesfaye, S | 1 |
| Burnell-Nugent, M; Fallon, MT; Ganae-Motan, ED; Johnson, JR; Lossignol, D; Potts, R | 1 |
| Juknat, A; Kozela, E; Levy, R; Pietr, M; Rimmerman, N; Vogel, Z | 1 |
| Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, S; Crippa, JA; Fusar-Poli, P; Giampietro, V; Kapur, S; Martin-Santos, R; McGuire, PK; Mehta, MA; Morrison, PD; Murray, RM; Nosarti, C; O' Carroll, CM; Seal, M; Stone, JM; Tunstall, N; Winton-Brown, T; Zuardi, AW | 1 |
| Charlier, C; De Backer, B; Debrus, B; Decock, L; Dubois, N; Hubert, P; Lebrun, P; Theunis, L; Verstraete, A | 1 |
| Allison, J; Christian, RT; Desprez, PY; Horowitz, MP; Lau, D; Lee, J; Limbad, C; Marcu, JP; McAllister, SD; Moore, DH; Pakdel, A; Yount, GL; Zielinski, AJ | 1 |
| Barnes, AJ; Huestis, MA; Karschner, EL; Lowe, RH; Scheidweiler, KB | 1 |
| Alsindi, Z; Ambler, Z; Collin, C; Davies, P; Ehler, E; Notcutt, W; Nováková, I; O'Leary, C; Piková, J; Powell, K; Ratcliffe, S; Waberzinek, G; Zapletalova, O | 1 |
| Ahmed, S; El-Alfy, AT; ElSohly, M; Ivey, K; Khan, I; Radwan, M; Robinson, K; Ross, S; Slade, D | 1 |
| Ahrens, J; Buchholz, V; de la Roche, J; Demir, R; Dengler, R; Foadi, N; Haeseler, G; Karst, M; Leuwer, M | 1 |
| Curran, HV; Freeman, TP; Morgan, CJ; Schafer, GL | 1 |
| Crippa, JA; Hallak, JE; Zuardi, AW | 2 |
| Collin, C; Duncombe, P; Stott, C; Wade, DT | 1 |
| Kmietowicz, Z | 1 |
| Jamontt, JM; Molleman, A; Parsons, ME; Pertwee, RG | 1 |
| Alhamoruni, A; Larvin, M; Lee, AC; O'Sullivan, SE; Wright, KL | 1 |
| Bernardi, G; Buttari, F; Centonze, D; Codecà, C; Fiore, S; Koch, G; Kusayanagi, H; Monteleone, F; Mori, F | 1 |
| Dórea, HS; Emídio, ES; Prata, Vde M | 1 |
| Constantinescu, CS; De Ridder, D; Fowler, CJ; Kavia, RB; Stott, CG | 1 |
| Henquet, C; Kuepper, R | 1 |
| Curran, HV; Freeman, TP; Morgan, CJ; Schafer, G | 1 |
| Abanades, S; Arriola, E; Capellà, D; Duran, M; Farré, M; Laporte, JR; Majem, M; Pastor, A; Pérez, E; Rabanal, M; Rams, N; Saura, C; Vidal, X | 1 |
| Demirakca, T; Ende, G; Hermann, D; Mann, K; Meyer, N; Sartorius, A; Skopp, G; Welzel, H | 1 |
| Darwin, WD; Goodwin, RS; Huestis, MA; Karschner, EL; Wright, S | 1 |
| Lichtman, AH; Long, KA; Poklis, A; Poklis, JL; Thompson, CC | 1 |
| Burgdorf, JR; Kilmer, B; Pacula, RL | 1 |
| Darwin, WD; Goodwin, RS; Huestis, MA; Karschner, EL; Liu, F; McMahon, RP; Wright, S | 1 |
| Gross, H | 1 |
| Bellimam, MA; Bouayoun, T; El Bouri, A; El Karni, N; Stambouli, H | 1 |
| Ebisawa, J; Okushima, Y; Watanabe, K; Yamamoto, I; Yamaori, S | 1 |
| Ambler, Z; Cefaro, L; Comi, G; Davies, P; Erdmann, A; Gasperini, C; Klimek, A; Mares, J; Montalban, X; Novakova, I; Novotna, A; Pozzilli, C; Ratcliffe, S; Rossi, P; Stelmasiak, Z; Vachova, M; Zapletalova, O | 1 |
| Mo, S; Wang, Q; Zhang, A | 1 |
| Allen, P; Atakan, Z; Bhattacharrya, S; Bhattacharyya, S; Borgwardt, SJ; Crippa, JA; Ffytche, D; Fusar-Poli, P; Martin-Santos, R; McGuire, PK; Seal, ML; Winton-Brown, TT; Zuardi, AW | 1 |
| Cummin, AR; Guz, A; Holdcroft, A; Moosavi, SH; Murphy, K; Nazir, MS; Pickering, EE; Semple, SJ; Snow, TM | 1 |
| Haas, J | 1 |
| Di Marzo, V | 1 |
| Vermersch, P | 2 |
| Clissold, S; Montalban, X; Sastre-Garriga, J; Vila, C | 1 |
| Koo, BN; Morton, R; Xiong, W; Zhang, L | 1 |
| Bradshaw, HB; Juknat, A; Kozela, E; Levy, R; Rimmerman, N; Vogel, Z | 1 |
| Robson, P | 1 |
| Coppola, G; Geschwind, D; Juknat, A; Kozela, E; Levy, R; Pietr, M; Rimmerman, N; Vogel, Z | 1 |
| Arnold, JC; Gunasekaran, N; Huang, XF; Huynh, T; Karanges, E; Karl, T; Klein, C; Liu, K; Long, LE; McGregor, IS; Spencer, J; Spiro, A; Wong, A | 1 |
| Chen, N; Guy, G; Hilliard, A; Romach, MK; Russo, E; Schoedel, KA; Sellers, EM; Stott, C; White, L; Wright, S | 1 |
| Fernández-Ruiz, J; Pazos, MR; Pertwee, RG; Ramos, JA; Sagredo, O; Satta, V | 1 |
| Barnes, AJ; Goodwin, RS; Hirvonen, J; Huestis, MA; Lee, D; Milman, G | 1 |
| Solaro, C | 1 |
| Aviello, G; De Petrocellis, L; Di Marzo, V; Izzo, AA; Moriello, AS; Orlando, P; Stott, C | 1 |
| Amada, N; Arthur, M; Close, S; Deiana, S; Dorward, P; Fleming, S; Pigliacampo, B; Platt, B; Riedel, G; Watanabe, A; Woodcock, H; Yamasaki, Y | 1 |
| Curran, HV; Demarchi, C; Freeman, TP; Gardener, C; Lewis, S; Morgan, CJ; Ramoutar, A; Rupasinghe, I; Schafer, G; Swan, S; Tan, N; Warrington, P; Wingham, G | 1 |
| Okamoto, Y; Watanabe, K; Yamamoto, I; Yamaori, S | 1 |
| Gorelick, DA; Huestis, MA; Karschner, EL; Schwope, DM | 1 |
| Davies, P; Langford, R; Notcutt, W; Potts, R; Ratcliffe, S | 1 |
| Ashton, CH; Moore, PB | 1 |
| Heekeren, K | 1 |
| Hada, Y; Koeda, K; Kushihara, M; Watanabe, K; Yamamoto, I; Yamaori, S | 1 |
| Allen, P; Atakan, Z; Bhattacharyya, S; Borgwardt, S; Brammer, M; Crippa, JA; Fusar-Poli, P; Giampietro, V; Kambeitz, J; Martin-Santos, R; McGuire, PK; O'Carroll, C; Rubia, K; Seal, ML; Zuardi, AW | 1 |
| Barnes, AJ; Gorelick, DA; Huestis, MA; Lee, D; Milman, G; Schwope, DM | 1 |
| Bodmer, M; Drewe, J; Eichler, M; Luedi, M; Spinedi, L; Surber, C; Unfer-Grauwiler, S | 1 |
| Brower, V | 1 |
| Allende, S; Fallon, MT; Ganae-Motan, ED; McQuade, R; Portenoy, RK; Shaiova, L; Weinstein, S; Wright, S; Yanagihara, R | 1 |
| Oreja-Guevara, C | 2 |
| Wade, D | 1 |
| Akutsu, M; Aoki, R; Fujii, H; Fukada, M; Kataoka, T; Kawase, Y; Kurahashi, K; Mizuno, T; Takagi, T; Tokieda, Y; Tsumura, Y | 1 |
| Duvigneau, JC; Kranner, B; Krewenka, C; Moldzio, R; Novak, J; Pacher, T; Rausch, WD | 1 |
| Broecker, S; Pragst, F | 1 |
| Cristino, L; De Petrocellis, L; Di Marzo, V; Iappelli, M; Ligresti, A; Orlando, P; Schiano Moriello, A; Stott, CG; Verde, R | 1 |
| Gras, A; Slof, J | 1 |
| Arnold, JC; Boucher, AA; Karl, T | 1 |
| Allen, P; Atakan, Z; Batalla, A; Bhattacharyya, S; Borgwardt, S; Crippa, JA; Farré, M; Langohr, K; Martin-Santos, R; McGuire, PK; Seal, M; Zuardi, AW | 1 |
| Antonino de la Camara, G; Dominguez Moran, JA; García del Busto, N; Garcia-Llopis, P; Lopez Tinoco, MJ; Mejia Andujar, L; Peiro Vilaplana, C; Quintana Vergara, B; Sánchez Alcaraz, A; Vicente-Valor, MI | 1 |
| Notcutt, WG | 1 |
| Allen, JD; Arnold, JC; Holland, ML; Hone, P | 1 |
| Fernández-Ruiz, J; Pertwee, RG; Sagredo, O; Satta, V; Valdeolivas, S | 1 |
| Collin, C; Notcutt, W; Serpell, MG | 1 |
| Barnes, AJ; Desrosiers, NA; Gorelick, DA; Huestis, MA; Lee, D; Milman, G; Schwope, DM | 1 |
| Constantinescu, CS; Podda, G | 1 |
| Aalberg, L; Flink, A; Kauppila, TJ; Ketola, RA; Laakkonen, UM | 1 |
| Bonaccorso, S; Brenneisen, R; Englund, A; Feilding, A; Hague, D; Holt, D; Kane, F; Kapur, S; Morrison, PD; Murray, RM; Nottage, J; Reichenberg, A; Stone, JM; Walker, L | 1 |
| Altman, DG; Duncombe, P; Wright, S | 1 |
| Guy, GW; Stott, CG; White, L; Wilbraham, D; Wright, S | 2 |
| Lang, IA; Lu, L; Pearce, H; Roome, C; Shearer, J; Stein, K | 1 |
| Dashney, B; Limebeer, CL; O'Brien, LD; Parker, LA; Rock, EM; Segsworth, B; Wills, KL | 1 |
| Di Marzo, V; Skaper, SD | 1 |
| Deiana, S | 1 |
| Barnes, AJ; Goodwin, RS; Huestis, MA; Karschner, EL; Lee, D; Milman, G | 1 |
| Langford, RM; Mares, J; Notcutt, W; Novakova, I; Novotna, A; Ratcliffe, S; Vachova, M | 1 |
| Gramstad, L; Sagabråten, AS | 1 |
| Aberturas, Mdel R; García-Taboada, E; Gil-Alegre, ME; Hernán Pérez de la Ossa, D; Lorente, M; Molpeceres, J; Torres, S; Torres-Suárez, AI; Velasco, G | 1 |
| Trojano, M | 3 |
| García-Merino, A | 1 |
| Flachenecker, P | 2 |
| Florek, E; Piekoszewski, W; Tkaczyk, M | 1 |
| Casarejos, MJ; de Yebenes, JG; Fernandez Ruiz, J; Fernandez-Estevez, M; Gomez, A; Guzman, M; Mena, MA; Muñoz, MP; Perucho, J; Sagredo, O | 1 |
| Desrosiers, NA; Gorelick, DA; Huestis, MA; Karschner, EL; Scheidweiler, KB; Schwope, DM | 1 |
| Taffe, MA; Vandewater, SA; Wright, MJ | 1 |
| Hazekamp, A; Heerdink, ER | 1 |
| Constantinescu, CS; Tanasescu, R | 1 |
| Cesar-Rittenberg, P; Hohmann, AG; Lynch, ME | 1 |
| Ben-Nun, A; Juknat, A; Kaushansky, N; Kozela, E; Rimmerman, N; Vogel, Z | 1 |
| Feliszek, M; Ilayan, E; Malinowska, B; Schlicker, E | 1 |
| Mechoulam, R; Parker, L | 1 |
| Boscá Blasco, I; Casanova-Estruch, B; Escutia Roig, M; Gil Gómez, I; Lorente Fernández, L; Monte Boquet, E; Pérez-Miralles, F; Poveda Andrés, JL | 1 |
| Andrade, MA; Baetas, AC; Batista, J; Borges, RS; da Silva, AB; Honório, KM; Orestes, E; Viana, RB | 1 |
| Amato, MP; Koehler, J; Lycke, J; Oreja-Guevara, C | 1 |
| Feneberg, W; Koehler, J; Meier, M; Pöllmann, W | 1 |
| Ehler, E; Hovorka, J; Lauder, H; Ratcliffe, S; Schofield, M; Serpell, M; Taylor, L | 1 |
| Allsop, DJ; Booth, J; Copeland, J; Dunlop, AJ; Holland, RM; Lintzeris, N; McGregor, IS; Montebello, M; Muhleisen, P; Norberg, MM; Rivas, GR; Sadler, C | 1 |
| Pozzilli, C | 1 |
| Rekand, T | 1 |
| Koehler, J | 1 |
| Flachenecker, P; Henze, T; Zettl, UK | 2 |
| Dulaurent, S; Gaulier, JM; Imbert, L; Lachâtre, G; Morla, A | 1 |
| Erbe, B | 1 |
| de Meijer, E; Staginnus, C; Zörntlein, S | 1 |
| Barnes, AJ; Huestis, MA; Scheidweiler, KB | 1 |
| Shen, H | 1 |
| McKeage, K; Scott, LJ; Syed, YY | 1 |
| Allsop, DJ; Copeland, J; Fu, S; Lewis, J; Molnar, A | 1 |
| Benyamina, A; Reynaud, M | 1 |
| de Lago, E; Espejo-Porras, F; Fernández-Ruiz, J; Moreno-Martet, M | 1 |
| Brunt, TM; Höner-Snoeken, K; Niesink, RJ; van de Velde, MJ; van Genugten, M | 1 |
| Abood, ME; Brailoiu, E; Brailoiu, GC; Console-Bram, L; Sharir, H | 1 |
| Curran, HV; Das, RK; Freeman, TP; Hindocha, C; Morgan, CJ; Schafer, G | 1 |
| Anizan, S; Barnes, AJ; Bergamaschi, MM; Desrosiers, N; Gorelick, DA; Huestis, MA; Lee, D; Milman, G | 1 |
| Ambach, L; Bernhard, W; Broillet, A; König, S; Penitschka, F; Weinmann, W | 1 |
| Fišar, Z; Hroudová, J; Singh, N | 1 |
| Essner, U; Freidel, M; Lang, M; Prechtl, A; Schreiber, H; Tiel-Wilck, K | 1 |
| Barnes, AJ; Huestis, MA; Lee, D; Mendu, DR; Murray, JA; Vandrey, R | 1 |
| Sirven, JI | 1 |
| Atakan, Z; Bhattacharyya, S; Brammer, M; Crippa, JA; Falkenberg, I; Giampietro, V; Martin-Santos, R; McGuire, P | 1 |
| Di Marzo, V; Duncan, M; McPartland, JM; Pertwee, RG | 1 |
| Arie, S; Mahony, C | 1 |
| Ehler, E; Hoggart, B; Hovorka, J; Lauder, H; Lejčko, J; Ratcliffe, S; Serpell, M; Simpson, KH; Taylor, L | 1 |
| Arroyo, R; Dechant, KL; Vila, C | 1 |
| Centonze, D | 1 |
| Fernández, O | 3 |
| Celius, EG; Donzé, C; Izquierdo, G; Patti, F; Pöhlau, D; Trojano, M | 1 |
| Bebin, EM; Szaflarski, JP | 1 |
| Broyd, SJ; Hazekamp, A; Solowij, N; van Hell, HH | 1 |
| Garcia-Merino, A; Moreno Torres, I; Sanchez, AJ | 1 |
| Colombo, C; Mosconi, P | 1 |
| Batt, S | 1 |
| Basinski, H; Jensen, HB; Stenager, E | 1 |
| Dalgleish, AG; Liu, WM; Scott, KA | 1 |
| Creehan, KM; Taffe, MA; Vandewater, SA | 1 |
| Desrosiers, NA; Huestis, MA; Scheidweiler, KB | 1 |
| Centonze, D; Di Marzo, V | 1 |
| Crippa, JA; dos Santos, RG; Hallak, JE; Leite, JP; Zuardi, AW | 1 |
| Kramer, JL | 1 |
| Curran, HV; Das, RK; Freeman, TP; Gardener, C; Hindocha, C; Morgan, CJ; Schafer, G | 1 |
| Brunt, T; van Amsterdam, J; van den Brink, W | 1 |
| Cawthorne, M; Di Marzo, V; Guadagnino, I; Martella, A; Melck, D; Motta, A; Paris, D; Silvestri, C | 1 |
| Berger, WT; Deutsch, DG; Elmes, MW; Kaczocha, M; Leung, K; Miyauchi, JT; Ojima, I; Ralph, BP; Sweeney, JM; Tsirka, SE; Wang, L | 1 |
| Fowler, CJ | 1 |
| Armstrong, JL; Babatunde, F; Corazzari, M; Eleni Anagnostou, M; Hernandez-Tiedra, S; Hill, DS; Lopez-Valero, I; Lorente, M; Lovat, PE; McKee, CS; Redfern, CPF; Velasco, G | 1 |
| Bramanti, P; Calabrò, RS; D'Aleo, G; De Luca, R; Leo, A; Naro, A; Quartarone, A; Rifici, C; Russo, M; Sessa, E | 1 |
| Cimas-Hernando, I; Lorenzo-González, JR; Pato-Pato, A; Rodríguez-Constenla, I | 1 |
| Degenhardt, L; Hall, W | 1 |
| Ruiz, L; Slof, J; Vila, C | 1 |
| Allsop, DJ; Copeland, J; Dunlop, A; Lintzeris, N; McGregor, IS | 1 |
| Reardon, S | 2 |
| Bertoglio, LJ; Galve-Roperh, I; Gazarini, L; Guimaraes, FS; Stern, CA; Takahashi, RN; Vanvossen, AC; Zuardi, AW | 1 |
| Hamilton, I | 1 |
| Lebrun, C; Vermersch, P | 1 |
| Hagerty, SL; Hutchison, KE; Mittal, VA; Williams, SL | 1 |
| Carrillo-Salinas, FJ; de Lago, E; Feliú, A; Fernández-Ruiz, J; Guaza, C; Mecha, M; Moreno-Martet, M | 1 |
| Bramanti, P; Calabrò, RS; D'Aleo, G; Rifici, C; Russo, M; Sessa, E | 1 |
| Parker, LA; Rock, EM | 2 |
| Barrett, DA; Constantinescu, CS; Fischer, PM; Gershkovich, P; Sabri, A; Wong, JC; Zgair, A | 1 |
| Peschel, W; Politi, M | 1 |
| Laprevote, V; Rolland, B; Schwan, R; Schwitzer, T; Thome, J | 1 |
| Dechant, KL; Meuth, SG; Vila, C | 1 |
| Brunt, TM; Koeter, MW; Niesink, RJ; Rigter, S | 1 |
| Cocco, E; Coghe, G; Corona, F; Fenu, G; Frau, J; Lorefice, L; Mamusa, E; Marrosu, MG; Massa, R; Massole, S; Musu, L; Pau, M; Spinicci, G | 1 |
| Andrews, R; Murphy, KG; Nahar, L; Paterson, S | 1 |
| Amadio, S; Comi, G; Del Carro, U; Houdayer, E; Leocani, L; Martinelli, V; Nuara, A; Rossi, P; Schiavetti, I; Sormani, MP; Straffi, L; Vila, C | 1 |
| Devinsky, O; Friedman, D | 1 |
| Arnold, JC; Todd, SM | 1 |
| Pain, S | 1 |
| Owens, B | 1 |
| Colombo, B; Comi, G; Esposito, F; Ferrè, L; Keller Sarmiento, IJ; Leocani, L; Martinelli Boneschi, F; Martinelli, V; Moiola, L; Nuara, A; Pavan, G; Radaelli, M; Rodegher, M | 1 |
| Dalgleish, AG; Dennis, JL; Liu, WM; Scott, KA | 1 |
| Bazinski, H; Jensen, HB; Stenager, E | 1 |
| Trojano, M; Vila, C | 1 |
| Carrillo-Salinas, FJ; de Lago, E; Espejo-Porras, F; Feliú, A; Fernández-Ruiz, J; Guaza, C; Mecha, M; Moreno-Martet, M | 1 |
| D'Onghia, M; Di Lecce, V; Direnzo, V; Iaffaldano, A; Manni, A; Paolicelli, D; Tortorella, C; Trojano, M; Zoccolella, S | 1 |
| Babalonis, S; Bedi, G; Cooper, ZD; Gray, KM; Haney, M; Lofwall, MR; Malcolm, RJ; McRae-Clark, A; Nuzzo, PA; Sparenborg, S; Walsh, SL | 1 |
| Broughton, J; Gras, A | 1 |
| Fornito, A; Lorenzetti, V; Lubman, DI; Solowij, N; Suo, C; Takagi, MJ; Yücel, M; Zalesky, A | 1 |
| Bramanti, P; Calabrò, RS; D'Aleo, G; Leo, A; Naro, A; Russo, M; Sessa, E | 1 |
| Ablin, J; Fitzcharles, MA; Häuser, W; Schäfer, M; Ste-Marie, PA | 1 |
| Radbruch, L; Schäfer, M | 1 |
| Lorenzetti, V; Solowij, N; Yücel, M | 1 |
| Martin, JH; Reuter, SE | 1 |
| Andrés-Benito, P; Aso, E; Carmona, M; Ferrer, I; Maldonado, R | 1 |
| Patti, F | 2 |
| Barnes, AJ; Fischer, B; Gamaleddin, I; Huestis, MA; Lagzdins, D; Le Foll, B; Rehm, J; Selby, P; Trigo, JM | 1 |
| Abbruzzese, G; Bandini, F; Canneva, S; Capello, E; Colombano, F; Currà, A; Fattapposta, F; Marinelli, L; Mori, L; Trompetto, C | 1 |
| Fu, S; Molnar, A | 1 |
| Barbera, N; Indorato, F; Ledda, C; Liberto, A; Romano, G | 1 |
| Alonso Arias, MA; Fernández Ruiz, J; Galve-Roperh, I; García Caldentey, J; García de Yébenes Prous, J; García de Yébenes, MJ; García Ribas, G; García-Bermejo, ML; Guzmán, M; López-Sendón Moreno, JL; Ortega-Gutierrez, S; Resel, E; Ruiz Romero, C; Sagredo, O; Tolón, RM; Trigo Cubillo, P; Valdeolivas, S | 1 |
| Álvarez-Ossorio, L; Haupts, M; Jonas, A; Vila, C; Witte, K | 1 |
| Amato, MP; Bergamaschi, R; Bonavita, S; Brescia Morra, V; Bruno Bossio, R; Cavalla, P; Centonze, D; Comi, G; Costantino, GF; Cottone, S; Danni, M; Francia, A; Gajofatto, A; Gasperini, C; Ghezzi, A; Iudice, A; Lus, G; Maniscalco, GT; Marrosu, MG; Matta, M; Messina, S; Mirabella, M; Montanari, E; Patti, F; Pozzilli, C; Rovaris, M; Sessa, E; Solaro, C; Spitaleri, D; Trojano, M; Valentino, P; Zappia, M | 1 |
| Comi, G; Gold, R; Hartung, HP; Montalban, X; Otero-Romero, S; Sastre-Garriga, J; Soelberg Sørensen, P; Thompson, AJ; Vermersch, P | 1 |
| ElSohly, MA; Gul, W; Harris, HM; Sufka, KJ | 1 |
| Barnes, AJ; Huestis, MA; Newmeyer, MN; Scheidweiler, KB | 1 |
| ElSohly, MA; Fasinu, PS; Phillips, S; Walker, LA | 1 |
| McMahon, LR | 1 |
| Erdmann, F; Heinl, S; Lerch, O | 1 |
| Gajofatto, A | 1 |
| Bramanti, P; Calabrò, RS; De Luca, R; Naro, A; Rifici, C; Russo, M; Sessa, E; Torrisi, M | 1 |
| Aroni, K; Bacci, M; Fucci, N; Gambelunghe, C; Marcelli, A; Rossi, R | 1 |
| Brunetti, A; Carotenuto, A; Cerillo, I; Cocozza, S; Inglese, M; Iodice, R; Manganelli, F; Orefice, G; Petracca, M; Saiote, C; Tedeschi, E | 1 |
| Brescia Morra, V; Carotenuto, A; Florio, EB; Lanzillo, R; Massarelli, M; Pane, C; Saccà, F | 1 |
| Andersson, M; Huestis, MA; Scheidweiler, KB; Sempio, C; Swortwood, MJ | 1 |
| Bird, R; Evans, L; Trainor, D | 1 |
| Barrett, DA; Bell, JD; Jadoon, KA; O'Sullivan, SE; Ratcliffe, SH; Stott, C; Tan, GD; Thomas, EL | 1 |
| Bloomfield, MA; Curran, HV; Das, RK; Freeman, TP; Harvey, L; Hindocha, C; Joye, A; Lawn, W; Mokrysz, C; Morgan, CJ; Moss, A; Nutt, DJ; Pope, RA; Wall, MB | 1 |
| Ciccone, CD | 1 |
| Cameriere, R; Cingolani, M; Cippitelli, M; Froldi, R; Ottaviani, G; Tassoni, G; Zampi, M | 1 |
| Bergman, J; Jacobs, DS; Jiang, S; Kohut, SJ; Makriyannis, A; Nikas, SP | 1 |
| Trojano, M; Vermersch, P | 1 |
| Deotto, L; Donato, F; Erro, R; Moretto, G; Squintani, G; Teatini, F; Turri, M | 1 |
| Poklis, A; Poklis, JL; Wolf, CE | 1 |
| Anand, L; Furtado, M; Katzman, MA | 1 |
| Bachs, L; Bramness, JG; Bretteville-Jensen, AL; Mørland, J; Vindenes, V | 1 |
| Filli, L; Ghezzi, A; Landete, L; Lycke, J; Mekies, C; Solaro, C | 1 |
| Ghezzi, A | 1 |
| Osborne, AL; Solowij, N; Weston-Green, K | 1 |
| Arnold, JC; Bahceci, D; Chohan, TW; Clarke, DJ; Todd, SM; Zhou, C | 1 |
| Andrenyak, DM; Haney, M; Moody, DE; O'Leary, DS; Slawson, MH | 1 |
| Friedman, D; Gaston, TE | 1 |
| Friedman, D; Sirven, JI | 1 |
| Allendorfer, JB; Szaflarski, JP | 1 |
| de Freitas, L; Mammen, G; Rehm, J; Rueda, S | 1 |
| Mead, A | 1 |
| Laviolette, SR; Norris, C; Renard, J; Rushlow, W | 1 |
| Devinsky, O; Gloss, D; O'Connell, BK | 1 |
| Jouanjus, E; Wolff, V | 1 |
| Adams, WK; Hill, MN; Morena, M; Silveira, MM; Winstanley, CA | 1 |
| Casas, M; Centonze, D; Henze, T; Maccarrone, M; Maldonado, R | 1 |
| Keating, GM | 1 |
| Di Marzo, V; Izzo, AA; Lauritano, A; Pagano, E; Piscitelli, F | 1 |
| Androvicova, R; Balikova, M; Hlinka, J; Hlozek, T; Horacek, J; Jezova, D; Kuchar, M; Miksatkova, P; Palenicek, T; Roman, M; Rydlo, J; Tintera, J; Tomicek, P; Tyls, F; Viktorinova, M | 1 |
| Arellano, AL; Farré, M; Papaseit, E; Romaguera, A; Torrens, M | 1 |
| Limebeer, CL; Mechoulam, R; Parker, LA; Petrie, GN; Rock, EM; Williams, LA | 1 |
| Britch, SC; Clowers, BH; Craft, RM; Wiley, JL; Yu, Z | 1 |
| Bachs, L; Brochmann, GW; Havig, SM; Høiseth, G; Karinen, RA; Strand, DH; Strand, MC; Vindenes, V | 1 |
| Carmona, NE; Cha, DS; Ho, RC; Lee, Y; Mansur, RB; McIntyre, RS; Ragguett, RM; Rong, C; Rosenblat, JD | 1 |
| King, KM; Myers, AM; Soroka-Monzo, AJ; Tallarida, RJ; Tuma, RF; Walker, EA; Ward, SJ | 1 |
| Alabajos-Cea, A; Manez-Anon, I; Montalva-Iborra, A; Roda-Alcayde, C | 1 |
| Hasselstrøm, JB; Sørensen, LK | 1 |
| Callesen, MB; Feldstein Ewing, SW; Rømer Thomsen, K | 1 |
| Carlsen, S; Carvalho, Â; Hansen, EH; Kayser, O; Stehle, F | 1 |
| Clasen, MM; Hempel, BJ; Pomfrey, RL; Riley, AL; Taylor, WW; Wakeford, AGP; Wetzell, BB | 1 |
| Bianco, A; De Fino, C; Losavio, F; Lucchini, M; Mirabella, M; Nociti, V; Sabino, A; Santoro, M | 1 |
| Cherniakov, I; Domb, AJ; Hoffman, A; Izgelov, D | 1 |
| Bergamaschi, R; Bonavita, S; Bossio, RB; Brescia Morra, V; Castelli, L; Cavalla, P; Centonze, D; Comi, G; Costantino, G; Cottone, S; Danni, MC; Francia, A; Gajofatto, A; Gasperini, C; Granata, A; Maniscalco, GT; Matta, M; Messina, S; Mirabella, M; Paolicelli, D; Patti, F; Pedà, G; Petrucci, L; Righini, I; Rovaris, M; Sessa, E; Signoriello, E; Solaro, C; Spinicci, G; Spitaleri, D; Zaffaroni, M; Zappia, M | 1 |
| Zhu, YP | 1 |
| Boggs, DL; Morgenson, D; Nguyen, JD; Ranganathan, M; Taffe, MA | 1 |
| Abbruzzese, G; Balestrino, M; Currà, A; Fattapposta, F; Gandolfo, C; Giorello, L; Marinelli, L; Mori, L; Puce, L; Rosa, GM; Serrati, C; Trompetto, C | 1 |
| Atwal, N; Casey, SL; Vaughan, CW | 1 |
| Barasch, D; Cherniakov, I; Davidson, E; Domb, AJ; Hoffman, A; Izgelov, D | 1 |
| Fallon, MT; Kornyeyeva, E; Lichtman, AH; Lux, EA; McQuade, R; Rossetti, S; Sanchez, R; Sun, W; Wright, S | 1 |
| Giner-Pascual, M; Gonzalez, LM; Grao-Castellote, C; Torralba-Collados, F | 1 |
| Aviram, J; Samuelly-Leichtag, G | 1 |
| de Haan, L; Dekker, M; Schipper, R; van den Brink, W | 1 |
| Aponte, R; Bruzzese, D; Chiariello, F; Florio, C; Guarcello, G; Maniscalco, GT; Manzo, V; Moreggia, O; Napolitano, M | 1 |
| Bramanti, P; Giacoppo, S; Mazzon, E | 1 |
| Alageel, A; Almatham, F; Carmona, NE; Ho, RC; Lee, YL; Mansur, R; McIntyre, RS; Pan, Z; Ragguett, RM; Rong, C; Rosenblat, JD; Shekotikhina, M; Subramaniapillai, M | 1 |
| Carty, DR; Gledhill, JH; Thornton, C; Willett, KL | 1 |
| Atsmon, J; Deutsch, F; Deutsch, L; Heffetz, D; Sacks, H | 1 |
| Balíková, M; Hložek, T; Horsley, RR; Kadeřábek, L; Kuchař, M; Lhotková, E; Nováková, P; Páleníček, T; Šíchová, K; Štefková, K; Tylš, F; Uttl, L | 1 |
| Häuser, W; Krcevski-Skvarc, N; Wells, C | 1 |
| Izquierdo, G | 1 |
| Linker, R | 1 |
| Bramanti, A; Bramanti, P; Calabrò, RS; Ciurleo, R; Dattola, V; De Luca, R; Logiudice, AL; Naro, A; Russo, M; Sessa, E | 1 |
| Lötsch, J; Tegeder, I; Weyer-Menkhoff, I | 1 |
| Lewis, MA; Russo, EB; Smith, KM | 1 |
| Antinori, L; Corlazzoli, D; Graziano, S; Pellegrini, M; Pichini, S; Porcarelli, L; Rotolo, MC | 1 |
| Deng, K; Fu, Q; Luo, X; Shu, Z; Zeng, CG | 1 |
| Ameline, A; Berthelon, L; Eibel, A; Farrugia, A; Feisthauer, E; Geraut, A; Gheddar, L; Kintz, P; Raul, JS | 1 |
| Groppi, A; Liso, M; Morini, L; Porro, G | 1 |
| Cannazza, G; Citti, C; Forni, F; Licata, M; Manca, L; Palazzoli, F; Vandelli, MA; Vilella, A; Zoli, M | 1 |
| Abdel Salam, RA; Ahmed, SA; Chandra, S; ElSohly, MA; Gul, SW; Gul, W; Hadad, GM; Ibrahim, AK; Ibrahim, EA; Lata, H; Radwan, MM; Stamper, BJ | 1 |
| Appendino, G; Caprioglio, D; De Petrocellis, L; Marotta, P; Moriello, AS; Pollastro, F; Taglialatela-Scafati, O | 1 |
| Atsmon, J; Cherniakov, I; Deutsch, F; Deutsch, L; Domb, AJ; Heffetz, D; Hoffman, A; Izgelov, D; Sacks, H | 1 |
| MacCallum, CA; Russo, EB | 1 |
| Barnes, AJ; Fischer, B; George, TP; Huestis, MA; Le Foll, B; Quilty, LC; Rehm, J; Selby, P; Soliman, A; Staios, G; Streiner, DL; Trigo, JM | 1 |
| Cosenza, A; Di Gaudio, F; Fanara, S; Maida, CM; Piscionieri, D; Viviani, G | 1 |
| Di Forti, M; Hammond, K; Potter, DJ; Tuffnell, S; Walker, C | 1 |
| Buckley, N; Degenhardt, L; Farrell, M; Germanos, R; Hall, W; Nielsen, S; Pollard, J; Weier, M | 1 |
| Asbridge, M; Brubacher, JR; Chan, H; Erdelyi, S; Mann, RE; Purssell, RA; Solomon, R | 1 |
| Häuser, W; Mücke, M; Petzke, F; Phillips, T; Radbruch, L | 1 |
| Benigni, F; Clarelli, F; Comi, G; Esposito, F; Ferrè, L; Martinelli Boneschi, F; Martinelli, V; Mascia, E; Osiceanu, AM; Sorosina, M; Unal, NT | 1 |
| Castelli, L; Pozzilli, C; Prosperini, L | 1 |
| Angelo, C | 1 |
| Djamshidian, A; Heim, B; Lücke, T; Peball, M; Saft, C; Seppi, K; Thiels, C; von Hein, SM | 1 |
| Constantinescu, CS; Gershkovich, P | 1 |
| Achenbach, JC; Berrue, F; Ellis, LD; Hill, J; Hui, JPM; Morash, MG | 1 |
| Clasen, MM; Hempel, BJ; Nelson, KH; Riley, AL; Woloshchuk, CJ | 1 |
| Cuttler, C; McLaughlin, RJ; Spradlin, A | 1 |
| Cantello, R; Danni, MC; Lus, G; Rini, A; Sarchielli, P; Signoriello, E; Tassinari, T | 1 |
| Grof, CPL | 1 |
| Baranowski, DC; Buchanan, B; Gabriele, J; Meng, Q; Poulin, MM; Zuccolo, J | 1 |
| Crestani, F | 1 |
| Celius, EG; Vila, C | 1 |
| Liu, Z; Martin, JH | 1 |
| Allsop, DJ; Bhardwaj, AK; Bruno, R; Copeland, J; Dunlop, A; Gugusheff, J; Jackson, M; Lintzeris, N; Luksza, J; McGregor, IS; Montebello, M; Phung, N; Sadler, C; Shanahan, M | 1 |
| Akmaz, B; Essner, U; Lentschat, A; Marinelli, M; Markovà, J; Trompke, C; Vila, C | 1 |
| Daniel, RT; Maduri, R; Messerer, M; Pralong, E | 1 |
| Mallada Frechín, J | 1 |
| Allen, N; Chioma, VC; Garcia-Keller, C; Kalivas, PW; Neuhofer, D; Ortiz-Ithier, T; Schwartz, DJ; Scofield, MD; Spencer, S | 1 |
| Flor, H; Grimm, O; Hartmann, A; Kamping, S; Leweke, M; Löffler, M; Rohleder, C | 1 |
| Cole, M; Grant, Y; Javadi-Paydar, M; Kerr, TM; Nguyen, JD; Taffe, MA; Vandewater, SA | 1 |
| Cameron, M; Rice, J | 1 |
| Groessl, M; Hädener, M; Kamrath, MZ; Weinmann, W | 1 |
| Galettis, P; Lucas, CJ; Schneider, J | 1 |
| Ahmed, KT; Ali, DW; Amin, MR; Shah, P | 1 |
| Abdallah, SJ; Bourbeau, J; Jensen, D; Li, PZ; Moore, M; Smith, BM; Ware, MA | 1 |
| Kawohl, W; Pichler, EM; Roser, P; Seifritz, E | 1 |
| García-Taboada, E; Guzmán, M; Hernández-Tiedra, S; López-Valero, I; Lorente, M; Salazar-Roa, M; Sepúlveda, JM; Torres, S; Velasco, G | 1 |
| Bramness, JG; Dom, G; Gual, A; Mann, K; Wurst, FM | 1 |
| Cannazza, G; Citti, C; Forni, F; Leo, G; Licata, M; Pacchetti, B; Palazzoli, F; Vandelli, MA; Vilella, A; Zoli, M | 1 |
| Andresen-Streichert, H; Beike, J; Kieliba, T; Lerch, O; Rothschild, MA | 1 |
| Curran, HV; Freeman, TP; Gardner, C; Hindocha, C; Morgan, CJA; Schafer, G | 1 |
| Barba, M; Dávila, D; García-Taboada, E; Guzmán, M; Hernández-Tiedra, S; López-Valero, I; Lorente, M; Rodríguez-Fornés, F; Saiz-Ladera, C; Salvador-Tormo, N; Sánchez-Gómez, P; Sepúlveda, JM; Torres, S; Velasco, G | 1 |
| Aghmesheh, M; Allsop, DJ; Briscoe, K; Clarke, S; Fox, P; Gedye, C; Grimison, P; Haber, PS; Hahn, C; Kirby, AC; Lintzeris, N; McGregor, I; Mersiades, AJ; Morton, RL; Olver, I; Simes, J; Stockler, M; Tognela, A; Walsh, A; Wong, N | 1 |
| Campíns-Falcó, P; Herráez-Hernández, R; Jornet-Martínez, N; Ortega-Sierra, A; Verdú-Andrés, J | 1 |
| Madras, BK | 1 |
| Arroyo González, R | 1 |
| Clowers, BH; Craft, RM; Greene, NZ; Wiley, JL; Yu, Z | 1 |
| Benyamina, A; Desterke, C; Lafaye, G; Marulaz, L | 1 |
| Dolgin, E | 1 |
| Duipmans, JC; Jonkman, MF; Molenbuur, B; Schräder, NHB; Wolff, AP | 1 |
| Chande, N; Kafil, TS; MacDonald, JK; Nguyen, TM | 3 |
| Bizon, JL; Blaes, SL; Bruijnzeel, AW; Bruner, MM; Febo, M; Ferguson, SN; Heshmati, SC; Holik, HM; Orsini, CA; Setlow, B; Stubbs, TD; Wall, SC | 1 |
| Allman, BL; Desai, SJ; Jobson, CEL; Laviolette, SR; Norris, C; Pereira, B; Rajakumar, N; Renard, J; Szkudlarek, HJ | 1 |
| Bradshaw, H; Daily, L; Leishman, E; Miller, S; Straiker, A | 1 |
| Comi, G; Comola, M; Falzone, Y; Fazio, R; Ferraro, OE; Leocani, L; Lunetta, C; Mora, G; Riva, N; Sorarù, G | 1 |
| de Visser, M | 1 |
| Chericoni, S; Giorgi, M; Lisowski, A; Owen, H; Poapolathep, A; Stefanelli, F; Łebkowska-Wieruszewska, B | 1 |
| Dahan, A; Kowal, MA; Niesters, M; Olofsen, E; van de Donk, T; van Velzen, M | 1 |
| Carty, DR; Kutchma, ML; Miller, ZS; Pandelides, Z; Thornton, C; Willett, KL | 1 |
| Ziemssen, T | 1 |
| Marková, J | 1 |
| Brouillette, MJ; Chomont, N; Costiniuk, CT; Cox, J; Jenabian, MA; Klein, MB; Lebouché, B; Mandarino, E; Margolese, S; Routy, JP; Saneei, Z; Singer, J; Szabo, J | 1 |
| Broyd, S; Croft, R; Galettis, P; Greenwood, LM; Jones, A; Liu, Z; Martelozzo, D; Martin, J; Michie, PT; Murray, R; Rueb, K; Solowij, N; Todd, J; van Hell, H | 1 |
| Friemel, CM; Hasan, A; Hoch, E; Niemann, D; Pogarell, O; Preuss, UW; Schneider, M; von Keller, R | 1 |
| Almogi-Hazan, O; Khuja, I; Or, R; Yekhtin, Z | 1 |
| Coppola, G; Gao, F; Juknat, A; Kozela, E; Vogel, Z | 1 |
| Lederman, IR; Morean, ME | 1 |
| Jay, TM; Kebir, O; Krebs, MO | 1 |
| Brockelman, F; Hall, B; Keeling, K; Stith, SS; Vigil, JM | 1 |
| Koltai, H; Namdar, D; Poulin, P | 1 |
| DiFrancesco, R; Hagler, CE; Lombardo, J; Morse, GD; Ocque, AJ | 1 |
| Martinez, AE | 1 |
| Busardò, FP; Giorgetti, R; Huestis, MA; Pacifici, R; Pellegrini, M; Pichini, S; Rotolo, MC; Tagliabracci, A | 1 |
| Bloomfield, MA; Curran, HV; Demetriou, L; Feilding, A; Freeman, AM; Freeman, TP; Hindocha, C; Kowalczyk, OS; Lawn, W; Mokrysz, C; Nutt, D; Pope, R; Wall, MB | 1 |
| Bloomfield, MAP; Bramon, E; Curran, HV; Freeman, TP; Gardner, C; Hindocha, C; Morgan, CJA; Schafer, G | 1 |
| Arkell, TR; Haber, PS; Irwin, C; Kevin, RC; Lintzeris, N; McGregor, IS; Ramaekers, JG; Vandrey, R | 1 |
| Bonn-Miller, MO; Spindle, TR; Vandrey, R | 1 |
| Brown, PN; Mudge, EM; Murch, SJ | 1 |
| Müller, CE | 1 |
| Mendes, A | 1 |
| Andersen, TE; Bachmann, AG; Bojesen, AB; Christiansen, AA; Ellingsen, T; Hauge, EM; Hendricks, O; Horsted, TI; Krogh, NS; Loft, AG; Lund Hetland, M; Petersen, KH; Primdahl, J; Roessler, KK; Østergaard, M | 1 |
| Maggio, N; Stein, ES; Yao, I | 1 |
| Bussick, D; Eckert-Lill, C; Hörnig, M; Kiefer, A; Reimann, H | 1 |
| Alessi-Severini, S; Alkabbani, W; Bolton, JM; Bugden, S; Daeninck, P; Leong, C; Marrie, RA | 1 |
| Ernst, L; Kellogg, M; Kerr, A; Walston, V; Wong, VSS | 1 |
| Broyd, SJ; de Krey, P; Galettis, P; Greenwood, LM; Liu, Z; Martin, JH; Schneider, J; Solowij, N; Steigler, A; van Hell, H; Zhu, X | 1 |
| Dunn, JN; Sargeant, JM; Stevens, CPG; Vogt, NA | 1 |
| Chow, AM; de Costa, F; Deshmukh, K; Hacke, ACM; Kerman, K; Li, N; Lima, D; Marques, JA; Pereira, RP | 1 |
| Ali, DW; Amin, MR | 1 |
| Beezhold, DH; Couch, JR; Glassford, EK; Green, BJ; Grimes, GR; Jackson, SR; Lemons, AR; Wiegand, DM; Zwack, LM | 1 |
| Chung, H; Fierro, A; Pessoa-Mahana, CD | 1 |
| Creehan, KM; Javadi-Paydar, M; Kerr, TM; Taffe, MA | 1 |
| Al-Ghezi, ZZ; Alghetaa, H; Busbee, PB; Nagarkatti, M; Nagarkatti, PS | 1 |
| Bianco, A; Castelli, L; Centonze, D; Cortese, A; Crisafulli, SG; De Giglio, L; Galgani, S; Grimaldi, AE; Haggiag, S; Marfia, G; Mirabella, M; Monteleone, F; Pozzilli, C; Prosperini, L | 1 |
| Burggren, AC; Ginder, N; London, ED; Shirazi, A | 1 |
| Choi, SH; Mou, Y; Silva, AC | 1 |
| Cao, Y; Pacula, RL; Shang, C; Shi, Y | 1 |
| Arbus, MS; Beliveau, JN; Casarett, DJ | 1 |
| Berretta, P; Busardò, FP; Mannocchi, G; Pacifici, R; Pichini, S; Pirani, F; Zaami, S | 1 |
| Domb, AJ; Hoffman, A; Itin, C | 1 |
| Arkell, TR; Haber, PS; Kevin, RC; Lintzeris, N; McGregor, IS; Ramaekers, JG; Stuart, J | 1 |
| Worth, T | 1 |
| Drew, L | 1 |
| Nguyen, T | 1 |
| Funke, A; Kettemann, D; Maier, A; Meyer, T; Münch, C; Spittel, S; Thomas, A; Walter, B | 1 |
| Al-Ghezi, ZZ; Miranda, K; Nagarkatti, M; Nagarkatti, PS | 1 |
| Brockelman, F; Hall, B; Keeling, K; Li, X; Stith, SS; Vigil, JM | 1 |
| Fitzgerald, RL; Grant, I; Grelotti, DJ; Hoffman, MA; Hubbard, JA; Huestis, MA; Kim, S; Marcotte, TD; Smith, BE; Sobolesky, PM; Stone, J | 1 |
| Chapman, KE; Galinkin, J; Helmkamp, LJ; Jost, K; Knupp, KG; Rice, JD; Sempio, C | 1 |
| Bar-Lev Schleider, L; Konikoff, FM; Lish, I; Naftali, T; Ringel, Y; Sklerovsky Benjaminov, F | 1 |
| Hudson, R; Laviolette, SR; Norris, C; Renard, J; Rushlow, WJ | 1 |
| Curran, HV; Freeman, AM; Freeman, TP; Hindocha, C; Lees, R; Mokrysz, C; Petrilli, K; Saunders, R | 1 |
| Dicpinigaitis, PV; Fakier, F; Suhrland, MJ; Teka, M; Trachuk, P | 1 |
| Freeman, TP; Lorenzetti, V | 1 |
| Campbell, CM; Caufield-Noll, C; DiRenzo, D; Finan, PH; Gajewski-Nemes, J; Letzen, JE; Mun, CJ; Peters, EN; Vandrey, R | 1 |
| Madaka, F; Monton, C; Settharaksa, S; Songsak, T; Suksaeree, J; Wunnakup, T | 1 |
| Agrati, D; Castro, MJ; Falconi, A; Fernández, S; Garcia-Carnelli, C; Mondino, A; Torterolo, P; Umpierrez, E | 1 |
| Montagnese, F; Schoser, B; Stahl, K; Wenninger, S | 1 |
| Bruera, E; Farinholt, P; Tanco, K | 1 |
| Abrams, DI; Cooper, ZD | 1 |
| Isais-Millán, S; Millán-Guerrero, RO | 2 |
| Mata, D; Meneses, V | 1 |
| Blagev, DP; Dunn, AC; Grissom, CK; Guidry, DW; Harris, D; Lanspa, MJ | 1 |
| Beloate, LN; Chioma, VC; Kalivas, PW; Neuhofer, D; Schwartz, D; Spencer, SM | 1 |
| Borroto Fernandez, E; de Meijer, E; Hackl, G; Menges, S; Peterseil, V; Staginnus, C | 1 |
| Cock, H; Cross, JH | 1 |
| Abraham, AD; Clark, JJ; Kruse, LC; Land, BB; Leung, EJY; Rivera, ZMG; Wong, BA | 1 |
| Bisogno, T; Cristino, L; Di Marzo, V | 1 |
| Asth, L; De Oliveira, AC; Iglesias, LP; Moraes, MFD; Moreira, FA | 1 |
| Boles Ponto, LL; Kamholz, J; Kindred, JH; Rudroff, T; Workman, CD | 1 |
| Holland, JG; Torres, CA | 1 |
| Belardo, C; Cannazza, G; Citti, C; Forni, F; Gigli, G; Laganà, A; Linciano, P; Luongo, L; Maione, S; Montone, CM; Vandelli, MA | 1 |
| Köstenberger, M; Likar, R; Nahler, G | 1 |
| Augsburger, M; Favrat, B; Joye, T; Thomas, A; Widmer, C | 1 |
| Levin, FR; Mariani, JJ | 1 |
| Kleinman, RA; Ostacher, MJ | 1 |
| Bruno, R; Copeland, J; Lintzeris, N | 1 |
| Cross, HJ; Pietrafusa, N; Specchio, N | 1 |
| Highet, BH; Johnson, PW; Kaur, JS; Lesser, ER | 1 |
| Erythropel, HC; Prasse, A; Schupp, JC | 1 |
| Filbey, FM | 1 |
| Chesney, E; Chester, L; Englund, A; Oliver, D; Wilson, J | 1 |
| Hudnall, MT; Nadler, RB; Pham, MN | 1 |
| Kiselak, TD; Koerber, R; Verbeck, GF | 1 |
| Boyer, EW; Casey, A; Levy, S; Smelson, D; Vargas, S | 1 |
| Hill, KP; Levinsohn, EA | 1 |
| Alcacer, J; Camps, C; Carda, C; Carretero, J; Galbis, J; Martín de Llano, JJ; Mata, M; Milian, L; Oliver, M; Sancho-Tello, M | 1 |
| Essner, U; Henze, T; Meuth, SG; Trompke, C; Vila Silván, C | 1 |
| Volkow, ND; Weiss, SRB | 1 |
| Bock, V; Fischer, B; Habel, S; Herbi, F; Lachenmeier, DW; Rajcic de Rezende, T; Sproll, C; Walch, SG; Zerbe, Y | 1 |
| Brescia Morra, V; Carotenuto, A; Costabile, T; De Angelis, M; De Lucia, M; Falco, F; Lanzillo, R; Moccia, M; Petruzzo, M; Russo, CV; Saccà, F | 1 |
| Cortesi, PA; Cozzolino, P; Mantovani, LG; Patti, F | 1 |
| Clauw, DJ; Fitzcharles, MA; Häuser, W | 1 |
| James, TR; Pepple, DJ; Watson, CT | 1 |
| Domb, AJ; Hoffman, A; Izgelov, D; Shmoeli, E | 1 |
| Barnett, SL; Gorab, RS; Luu, AN; Nassif, NA; Patel, JJ; Runner, RP; Scudday, TS | 1 |
| Chimuka, L; Cukrowska, E; Nuapia, Y; Tutu, H | 1 |
| Beck, K; Borgan, F; D'Souza, DC; Ganesh, S; Ginestet, CE; Hindley, G; Howes, OD; Kleinloog, D; McCutcheon, R; Radhakrishnan, R | 1 |
| Dyck, JRB; Ferdaoussi, M; Maayah, ZH; Takahara, S | 1 |
| Lyon, L | 1 |
| Broillet, A; Grafinger, KE; Krönert, S; Weinmann, W | 1 |
| Baldasso, GM; Bicca, MA; Capasso, R; Dutra, RC; Gonçalves, ECD; Paes, RS | 1 |
| Howlett, AC; Kendall, DA; Lichtman, AH; Lu, D; Schurman, LD | 1 |
| Bigelow, GE; Cone, EJ; Flegel, RR; Goffi, E; Mitchell, JM; Spindle, TR; Vandrey, R; Weerts, EM; Winecker, RE | 1 |
| Brown, PN; Deyton, L; ElSohly, MA; Elzinga, S; Giancaspro, GI; Hudalla, C; Johnson, HE; Khan, IA; Kim, NC; Marles, RJ; Melanson, JE; Russo, E; Sarma, ND; Vrdoljak, GA; Waye, A; Wurzer, JH | 1 |
| Chang-Douglass, S; Mulvihill, C; Pilling, S | 1 |
| Boks, MP; Conrod, P; de Witte, LD; Eijk, KV; Elkrief, L; Gastel, WV; He, Y; Hol, EM; Huguet, G; Kahn, RS; Paus, T; Schubart, CD; Vinkers, CH | 1 |
| Alibhai, SMH; Clarke, H; Dai, T; Downar, J; Hanlon, JG; Meng, H | 1 |
| Benedetti, MD; Berra, E; Bianco, A; Bruno Bossio, R; Buttari, F; Castelli, L; Cavalla, P; Cerqua, R; Chisari, CG; Costantino, G; Gasperini, C; Guareschi, A; Ippolito, D; Lanzillo, R; Maniscalco, GT; Matta, M; Paolicelli, D; Patti, F; Petrucci, L; Pontecorvo, S; Righini, I; Russo, M; Saccà, F; Salamone, G; Signoriello, E; Solaro, C; Spinicci, G; Spitaleri, D; Tavazzi, E; Trotta, M; Zaffaroni, M; Zappia, M | 1 |
| Bloomfield, MAP; Curran, HV; Freeman, A; Freeman, TP; Hindocha, C; Lawn, W; Mokrysz, C; Morgan, CJA; Nutt, DJ; Pope, RA; Shaban, NDC; Wall, MB | 1 |
| Checketts, D; Fairhurst, C; Kumar, R; Tayo, B; Turner, S | 1 |
| Brunetti, P; Busardò, FP; Del Rio, A; Pacifici, R; Pichini, S | 1 |
| Arnold, JC; Bartlett, DJ; D'Rozario, AL; Gordon, CJ; Grunstein, RR; Hoyos, CM; Irwin, C; Marshall, NS; McGregor, IS; Suraev, A; Vandrey, R; Wong, K; Yee, BJ | 1 |
| Balletta, T; Bramanti, P; Calabrò, RS; Ciurleo, R; D'Aleo, G; Destro, M; La Via, C; Naro, A; Rifici, C; Russo, M; Sessa, E | 1 |
| Linher-Melville, K; Ma, D; Parihar, V; Parzei, N; Seesankar, G; Shahid, A; Sharma, M; Sidhu, J; Singh, G; Wang, Z; Zacal, N; Zacharias, R; Zhu, YF | 1 |
| Bialer, M; Perucca, E | 1 |
| Carra, A; Fragoso, YD; Macias, MA | 1 |
| Alessandria, G; Bandini, F; Capello, E; Infante, MT; Meli, R; Vestito, L | 1 |
| Abdollahi, M; Baeeri, M; Bayrami, Z; Daghighi, SM; Haghi-Aminjan, H; Khan, F; Moini-Nodeh, S; Rahimifard, M; Rezaee, F; Salami, SA | 1 |
| Hall, W; Nielsen, S | 1 |
| Ashpole, NM; Carty, DR; Dickson, KE; Thornton, C; Willett, KL | 1 |
| Černe, K | 1 |
| Freeman, TP; Frison, G; Salomone, A; Zamengo, L; Zwitser, G | 1 |
| England, TJ; Murphy, AJ; O'Sullivan, SE; Stone, NL | 1 |
| Anderson, LL; Arnold, JC; Low, IK; McGregor, IS | 1 |
| Gogna, G; Good, P; Greer, R; Hardy, J; Haywood, A; Martin, J; Yates, P | 1 |
| Cantello, R; Naldi, P; Spagarino, A; Varrasi, C; Vecchio, D; Virgilio, E | 1 |
| Rubin, BK; Shinbashi, M | 1 |
| Annunziata, P; Bergamaschi, R; Bianco, A; Bonavita, S; Brescia Morra, V; Bruno Bossio, R; Capello, E; Castelli, L; Cavalla, P; Centonze, D; Chisari, CG; Costantino, G; Cottone, S; Danni, MC; Esposito, F; Gajofatto, A; Gasperini, C; Guareschi, A; Lanzillo, R; Lus, G; Maniscalco, GT; Matta, M; Paolicelli, D; Patti, F; Petrucci, L; Pontecorvo, S; Righini, I; Rovaris, M; Sessa, E; Solaro, C; Spinicci, G; Spitaleri, D; Valentino, P; Zaffaroni, M; Zappia, M | 1 |
| Deabold, KA; Gamble, LJ; Hannon, MB; Iqbal, A; Lyubimov, A; Talsma, BN; Wakshlag, JJ; Zakharov, A | 1 |
| Astbury, D; Baio, G; Bloomfield, MAP; Craft, S; Curran, HV; Freeman, AM; Freeman, TP; Hindocha, C; Kinghorn, J; Lees, R; Mofeez, A; Morgan, CJA; Morrison, PD; O'Ryan, D; Shaban, NDC; Thomas, EM | 1 |
| Bouso, JC; Crippa, JAS; Hallak, JEC; Morgan, CJA; Osório, FL; Rocha, JM; Rossi, GN; Santos, RGD; Zuardi, AW | 1 |
| Brizzi, A; Cerretani, D; Collodel, G; Fiaschi, AI; Menchiari, A; Micheli, L; Moltoni, L; Moretti, E | 1 |
| Bhardwaj, A; Bruno, R; Copeland, J; Dunlop, A; Hall, M; Jefferies, M; Kevin, R; Kirby, A; Lintzeris, N; Mcgregor, I; Mills, L; Montebello, M | 1 |
| Abdi, E; Aghmesheh, M; Begbie, S; Briscoe, K; Cheung, Y; Clarke, S; Della-Fiorentina, S; Fox, P; Gedye, C; Grimison, P; Haber, P; Hahn, C; Kirby, A; Lintzeris, N; McGregor, I; Mersiades, A; Morton, R; Olver, I; Shannon, J; Simes, J; Stockler, M; Tognela, A; Walsh, A | 1 |
| Cooray, R; Gupta, V; Suphioglu, C | 1 |
| Bertoglio, LJ; da Silva, TR; Raymundi, AM; Sohn, JMB; Stern, CA | 1 |
| Beitzke, B; Kruse, D | 1 |
| Hájková, K; Kuchař, M; Mikulů, L; Nemeškalová, A; Sýkora, D | 1 |
| Bøtker, J; Cornett, C; Frokjaer, S; Genina, N; Hansen, H; Öblom, H; Rades, T; Rantanen, J | 1 |
| Abelev, S; Arnold, JC; Cairns, EA; Cohen, R; Couch, D; Gauld, N; Henderson, M; McGregor, IS | 1 |
| Dawidowicz, AL; Dybowski, MP; Rombel, M; Typek, R | 1 |
| Jutras-Aswad, D; Mongeau-Pérusse, V | 1 |
| da Silva, AJ; Dos Santos, ES | 1 |
| Chye, Y; Kirkham, R; Lorenzetti, V; McTavish, E; Solowij, N; Yücel, M | 1 |
| Bohlmann, J; Booth, JK; Carvalho, Â; Crocoll, C; Gallage, NJ; Gülck, T; Khakimov, B; Motawia, MS; Møller, BL | 1 |
| Charipova, K; Cornett, E; Gress, K; Habib, K; Jung, JW; Kassem, H; Kaye, AD; Lee, C; Lee, D; Paladini, A; Urits, I; Varrassi, G; Viswanath, O | 1 |
| Gamal El-Din, M; How, ZT | 1 |
| Anceschi, L; Brighenti, V; Mercolini, L; Pellati, F; Protti, M; Zanardi, C | 1 |
| Araneda, JF; Chu, T; Leclerc, MC; Riegel, SD; Spingarn, N | 1 |
| Astatkie, T; Dincheva, I; Kačániová, M; Latkovic, D; Semerdjieva, IB; Sikora, V; Zheljazkov, VD | 1 |
| Beukes, N; Frost, C; Schoeman, R | 1 |
| Pennypacker, SD; Romero-Sandoval, EA | 1 |
| Lachenmeier, DW; Walch, SG | 1 |
| Amminger, GP; Berger, M; Doohan, P; Kevin, RC; McGregor, IS; Vogel, R | 1 |
| Jones, É; Vlachou, S | 1 |
| Goggin, MM; Janis, GC | 1 |
| Anavi-Goffer, S; Gorberg, V; McCaffery, P | 1 |
| Davis, CM; Moore, CF; Stiltner, JW; Weerts, EM | 1 |
| Dahlgren, MK; Gruber, SA; Lambros, AM; Sagar, KA; Smith, RT | 1 |
| Craft, S; Di Forti, M; ElSohly, M; Freeman, TP; Lynskey, MT; Stylianou, S; Wilson, J | 1 |
| Bobst, S; Plunkett, LM; Ryan, K; Willett, KL | 1 |
| Dumont, GJH | 1 |
| Finch, PM; Vickery, AW | 1 |
| Buhmann, C; Fründt, O; Hidding, U; Yenilmez, F | 1 |
| Bryk, M; Mlost, J; Starowicz, K | 1 |
| Cole, TB; Saitz, R | 1 |
| Rubin, R | 1 |
| Arkell, TR; Kevin, RC; McGregor, IS; Ramaekers, JG; Theunissen, EL; Vinckenbosch, F | 1 |
| Abu-Izneid, T; Almalki, FA; Alqahtani, AM; Bader, A; Berredjem, M; Elsharkawy, ER; Hadda, TB; Khalid, S | 1 |
| Amaratunga, P; Huang, P; Lemberg, BL; Lemberg, D; Lin, L; Reed, J | 1 |
| Cho, KH; Choi, P; Ham, J; Kim, T; Lee, J; Park, JG; Raj, V | 1 |
| Busardò, FP; Farré, M; Gottardi, M; Malaca, S; Mannocchi, G; Pacifici, R; Papaseit, E; Pérez-Acevedo, AP; Perez-Maña, C; Pichini, S; Tagliabracci, A | 1 |
| Antonoaea, P; Ciurba, A; Hancu, G; Muntean, DL; Rédai, EM; Silasi, O; Todoran, N; Vlad, RA | 1 |
| Belardo, C; Cannazza, G; Capriotti, AL; Citti, C; Forni, F; Gigli, G; Iannotta, M; Laganà, A; Linciano, P; Luongo, L; Maione, S; Russo, F; Tolomeo, F; Vandelli, MA | 1 |
| Alrafas, HR; Becker, W; Busbee, PB; Cai, G; Miranda, K; Nagarkatti, M; Nagarkatti, PS; Putluri, N; Putluri, V; Walla, MD; Wilson, K | 1 |
| Adel, Y; Alexander, SPH | 1 |
| Crippa, JAS; Dos Santos, RG; Hallak, JEC | 1 |
| Cáceres Guido, P; Caraballo, RH; Cruz, CV; García Bournissen, F; Pérez Montilla, CA; Reyes Valenzuela, G; Schaiquevich, PS | 1 |
| Badach, J; Bonawitz, S; De Leo, N; Lin, A; Miller, H; Ostrovsky, O; Williamson, J | 1 |
| Sampson, PB | 1 |
| Cain, SM; Greba, Q; Howland, JG; Laprairie, RB; McElroy, DL; Onofrychuk, TJ; Roebuck, AJ; Sandini, TM; Simone, J; Snutch, TP; Zagzoog, A | 1 |
| Cruz, JC; Miranda, LFC; Queiroz, MEC | 1 |
| Ab, O; Bs, R; F, S; Hb, S; K, L; Ps, S; R, T; S, G | 1 |
| Malone, T; McFadden, BR | 1 |
| Bhattacharyya, S; Davies, C; Gunasekera, B; Martin-Santos, R | 1 |
| Baudot, B; Grobler, A; Mohamed, MK; Takyi-Williams, J | 1 |
| Kabelac, M; Kos, M; Papouskova, B; Skarupova, D; Storch, J; Vacek, J; Vostalova, J | 1 |
| Hart, MK; Silvers, WS; Winders, TA; Zeiger, JS; Zeiger, RS | 1 |
| Geskovski, N; Gigopulu, O; Huck, CW; Makreski, P; Stefkov, G; Stefov, S | 1 |
| Chandra, S; Church, JC; ElSohly, MA; Majumdar, CG; Radwan, M | 1 |
| Dabney, C; Grassa, CJ; Michael, TP; Poplawski, SG; Schwartz, CJ; Timothy Motley, S; Weiblen, GD; Wenger, JP | 1 |
| Bhattacharyya, S; McGoohan, KL; Velayudhan, L | 1 |
| Fagiolino, P; García-Carnelli, C; Maldonado, C; Vázquez, M | 1 |
| Dykukha, I; Essner, U; Malessa, R; Überall, MA | 1 |
| Aguirre Dávila, L; Guizzaro, L; Koch, A; Lasch, F; Müller-Vahl, K | 1 |
| Cannazza, G; Citti, C; Forni, F; Gigli, G; Linciano, P; Russo, F; Strallhofer, SS; Tolomeo, F; Vandelli, MA | 1 |
| Brazil, L; Checketts, D; Jove, M; Miller, S; Sabel, M; Short, SC; Tayo, B; Twelves, C | 1 |
| de Paula, BHR; Doherty, GJ | 1 |
| Chayasirisobhon, S | 1 |
| Bergman, J; Charles, S; Eisold, JE; George, SR; Gumbert, AB; Kangas, BD; Madras, BK; Withey, SL | 1 |
| Paul, F; Silván, CV | 1 |
| Bhattacharyya, S; Diederen, K; Gunasekera, B | 1 |
| Boileau, AJ; Forsythe, ML | 1 |
| Baranowska-Kuczko, M; Kicman, A; Malinowska, B; Schlicker, E | 1 |
| Ataiants, J; Conn, BM; Fedorova, EV; Iverson, E; Lankenau, SE; Wong, CF | 1 |
| Kandasamy, R; Ouyang, L; Rodriguez, CEB | 1 |
| Bonn-Miller, MO; Land, MH; MacNair, L; Mosesova, I; Peters, EN; Turcotte, C; Vandrey, R; Ware, MA | 2 |
| Casey, SL; Harley, J; Mitchell, VA; Vaughan, AC; Vaughan, CW; Winters, BL | 1 |
| Bosco, A; Bratina, A; Dinoto, A; Manganotti, P; Mazzon, G; Morelli, ME; Pasquin, F; Sartori, A; Stragapede, L | 1 |
| Prieto González, JM; Vila Silván, C | 1 |
| Almaraz-Quinones, N; Christians, U; Jackson, M; Klawitter, J; Knupp, K; Leehey, M; Liu, Y; Sempio, C; Wang, GS; Zhao, W | 1 |
| Singh, JA | 1 |
| Chen, MH; Liang, CS; Tseng, PT | 1 |
| Downey, LA; Hayley, AC | 1 |
| Andrade, CC; Hutchison, KE; Karoly, HC; Mueller, RL | 1 |
| González-Soriano, J; Pérez-Lloret, P; Pérez-Moreno, M; Santos-Álvarez, I | 1 |
| Eglit, GM; Kulpa, JE; Paulionis, LJ; Vaughn, DM | 1 |
| Sevigny, EL | 1 |
| Elsner, K; Germerott, T; Hess, C; Röhrich, J; Scheunemann, A; Zörntlein, S | 1 |
| Evins, AE; Gilman, JM; Klawitter, J; Schmitt, WA; Schuster, RM; Sempio, C; Wheeler, G | 1 |
| Chakravarty, MM; Cupo, L; Guma, E; Plitman, E | 1 |
| De Blasiis, P; Fullin, A; Lus, G; Melone, MAB; Sampaolo, S; Sansone, M; Siani, MF; Signoriello, E | 1 |
| Estévez-Carrillo, A; Oppe, M; Ortín-Sulbarán, D; Ramos-Goñi, JM; Vila Silván, C | 1 |
| Burnham, WM; Liu, J; Scott, BW | 1 |
| Aluru, N; Pandelides, Z; Thornton, C; Watts, HE; Willett, KL | 1 |
| Babinszki, B; Bajtel, Á; Csupor, D; Csupor-Löffler, B; Czégény, Z; Kiss, T; Nagy, G; Sebestyén, Z; Tóth, B | 1 |
| Babula, P; Hönigova, K; Masarik, M; Papouskova, B; Polanska, H; Storch, J; Vacek, J | 1 |
| Cannazza, G; Capriotti, AL; Cavaliere, C; Cerrato, A; Citti, C; Grassi, G; Laganà, A; Marini, F; Montone, CM; Paris, R; Piovesana, S | 1 |
| Nutt, DJ; O'Sullivan, SE; Schlag, AK; Zafar, RR | 1 |
| Chukwunyere, UI; Frempong, D; Mishra, D; Puri, A; Thakur, D; Tijani, AO | 1 |
| Aebersold, A; Duff, M; Sloan, L; Song, ZH | 1 |
| Flegel, R; Hart, ED; Hayes, ED; Mitchell, JM; Vikingsson, S; Winecker, RE | 1 |
| Abdel-Wahhab, MA; Al-Razem, F; Alhamdan, Y; Alzeer, J; Basar, H; Hadeed, KA | 1 |
| Goodman, S; Hammond, D | 1 |
| Eglit, GML; Hage, CE; Kalaba, M; MacNair, L; Peters, EN; Prosk, E; Rapin, L; Ware, MA | 1 |
| Contreras Bolaños, LA; Guevara Moriones, N; Mejía Piñeros, AL; Moreno Vergara, AF; Rodríguez Mesa, XM; Santander González, SP | 1 |
| Baumgartner, MR; Kraemer, T; Madry, MM; Scholz, C | 1 |
| Arkell, TR; McCartney, D; McGregor, IS | 1 |
| Arnold, JC | 1 |
| Bigatti, G; González-José, R; Idaszkin, YL; Lozada, M; Márquez, F | 1 |
| Ali, DW; Allison, WT; Amin, MR; Bouvier, DD; Kanyo, R; Locskai, LF; Olthuis, AM | 1 |
| Clarkson, N; Horniman, N; Keir-Rudman, S; Page, C; Robaina Cabrera, CL | 1 |
| Bigelow, GE; Cone, EJ; Flegel, RR; Goffi, E; Kuntz, D; Mitchell, JM; Sholler, DJ; Spindle, TR; Vandrey, R; Winecker, RE | 1 |
| Chaiwangrach, N; Ingkaninan, K; Jaidee, W; Nessopa, S; Siridechakorn, I; Waranuch, N; Wisuitiprot, V | 1 |
| Ammerman, B; Aynardi, MC; Dhawan, A; Garner, MR; Lewis, G; Morgan, D; Sepulveda, D; Stauch, CM | 1 |
| Coulter, C; Wagner, JR | 1 |
| Hill, VA; Paulsen, RB; Schaffer, MI; Stowe, GN | 1 |
| D'haeseleer, M; D'hooghe, M; Delvaux, V; Guillaume, D; Laureys, G; Nagels, G; Popescu, V; Van Pesch, V; Vanderdonckt, P; Willekens, B | 1 |
| Circosta, C; Grassi, G; La Camera, E; Mandalari, G; Muscarà, C; Smeriglio, A; Trombetta, D | 1 |
| Chen, J; Henry, P; Jin, D; Shan, J | 1 |
| Bilbao, A; Spanagel, R | 1 |
| Araújo, FS; Batista Sohn, JM; Bertoglio, LJ; Guimarães, FS; Raymundi, AM; Rodrigues da Silva, T; Salemme, BW; Salviato, BZ; Stern, CA | 1 |
| Bitton, J; Bourgeois-Tardif, S; Champagne, PO; Diaz, PL; Hebert, FO; Lewis, E; Major, P; Nowicki, M; Sanon, NT; Sell, E; Weil, AG | 1 |
| Cliburn, KD; Huestis, MA; Kemp, PM; Wagner, JR | 1 |
| Guo, L; Li, Q; Li, S; Lü, W; Shen, S | 1 |
| Moser, U | 1 |
| Naik, H; Trojian, TH | 1 |
| Borah, R; Devi, S; Kamle, M; Kumar, P; Mahato, DK; Mishra, AK; Pandhi, S; Patil, U; Sharma, B; Tripathi, V; Xiao, J; Yadav, HS | 1 |
| Bitencourt, RM; Cavalheiro, EKFF; Costa, AB; Mendes, TF; Rezin, GT; Salla, DH; Silva, LED; Silva, MRD; Turatti, CDR | 1 |
| Daldegan-Bueno, D; Fischer, B; Glass, M; Jutras-Aswad, D; Maia, LO | 1 |
| Chatha, M; Geyer, MA; Grant, I; Halberstadt, AL; He, YV; Minassian, A; Roberts, BZ; Young, JW | 1 |
| Bonomo, Y; Eden, E; Graham, M; Greenwood, LM; Hallinan, CM; Mills, J; Popat, A; Truong, L | 1 |
| Aria, F; Ascrizzi, R; Bonini, SA; Flamini, G; Gianoncelli, A; Maccarinelli, G; Mastinu, A; Memo, M; Pistelli, L; Premoli, M; Ribaudo, G | 1 |
| Woldeamanuel, YW; Zhang, N | 1 |
| Griffiths, P; Hughes, B; Mounteney, J; Vandam, L | 1 |
| Grunstein, RR; Hoyos, CM; Irwin, C; Kevin, RC; McCartney, D; McGregor, IS; Suraev, AS | 1 |
| Lobsien, E; Schwittay, MA; Steinbrecher, A | 1 |
| Gabaglio, M; Manenti, C; Parolaro, D; Rubino, T; Zamberletti, E | 1 |
| Pastino, G; Shuster, D | 1 |
| Bidwell, LC; Bryan, AD; Ellingson, JM; Gibson, LP; Hutchison, KE; Karoly, HC; Klawitter, J; Sempio, C; Squeri, JE | 1 |
| Essner, U; Mueller-Schwefe, GHH; Ueberall, MA; Vila Silván, C | 1 |
| Das, A; Huff, HC; Kaul, A; Roy, P; Tajkhorshid, E; Vasan, A | 1 |
| Canfyn, M; De Braekeleer, K; Deconinck, E; Desmedt, B; Duchateau, C; Kauffmann, JM; Stévigny, C | 1 |
| Agoritsas, T; Agterberg, S; Busse, JW; Esfahani, MA; Guyatt, GH; Heen, AF; Kithulegoda, N; Lytvyn, L; Shergill, Y; Wang, X; Zeng, L | 1 |
| Bardhi, K; Chen, G; Fort, G; Lazarus, P; Nasrin, S; Watson, CJW | 1 |
| Lazarus, P; Nasrin, S; Perez-Paramo, YX; Watson, CJW | 1 |
| Hillard, CJ; Pollock, S; Stollenwerk, TM | 1 |
| Senderovich, H; Vinoraj, D; Wagman, H; Waicus, S; Zhang, D | 1 |
| Burr, JF; Cheung, CP; Close, GL; Gillham, SH; Kasper, AM | 1 |
| de Quervain, DJ; Fehlmann, B; Hotz, J; Papassotiropoulos, A; Schicktanz, NS | 1 |
| Kim, EKE; Sarvey, DB | 1 |
| Bramness, JG; Hjellvik, V; Skurtveit, S; Stubhaug, A | 1 |
| Davolio, PL; Giovannini, MG; Lana, D; Landucci, E; Mazzantini, C; Pellegrini-Giampietro, DE | 1 |
| A Moreira, F; de O P Leme, F; E M T Branco, S; G de Melo, E; M Melo, M; R C Coelho, MP | 1 |
| Abu Dabrh, AM; McLeod, HM; Perlman, AI; Post, PJ; Salinas, MG; Schuh, MJ; Ventresca, EC | 1 |
| Kayser, O; Nguyen, GN; Pitakbut, T | 1 |
| Moore, CF; Weerts, EM | 1 |
| Bonn-Miller, MO; Christians, U; Klawitter, J; Land, MH; MacNair, L; Mosesova, I; Peters, EN; Sempio, C; Turcotte, C; Ware, MA | 1 |
| Broyd, SJ; Croft, RJ; Greenwood, LM; Jones, A; Michie, PT; Murray, RM; Solowij, N; Todd, J; van Hell, HH | 1 |
| Conte, A; Vila Silván, C | 1 |
| Bala, C; Danila, GM; Puiu, M; Zamfir, LG | 1 |
| Brochmann, GW; Pettersen, S; Rogde, S; Vindenes, V; Øiestad, ÅML; Øiestad, EL | 1 |
| Abraham, OR; Waddell Smith, R | 1 |
| Fitzcharles, MA; Häuser, W; Petzke, F; Tölle, TR | 1 |
| Baandrup, L; Feldstein Ewing, SW; Freeman, TP; Kenyon, EA; Lees, R; Rømer Thomsen, K; Thylstrup, B | 1 |
| Dalai, AK; Kumar, V; Mohanty, S; Naik, S; Nanda, S; Pattnaik, F; Ponnusamy, SK | 1 |
| D'Amico, EJ; Dunbar, MS; Firth, CL; Klein, DJ; Pedersen, ER; Rodriguez, A; Seelam, R; Tucker, JS | 1 |
| Bagetta, G; Boccella, S; Corasaniti, MT; Gallo Afflitto, G; Guida, F; Hamamura, K; Maione, S; Nucci, C; Rombolà, L; Sakurada, S; Sakurada, T; Scuteri, D; Tonin, P; Watanabe, C | 1 |
| Arkell, TR; Kevin, RC; Lintzeris, N; McGregor, IS; Ramaekers, JG; Theunissen, E; Vinckenbosch, F | 1 |
| Curlewis, LG; Jooste, J; Jordaan, M; Laurens, JB; Marais, AAS | 1 |
| Hendrickson, E; Leas, EC; Nobles, AL; Shi, Y | 1 |
| Chen, SN; Friesen, JB; McAlpine, JB; Ohtsuki, T; Pauli, GF | 1 |
| Elder, EJ; Gidal, BE; Jones, KJ; Miller, OS | 1 |
| Beck, O; Christensson, B; Junlén, HR; Melén, CM; Merrien, M; Panagiotidis, G; Sander, B; Sonnevi, K; Wahlin, BE; Wasik, AM | 1 |
| Bouanani, S; Boumrah, Y; Drardja, ED; Kermouche, W; Zarita, B | 1 |
| Inoue, K; Morimoto, K; Takahashi, M; Takashina, S | 1 |
| Crow, AD; Garcia-Keller, C; Hodebourg, R; Kalivas, PW; Meyerink, ME; Reichel, CM | 1 |
| Azam, C; Buscail, L; Culetto, A; Lapeyre-Mestre, M | 1 |
| Frauchiger, S; Frei, P; Mercer-Chalmers-Bender, K; Scheurer, E | 1 |
| Kennedy, M | 1 |
| Lyoo, IK; Ma, J; Renshaw, PF; Yurgelun-Todd, DA | 1 |
| Angeli, I; Bergamaschi, RF; Binelli, G; Casati, S; Colombo, G; Minoli, M; Orioli, M; Ravelli, A | 1 |
| Nahler, G | 1 |
| Brockelman, F; Hall, B; Keeling, K; Li, X; Lopez, V; Orozco, J; Stith, SS; Vigil, JM | 1 |
| Cosgrave, JM; Gallagher, WM; O'Reilly, EM; Perry, AS | 1 |
| Cone, EJ; Dorsey, B; Flegel, RR; Hayes, ED; Jacques, M; Kuntz, DJ; Senter, M; Vikingsson, S; Winecker, RE | 1 |
| Anderson, C; Devinsky, O; Friedman, D; Hamlin, T; Marmanillo, A; Ryan, D; Todd, G; Wilken, P | 1 |
| Buckner, JD; Copeland, AL; Morris, PE; Tucker, RP; Walukevich-Dienst, K | 1 |
| Babayeva, M; Lara, J; Schweky, N | 1 |
| Good, P; Hardy, J; Lord, S | 1 |
| Bruno, R; Copeland, J; Dunlop, A; Jackson, MA; Jefferies, M; Lintzeris, N; McGregor, I; Mills, L; Montebello, M; Rivas, C; Silsbury, C | 1 |
| Avilia, G; Bifulco, M; Coppola, L; Laezza, C; Navarra, G; Pagano, C | 1 |
| Fearby, N; Penman, S; Thanos, P | 1 |
| Su, FF; Yang, G; Zheng, YG | 1 |
| Arai, T; Fukuyama, T; Kawano, K; Mogi, C; Yoshida, M | 1 |
| Chan, A; Silván, CV | 1 |
| Frei, P; Mercer-Chalmers-Bender, K; Monti, MC; Scheurer, E; Weber, S | 1 |
| Dawidowicz, AL; Dybowski, MP; Holowinski, P; Rombel, M; Typek, R | 3 |
| Dale, R; Maggi, F; Noller, JS; Zheljazkov, VD | 1 |
| Bergeria, CL; Bigelow, GE; Cone, EJ; Flegel, R; Goffi, E; Mitchell, JM; Sholler, D; Spindle, TR; Vandrey, R; Winecker, RE | 1 |
| Cabral, LM; Carvalho, VM; de Almeida, FG; de Macêdo Vieira, AC; Rocha, ED; Strongin, RM | 1 |
| Coombes, G; Couchman, L; Frinculescu, A; Johnston, A; Ramsey, J; Shine, T | 1 |
| Austin-Scott, FV; Barnard, IL; Howland, JG; Laprairie, RB; McElroy, DL; Onofrychuk, TJ; Roebuck, AJ; Sandini, TM; Zagzoog, A | 1 |
| Ikpi, DE; Mobisson, SK; Obembe, AO; Omotuyi, O; Wopara, I | 1 |
| Kovalchuk, I; Kovalchuk, O; Pryimak, N; Suryavanshi, SV; Zaiachuk, M | 1 |
| Adjamian, P; Bagul, M; Carod-Artal, FJ; Gasperini, C; Vila Silván, C | 1 |
| Chisari, CG; Fernández, Ó; Ferrer-Picón, E; Hernández Vicente, F; Patti, F; Sarroca, J; Vila Silván, C | 1 |
| Bloomfield, MA; Curran, HV; Demetriou, L; Ertl, N; Freeman, AM; Freeman, TP; Hindocha, C; Howes, OD; Jones, AP; Lawn, W; Mokrysz, C; Nutt, DJ; Pope, R; Solomons, D; Statton, B; Walker, HR; Wall, MB; Yamamori, Y; Yang, Z; Yim, JL | 1 |
| Charbonneau, LF; De Angelis, C; Marchese, M; Peragine, C; Zhu, C | 1 |
| D'Souza, LC; Gupta, SC; Lal, S; Rai, V; Sharma, A; Vimal, D | 1 |
| Basile, G; Busardò, FP; Lo Faro, AF; Pichini, S; Pilli, G; Ripani, U; Venanzi, B | 1 |
| Aykas, DP; Ball, C; Giusti, MM; Miyagusuku-Cruzado, G; Rodriguez-Saona, LE; Yao, S | 1 |
| Doohan, PT; Grunstein, RR; Hoyos, CM; Irwin, C; Kevin, RC; McCartney, D; McGregor, IS; Suraev, AS | 1 |
| Jordan, EN; Kayser, O; Nguyen, GN | 1 |
| Baghaei, K; Farrokhi, N; Moghadam, VE; Salami, SA; Tajik, T | 1 |
| Holt, AK; Peace, MR; Poklis, JL | 1 |
| Bacic, A; Deseo, MA; Doblin, MS; Welling, MT | 1 |
| Aprikian, S; Canac-Marquis, M; Kasvis, P; Vigano, A; Vigano, M | 1 |
| Iwata, YT; Kanamori, T; Kuwayama, K; Okada, Y; Segawa, H; Tsujikawa, K; Yamamuro, T | 3 |
| de Souza, MR; Henriques, AT; Koetz, M; Limberger, RP | 1 |
| Almenar-Ordaz, M; Carda, C; Cremades, A; Farras, R; Galbis, JM; Martín de Llano, JJ; Mata, M; Milián, L; Monleón-Guinot, I; Peñaroja-Martinez, J; Sancho-Tello, M | 1 |
| Attwood, K; Case, AA; Elibol, J; Hansen, ED; Hyland, A; Mupamombe, CT; Nathan, R; Smith, D | 1 |
| Grabenauer, M; Kuntz, D; Martin, EL; Sholler, DJ; Spindle, TR; Vandrey, R; Zamarripa, CA | 1 |
| Cunnane, K; Dobbins, M; Pennypacker, SD; Rakkar, M; Reboussin, BA; Romero-Sandoval, EA; Wagoner, KG | 1 |
| Berl, V; Evans, M; Hurd, YL; Lipshutz, BH; Mathur, EJ; Roggen, M | 1 |
| Hall, S; Henson, JD; Vitetta, L | 1 |
| Arrieta, O; Belgers, V; Chagas, MHN; de Almeida, CMO; de Witt Hamer, PC; Douw, L; Ket, JCF; Klein, M; Kouwenhoven, MCM; Lopez-Sendon, J; Niers, JM; Olde Rikkert, MG; Röttgering, JG; Svendsen, KB; van de Ven, PM; van Linde, ME; Weber, M; Würdinger, T | 1 |
| Analakkattillam, S; Hanrahan, JP; Langsi, VK; Moore, E | 1 |
| Jarocka-Karpowicz, I; Jastrząb, A; Skrzydlewska, E | 1 |
| Amminger, GP; Berger, M; McGregor, IS | 1 |
| Biagini, G; Cannazza, G; Capriotti, AL; Carbone, L; Citti, C; Fulvio, F; Gigli, G; Kaczorova, D; Laganà, A; Paris, R; Perrone, E; Russo, F; Tolomeo, F; Vandelli, MA | 1 |
| Chakrabarty, S; Coetzee, JF; Dahlen, CR; Kleinhenz, MD; Magnin, G; Neville, B; Serum, EM; Smith, DJ; Swanson, KC; Winders, TM | 1 |
| Barhdadi, S; Canfyn, M; De Braekeleer, K; De Leersnijder, C; Deconinck, E; Duchateau, C | 1 |
| Casey, SL; Mitchell, VA; Sokolaj, EE; Vaughan, CW; Winters, BL | 1 |
| Josan, C; Pfaff, N; Podinic, T; Raha, S | 1 |
| Bansal, N; Chugh, P; Minocha, N; Rao, K; Singh, C; Vashist, Y; Yadav, N | 1 |
| Bernstein, N; Eltzov, E; Harpaz, D; Namdar, D | 1 |
| Bagetta, G; Boccella, S; Corasaniti, MT; Guida, F; Luongo, L; Maione, S; Nicotera, P; Scuteri, D; Tonin, P | 1 |
| Barroso, M; Costa, S; Gallardo, E; Margalho, C; Oliveira, P; Passarinha, LA; Rosado, T; Rosendo, LM; Simão, AY | 1 |
| Alves, C; Bilibio, D; Galon, L; Kaizer, RR; Mesacasa, L; Müller, C; Santin, LF; Sutorillo, NT; Tamagno, WA; Vanin, AP | 1 |
| Boerkoel, P; Cullen, K; Hawkins, M; Lai, WW; Malas, A; Roesler, J; Velzeboer, R | 1 |
| Babu, D; Le, T; Reiz, B; Siraki, AG; Tonoyan, L | 1 |
| Britch, SC; Craft, RM | 1 |
| Ghasemi Gojani, E; Ilnytskyy, Y; Kovalchuk, I; Kovalchuk, O; Li, D | 1 |
| Afezolli, C; Anceschi, L; Brighenti, V; Caroli, C; Cocchi, M; Durante, C; Marchetti, A; Pellati, F; Pollastro, F; Salamone, S | 1 |
| Bauer, B; Croghan, I; Ranum, RM; Toussaint, LL; Vincent, A; Whipple, MO | 1 |
| Bosquez-Berger, T; Iliopoulos-Tsoutsouvas, C; Jiang, S; Mackie, KP; Makriyannis, A; Nikas, SP; Straiker, A; Wager-Miller, J; Wilson, S | 1 |
| Golombek, P; Hindelang, P; Lachenmeier, DW; Laible, M; Scharinger, A; Tamosaite, S; Walch, SG | 1 |
| Dykukha, I; Essner, U; Penner, IK; Raithel, LM; Schreiber, H | 1 |
| Chen, B; Fang, Z; Huang, S; Ma, M; Min, K; Qiu, R; Salentijn, GI; van Beek, TA; Zuilhof, H | 1 |
| Franz, S; Herzog, J; Musshoff, F; Skopp, G | 1 |
| Andersen, TE; Hendricks, O; Roessler, KK; Wieghorst, A | 1 |
| Carillo, P; Corrado, G; De Pascale, S; El-Nakhel, C; Graziani, G; Kyriacou, MC; Pannico, A; Ritieni, A; Rouphael, Y | 1 |
| Facharztmagazine, R | 1 |
| Bruno, R; Copeland, J; Dunlop, A; Jefferies, M; Lintzeris, N; Mcgregor, I; Mills, L; Montebello, M | 1 |
| Busardò, FP; Carlier, J; Giorgetti, R; Gottardi, J; Lo Faro, AF; Pichini, S; Tini, A | 1 |
| García, L; Groisman, R; Hurtado, AK; Pavlovsky, F | 1 |
| Han, BH; Kaufmann, CN; Lifset, ET; Malhotra, A; Moore, AA; Nafsu, R; Nguyen, K; Sexton, M; Yang, KH | 1 |
| Arkell, TR; Hutten, NRPW; Kevin, RC; Kuypers, KPC; McGregor, IS; Ramaekers, JG; Schepers, J; Theunissen, EL; Vinckenbosch, F | 1 |
| Bach, AP; Blevins, LK; Crawford, RB; Henriquez, JE; Kaminski, NE; Khan, DMIO; Rizzo, MD; Sermet, S; Small-Howard, AL; Turner, H; Zhou, J | 1 |
| Ben-Ami Shor, D; Gluck, N; Hochman, I; Scapa, E; Shibolet, O | 1 |
| Butcher, BE; Clarke, S; Hall, S; Henson, JD; McLachlan, AJ; Rutolo, D; Vitetta, L | 1 |
| Calvani, M; Giovannini, MG; Lana, D; Landucci, E; Magni, G; Mazzantini, C; Pellegrini-Giampietro, DE | 1 |
| Arnold, JC; McCartney, D; McGregor, IS; Suraev, A | 1 |
| Geci, M; Scialdone, M; Tishler, J | 1 |
| Gauvin, DV | 1 |
| Barrett, SP; Bartholomeusz, J; Spinella, TC; Stewart, SH | 1 |
| Markowitz, JS; Melchert, PW; Qian, Y | 1 |
| Bourgault, Z; Le Foll, B; Matheson, J | 1 |
| Giovannini, MG; Lana, D; Landucci, E; Magni, G; Mazzantini, C; Pellegrini-Giampietro, DE | 1 |
| Bylo, MP; Gawenis, JA; Greenlief, CM; Pescaglia, J; Ray, CL | 1 |
| Conner, BT; Emery, NN; Karoly, HC; Piercey, CJ; Prince, MA; Smith, EE | 1 |
| Desimone, MF; Silva Sofrás, FM | 1 |
| Cheaha, D; Kumarnsit, E; Nukitram, J | 1 |
| Green, R; Khalil, R; Mohapatra, S; Mohapatra, SS | 1 |
| Cheng, Y; Dai, M; Li, B; Li, F; Pu, Q; Rao, Q; Wu, ZE; Yan, D; Zhang, T; Zhao, M; Zhao, Q | 1 |
| Downey, LA; Hayley, AC; Manning, B; Narayan, AJ | 1 |
| Chesney, E; Chester, L; De Micheli, A; Englund, A; Freeman, TP; Fusar-Poli, P; Hodsoll, J; McGuire, P; Murray, RM; Oliver, D; Sovi, S; Strang, J; Wilson, J | 1 |
| Laurella, LC; Martini, MF; Moglioni, AG | 1 |
| Clouse, G; Hadjiargyrou, M; Komatsu, DE; Penman, S; Thanos, PK | 1 |
| Campos, DA; García, M; Martínez, ME; Mendivil, EJ; Romano, M | 1 |
| Issaris, V; Milas, GP; Zareifopoulos, N | 1 |
| Alffenaar, JC; Barlow, JW; Johnstone, MT; Schubert, EA; Wheate, NJ | 1 |
| Bedoya-Pérez, MA; Doohan, PT; Grunstein, RR; Hoyos, CM; Kevin, RC; McCartney, D; McGregor, IS; Sahinovic, A; Suraev, AS | 1 |
| Bolling, MC; Duipmans, JC; Renken, RJ; Schräder, NHB; Sörös, P; Vermeulen, KM; Wolff, AP | 1 |
| Benamar, K; Blanton, H; Duong, J; Yin, L | 1 |
| Englund, A; Freeman, TP; Gaillard, A; Lorenzetti, V; Thomson, D | 1 |
| Almdal, TP; Bach, FW; Enggaard, TP; Finnerup, NB; Hansen, CS; Heinesen, A; Holbech, JV; Jensen, TS; Petersen, M; Sindrup, SH; Vase, L; Zubcevic, K | 1 |
| White, RM | 1 |
| Becam, J; Doudon, E; Fabresse, N; Faltot, M; Lacarelle, B; Pelissier-Alicot, AL; Roux, P; Solas, C | 1 |
| Stella, N | 1 |
| Borissova, A; Curran, HV; Fernandez-Vinson, N; Freeman, TP; Hall, D; Langley, C; Lawn, W; Mokrysz, C; Ofori, S; Petrilli, K; Sahakian, BJ; Skumlien, M; Trinci, K; Wall, MB | 1 |
| Adell, A; Andrés, MF; Astigarraga, E; Barreda-Gómez, G; Domínguez-Fernández, C; Fernández, R; García, J; González-Coloma, A; Laso, A; Noskova, E; Ochoa, E | 1 |
| Blebea, NM; Hancu, G; Pricopie, A; Vlad, RA | 1 |
| Alasvand, M; Bozorgi, H; Di Ciano, P; Ghasemi-Pirbaluti, M; Motaghi, E; Rashidi, M | 1 |
| Filer, CN | 1 |
| Cooper, ZD; Pabon, E | 1 |
| Mantri, N; Reddy, TS; Zomer, R | 1 |
| Bloomfield, M; Borissova, A; Chesney, E; Curran, HV; Englund, A; Fernandez-Vinson, N; Freeman, TP; Hall, D; Haniff, ZR; Lawn, W; Mokrysz, C; Ofori, S; Petrilli, K; Trinci, K; Wall, MB; Wang, S | 1 |
| Carey, LM; France, CP; Maguire, DR | 1 |
| Avilia, G; Bifulco, M; Coppola, L; Laezza, C; Navarra, G; Pagano, C; Savarese, B | 1 |
| Biosca-Micó, J; Campíns-Falcó, P; Herráez-Hernández, R; Jornet-Martínez, N | 1 |
| Bansal, S; Paine, MF; Spindle, TR; Surujunarain, R; Unadkat, JD; Vandrey, R; Weerts, EM; Zamarripa, CA | 1 |
| Beaufrère, H; Gomez, B; Guzman, DS; Knych, H; Lyubimov, A; Sosa-Higareda, M; Zakharov, A | 1 |
| Banerjee, A; Hayward, JJ; Trant, JF | 1 |
| ElSohly, MA; Gul, W; Ibrahim, EA; Radwan, MM; Wanas, AS | 1 |
| Adell, A; Astigarraga, E; Barreda-Gómez, G; Egiguren-Ortiz, J; Fe Andrés, M; Fernández, R; García, J; González-Coloma, A; Gulak, M; Laso, A; Noskova, E; Ochoa, E; Oiarbide, M; Sánchez-Sánchez, L; Santos, JI | 1 |
| Bacle, A; Corso, B; Demay, E; Gicquel, T; Le Daré, B; Mercerolle, M; Pelletier, R | 1 |
| Egan, KL; Soule, EK; Villani, S | 1 |
| Borodovsky, JT; Dowd, AN; Goffi, E; Sholler, DJ; Spindle, TR; Strickland, JC; Vandrey, R; Weerts, EM; Zamarripa, CA | 1 |
| Eeswara, A; Jergova, S; Pacheco-Spiewak, A; Sagen, J | 1 |
| Natale, BV; Natale, DRC; Rokeby, ACE | 1 |
| Angela Vandelli, M; Biagini, G; Cannazza, G; Carbone, L; Cavazzini, A; Cerrato, A; Citti, C; Gigli, G; Laganà, A; Laura Capriotti, A; Maiorano, V; Perrone, E; Russo, F; Tolomeo, F | 1 |
| Greene, KM; Henry, D; Livingston, MD; LoParco, CR; Olsson, SE; Rossheim, ME; Trangenstein, PJ; Walker, A | 1 |
| Schwark, WS; Wakshlag, JJ | 1 |
| Ghosh, R; Howlader, MMR; Pazuki, D | 1 |
| Caria, F; De Luca, MA; Miliano, C; Pintori, N | 1 |
| Kitdumrongthum, S; Trachootham, D | 1 |
| Benedetti, MD; Calabrese, M; Cardobi, N; Gajofatto, A; Gobbin, F; Turatti, M | 1 |
| Haycraft, AL | 1 |
| Crosignani, N; di Mateo, A; García-Carnelli, C; Gutierre, E; Recchi, L | 1 |
| Craft, RM; Freels, TG; Glodosky, NC; Gogulski, HY; McLaughlin, RJ | 1 |
| Dahlgren, MK; El-Abboud, C; Gruber, SA; Kosereisoglu, D; Lambros, AM; Sagar, KA; Smith, RT | 1 |
| Choi, P; Ham, J; Kim, J; Kim, JC; Kim, T; Park, YT | 1 |
| Canseco-Alba, A; Castillo-Arellano, J; Cutler, SJ; León, F | 1 |
| Barhdadi, S; Courselle, P; Deconinck, E; Vanhee, C | 1 |
| Baio, G; Curran, HV; Freeman, TP; Hindocha, C; Hua, DY; Lees, R; Mofeez, A; Morgan, CJ; Shaban, N | 1 |
| Catchlove, S; Downey, LA; Hayley, AC; Manning, B; Shiferaw, B; Stough, C | 1 |
| Kolishetti, N; Llaguno, L; Madepalli, L; Nair, M; Vashist, A; Yndart Arias, A | 1 |
| Di Marzo, V; Gertsch, J; Grether, U; Howlett, AC; Hua, T; Maccarrone, M; Makriyannis, A; Piomelli, D; Ueda, N; van der Stelt, M | 1 |
| Breuer, A; Colodete, DAE; Cortez, I; Del-Bel, EA; Fogaça, MV; Gomes, FV; Guimarães, FS; Mechoulam, R; Pedrazzi, JFC; Silva, NR | 1 |
| Sun, X | 1 |
| Baglole, CJ; Eidelman, DH; Haidar, Z; Traboulsi, H | 1 |
| Berwaerts, J; Checketts, D; Chinnapongse, R; Javaid, S; Klineova, S; Lublin, F; Nicholas, J; Steinerman, JR | 1 |
| Adkins, M; Bainbridge, J; Domen, CH; Klawitter, J; Leehey, MA; Liu, Y; Rajkovic, S; Sempio, C; Sillau, S | 1 |
| Hopkins, WS; Ieritano, C; Thomas, P | 1 |
| Kaur, S; Nathani, A; Singh, M | 1 |
| Anchesi, I; Caprioglio, D; Chiricosta, L; Gugliandolo, A; Mazzon, E; Pollastro, F; Salamone, S; Schepici, G | 1 |
| Bellocchio, L; de Ruvo, E; Dipalma, G; Inchingolo, AD; Inchingolo, AM; Inchingolo, F; Isacco, CG; Lorusso, F; Malcangi, G; Mancini, A; Patano, A; Rapone, B; Scarano, A | 1 |
| Churcher, NKM; Dhamu, VN; Prasad, S | 1 |
| Bansal, S; Paine, MF; Spindle, TR; Thummel, KE; Unadkat, JD; Vandrey, R; Weerts, EM; Zamarripa, CA | 1 |
| Alves, C; Barcellos, LJG; Pompermaier, A; Tamagno, WA; Vanin, AP | 1 |
| Berthold, EC; Chiang, YH; Kamble, SH; Kanumuri, SRR; Kuntz, MA; McCurdy, CR; McMahon, LR; Senetra, AS; Sharma, A | 1 |
| Acosta, A; Almirall, J; Capote, R; Dos Santos, MK; Ley, J; Quirke, M; Tabassam, B | 1 |
| Batinic, A; Bozic, J; Burcul, F; Dujic, G; Dujic, Z; Kalajzic, N; Kumric, M; Kuret, S; Matana, A; Sutlovic, D; Vrdoljak, J | 1 |
| Inoue, K; Katagi, M; Katehashi, H; Minamoto, K; Nunome, M; Takashina, S | 1 |
| Biagini, G; Cannazza, G; Capriotti, AL; Carbone, L; Citti, C; Gallo, A; Gigli, G; Laganà, A; Luongo, L; Maione, S; Perrone, E; Perrone, M; Ricciardi, F; Russo, F; Schmid, M; Vandelli, MA | 1 |
| Cone, EJ; Flegel, RR; Hart, ED; Hayes, ED; Mullen, L; Vikingsson, S; Winecker, RE | 1 |
| Canseco-Alba, A; Rodríguez-Manzo, G | 1 |
| Ahmad, SM; Correia, B; Quintas, A | 1 |
| Correia-da-Silva, G; Fonseca, BM; Maia, J; Teixeira, N | 1 |
| Glinn, MA; Michaud, GP | 1 |
| Bunduc, S; Csupor, D; Fehérvári, P; Gergő, D; Hegyi, P; Horváth, IL; Kleiner, D; Lugosi, K | 1 |
| Cooper, JA; Rosano, TG; Scholz, KL; Wood, M | 1 |
| Barhoun, P; Bower, IS; Enticott, PG; Ford, TC; Hill, AT; Parrella, NF | 1 |
| Alonso, R; Desimone, MF; Di Leo Lira, P; Retta, DS; Silva Sofrás, FM; van Baren, CM | 1 |
| Alves, P; Amaral, C; Correia-da-Silva, G; Teixeira, N | 1 |
| Lee, J; Liu, J; Tan, ASL | 1 |
| Pokhai, AA; Poklis, JL; Williams, GR; Wolf, CE | 1 |
| Clark, M; Cone, EJ; Flegel, RR; Hart, ED; Hayes, ED; Jacques, M; Kuntz, DJ; Vikingsson, S; Winecker, RE | 1 |
| Cannazza, G; Capriotti, AL; Cavazzini, A; Citti, C; Ferri, E; Gigli, G; Laganà, A; Pinetti, D; Russo, F; Vandelli, MA | 1 |
| Azhdary, P; Fardindoost, S; Hoorfar, M; Janfaza, S; Tasnim, N | 1 |
| Eitan, A; Gover, O; Meiri, D; Schwartz, B; Sulimani, L | 1 |
| Chaiyo, S; Deenin, W; Kalcher, K; Ortner, A; Schmid, MG; Wenninger, N | 1 |
| Hřib, R; Landa, L; Slíva, J; Šulcová, A; Trojan, V | 1 |
| Bouma, J; Broekhuis, JD; Heitman, LH; Kumar, P; Ligresti, A; van der Horst, C; van der Stelt, M | 1 |
| Fan, B; Li, L; Sun, Y; Tao, R; Wang, F; Zhu, D | 1 |
| Austin-Scott, FVL; Baccetto, SL; Barnard, IL; Black, T; Finch, E; Greba, Q; Howland, JG; Laprairie, RB; McElroy, DL; Michel, D; Zagzoog, A | 1 |
| Hughs, ML; McMillin, GA | 1 |
240 review(s) available for dronabinol and cannabidiol
| Article | Year |
|---|---|
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid | 2005 |
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
Eicosanoid mediation of cannabinoid actions.
Topics: Cannabinoids; Eicosanoids; Humans | 2019 |
The Essential Medicinal Chemistry of Cannabidiol (CBD).
Topics: Animals; Cannabidiol; Chemistry, Pharmaceutical; Clinical Trials as Topic; Humans; Placebo Effect | 2020 |
Toward drugs derived from cannabis.
Topics: Analgesics; Anti-Inflammatory Agents; Antiemetics; Asthma; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Epilepsy; Glaucoma; History, Ancient; History, Medieval; History, Modern 1601-; Humans; Hypertension; Medicine, Arabic; Medicine, East Asian Traditional; Phytotherapy; Sleep Initiation and Maintenance Disorders; Structure-Activity Relationship | 1978 |
Preclinical chronic effects: unlearned and learned behavior.
Topics: Animals; Avoidance Learning; Behavior, Animal; Cannabidiol; Cannabinoids; Cannabinol; Conditioning, Operant; Dronabinol; Drug Administration Schedule; Drug Tolerance; Humans; Motor Activity; Reinforcement Schedule; Substance Withdrawal Syndrome | 1977 |
Clinical studies on the interaction of psychopharmacologic agents with marihuana.
Topics: Animals; Barbiturates; Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Interactions; Euphoria; Humans; Male; Microsomes, Liver; Motor Skills; Postural Balance; Psychotropic Drugs; Pulse; Secobarbital; Time Factors | 1976 |
Pharmacokinetics and disposition of cannabinoids.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Humans; Marijuana Smoking | 1987 |
Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.
Topics: Animals; Biotransformation; Cannabidiol; Cannabinoids; Dronabinol; Drug Tolerance; Feces; Humans; Kinetics; Tissue Distribution | 1986 |
The pyrolysis of cannabinoids.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hot Temperature; Structure-Activity Relationship | 1987 |
Changes in CNS sensitivity to cannabinoids with repeated treatment: tolerance and auxoesthesia.
Topics: Animals; Brain; Cannabidiol; Cannabinoids; Dronabinol; Drug Tolerance; Electroshock; Kindling, Neurologic; Mice; Pentylenetetrazole; Phenytoin; Picrotoxin; Seizures | 1984 |
Marihuana.
Topics: Activities of Daily Living; Cannabidiol; Cannabis; Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Abuse; Radioimmunoassay | 1981 |
[A novel analgesics made from Cannabis].
Topics: Analgesics; Arachidonic Acids; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Drugs, Investigational; Endocannabinoids; Europe; Humans; Multiple Sclerosis; Pain; Plant Extracts; Polyunsaturated Alkamides | 2004 |
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.
Topics: Arachidonic Acids; Bipolar Disorder; Cannabidiol; Cannabinoids; Dronabinol; Endocannabinoids; Humans; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1 | 2005 |
Cannabinoids.
Topics: Animals; Anxiety Disorders; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Dronabinol; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Psychotropic Drugs; Receptors, Cannabinoid | 2005 |
Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
Topics: Analgesics; Cannabidiol; Cannabinoids; Dronabinol; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Self Administration; Sleep Wake Disorders | 2006 |
Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.
Topics: Absorption; Animals; Cannabidiol; Cannabinol; Dronabinol; Hair; Half-Life; Humans; Liver; Marijuana Smoking; Sweat; Tissue Distribution | 2005 |
Latest pain relief a combination of new and old.
Topics: Cannabidiol; Carbazoles; Delayed-Action Preparations; Dronabinol; Drug Combinations; Humans; Nurse Practitioners; Pain; Plant Extracts; Serotonin Receptor Agonists; Tryptamines | 2007 |
Update on pharmacotherapy guidelines for treatment of neuropathic pain.
Topics: Analgesics; Animals; Cannabidiol; Chronic Disease; Dronabinol; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Guidelines as Topic; Humans; Pain; Peripheral Nervous System Diseases; Pregabalin; Thiophenes | 2007 |
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
Topics: Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Pain; Phytotherapy; Plant Extracts; Plant Preparations; Sleep; Sleep Wake Disorders | 2007 |
The toxicology of cannabis and cannabis prohibition.
Topics: Animals; Blood Pressure; Cannabidiol; Cannabis; Cognition; Dronabinol; Drug Combinations; Heart Rate; Humans; Legislation, Drug; Marijuana Abuse; Plant Extracts; Psychomotor Performance; Risk Assessment | 2007 |
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Topics: Animals; Cannabidiol; Dronabinol; Drug Tolerance; Humans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Synaptic Transmission | 2008 |
Managing neuropathic pain with Sativex: a review of its pros and cons.
Topics: Analgesics; Cannabidiol; Chronic Disease; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Neuralgia; Pain Measurement; Plant Extracts | 2008 |
What is the mechanism whereby cannabis use increases risk of psychosis?
Topics: Abnormalities, Drug-Induced; Cannabidiol; Cannabinoid Receptor Modulators; Dopamine; Dronabinol; Humans; Marijuana Smoking; Paranoid Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia | 2008 |
Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Topics: Blood-Brain Barrier; Cannabidiol; Dronabinol; Drug Combinations; Drug Interactions; Humans; Ligands; Plant Extracts; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2009 |
[Therapeutical use of the cannabinoids in psychiatry].
Topics: Animals; Cannabidiol; Dronabinol; Humans; Mental Disorders; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant | 2010 |
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pain Measurement; Plant Extracts; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2010 |
Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Reproducibility of Results; Self Report; Severity of Illness Index | 2011 |
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Topics: Animals; Cannabidiol; Disease Models, Animal; Dronabinol; Drug Combinations; Endocannabinoids; Mice; Multiple Sclerosis; Muscle Spasticity; Muscle, Skeletal; Plant Extracts | 2011 |
Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Endocannabinoids; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Quality of Life; Treatment Outcome | 2011 |
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.
Topics: Administration, Mucosal; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic | 2011 |
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine.
Topics: Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Marijuana Abuse; Multiple Sclerosis; Plant Extracts; Psychotropic Drugs; Randomized Controlled Trials as Topic; Substance-Related Disorders | 2011 |
Endocannabinoid system dysfunction in mood and related disorders.
Topics: Anxiety; Bipolar Disorder; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Cerebral Cortex; Depression; Dronabinol; Electroencephalography; Endocannabinoids; Humans; Mood Disorders; Pain; Receptors, Cannabinoid; Schizophrenia; Suicide | 2011 |
[Does cannabis use lead to schizophrenia?].
Topics: Brain; Cannabidiol; Causality; Comorbidity; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Dopamine; Dronabinol; Humans; Marijuana Abuse; Neuropsychological Tests; Psychoses, Substance-Induced; Risk; Schizophrenia; Switzerland | 2011 |
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity.
Topics: Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Quality of Life; Spain | 2012 |
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?
Topics: Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Tolerance; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Psychotropic Drugs | 2012 |
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans; Male; Placebos; Reference Values | 2012 |
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
Topics: Analgesics; Animals; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Treatment Outcome; Urologic Diseases | 2012 |
[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
Topics: Administration, Sublingual; Cannabidiol; Clinical Trials, Phase III as Topic; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Legislation, Drug; Multicenter Studies as Topic; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts; Powders; Randomized Controlled Trials as Topic; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Retrospective Studies; Spain; Treatment Outcome | 2012 |
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach.
Topics: Bias; Cannabidiol; Clinical Trials, Phase III as Topic; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Linear Models; Marijuana Smoking; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Plant Extracts; Randomized Controlled Trials as Topic; Research Design; Self Report; Severity of Illness Index; Treatment Outcome | 2012 |
What place for ▾ cannabis extract in MS?
Topics: Adult; Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Drug Costs; Drug Interactions; Humans; Meta-Analysis as Topic; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
Topics: Anti-Dyskinesia Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Clinical Trials, Phase III as Topic; Cost of Illness; Dronabinol; Drug Combinations; Drug Resistance; Drugs, Investigational; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Practice Patterns, Physicians'; Quality of Life; Randomized Controlled Trials as Topic; Spain; United Kingdom | 2013 |
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany.
Topics: Anti-Dyskinesia Agents; Attitude of Health Personnel; Attitude to Health; Cannabidiol; Cannabinoid Receptor Agonists; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Drug Costs; Drug Resistance; Germany; Health Care Costs; Humans; Multiple Sclerosis; Muscle Spasticity; Physicians; Plant Extracts; Quality of Life | 2013 |
[Marihuana and cannobinoids as medicaments].
Topics: Arthritis, Rheumatoid; Cannabidiol; Cannabinoids; Cannabis; Contraindications; Dronabinol; Drug Combinations; Humans; Inflammatory Bowel Diseases; Multiple Sclerosis; Muscle Spasticity; Nausea; Nervous System Diseases; Pain; Plant Extracts; Vomiting | 2012 |
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.
Topics: Analgesics; Canada; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Evaluation, Preclinical; Humans; Multiple Sclerosis; Neuralgia; Plant Preparations; Randomized Controlled Trials as Topic | 2013 |
Clinical case reviews in multiple sclerosis spasticity: experiences from around Europe.
Topics: Adult; Aged; Cannabidiol; Dronabinol; Drug Combinations; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Treatment Outcome | 2013 |
THC:CBD spray and MS spasticity symptoms: data from latest studies.
Topics: Affect; Automobile Driving; Cannabidiol; Clinical Trials as Topic; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Parasympatholytics; Plant Extracts; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic | 2014 |
Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Topics: Adult; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Severity of Illness Index | 2014 |
Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Endocannabinoids; Humans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2015 |
Impact of Sativex(®) on quality of life and activities of daily living in patients with multiple sclerosis spasticity.
Topics: Activities of Daily Living; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Outcome Assessment, Health Care; Plant Extracts; Quality of Life | 2014 |
Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
Topics: Animals; Cannabidiol; Dronabinol; Epilepsy; Humans; Medical Marijuana; Seizures | 2014 |
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Plant Extracts | 2014 |
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Treatment Outcome | 2014 |
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes.
Topics: Cannabidiol; Clinical Trials as Topic; Dronabinol; Humans; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Oral Sprays; Placebo Effect | 2015 |
Phytocannabinoids and epilepsy.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cerebral Cortex; Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Evaluation, Preclinical; Endocannabinoids; Epilepsy; Humans; Phytotherapy; Plant Extracts | 2015 |
Medical marijuana for cancer.
Topics: Analgesics, Non-Narcotic; Antiemetics; Canada; Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Neoplasms; Pain; Treatment Outcome; United Kingdom; United States | 2015 |
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Humans; Psychoses, Substance-Induced | 2015 |
Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.
Topics: Cannabidiol; Cell Survival; Dronabinol; Humans; Neoplasms; Receptors, Cannabinoid | 2015 |
Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Marijuana Abuse; Substance Withdrawal Syndrome | 2015 |
Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.
Topics: Acetylcysteine; Amines; Cannabidiol; Cyclohexanecarboxylic Acids; Dronabinol; Drug Combinations; Gabapentin; gamma-Aminobutyric Acid; Humans; Inappropriate Prescribing; Marijuana Abuse; Marijuana Smoking; Off-Label Use; Patient Safety; Practice Patterns, Physicians'; Psychotropic Drugs; Risk Assessment; Risk Factors; Treatment Outcome | 2015 |
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Sleep; Visual Analog Scale | 2015 |
Cannabinoids in the Treatment of Epilepsy.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Epilepsy; Humans; Medical Marijuana | 2015 |
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Treatment Outcome | 2015 |
Advances in the management of MS symptoms: real-life evidence.
Topics: Activities of Daily Living; Cannabidiol; Disease Management; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Product Surveillance, Postmarketing | 2015 |
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
Topics: Algorithms; Cannabidiol; Clinical Trials as Topic; Disease Management; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2015 |
The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users.
Topics: Brain Mapping; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Hippocampus; Humans; Marijuana Smoking; Prefrontal Cortex; Time Factors | 2016 |
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.
Topics: Anorexia; Cachexia; Cannabidiol; Dronabinol; Humans; Neoplasms; Quality of Life | 2016 |
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
Topics: Accidental Falls; Cannabidiol; Depression; Dronabinol; Drug Combinations; Germany; Humans; Marijuana Abuse; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Plant Extracts; Prospective Studies; Registries; Retrospective Studies; Spain; Switzerland; Treatment Outcome; United Kingdom | 2016 |
Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds.
Topics: Analgesics; Cannabidiol; Doping in Sports; Dronabinol; Drug Combinations; Gas Chromatography-Mass Spectrometry; Hair; Humans; Multiple Sclerosis; Plant Extracts; Workplace | 2016 |
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Topics: Amines; Analgesics; Baclofen; Cannabidiol; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diazepam; Dronabinol; Drug Combinations; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Spinal; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Phenol | 2016 |
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
Topics: Cannabidiol; Dronabinol; Endocannabinoids; Epilepsies, Myoclonic; Epilepsy; Humans; Lennox Gastaut Syndrome; Receptors, Cannabinoid | 2016 |
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
Topics: Cannabidiol; Cognition Disorders; Confusion; Controlled Substances; Depression; Dronabinol; Drug Administration Routes; Hallucinations; Heart; Humans; Lung; Marijuana Abuse; Medical Marijuana; Memory Disorders; Muscle Spasticity; Nausea; Pain; Physical Therapists; Postural Balance; Professional Role; Vomiting | 2017 |
Targeting the Endocannabinoid System in Psychiatric Illness.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Design; Endocannabinoids; Humans; Mental Disorders; Molecular Targeted Therapy; Research Design | 2016 |
Evolution of multiple sclerosis spasticity-associated symptoms: latest data.
Topics: Administration, Oral; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Plant Extracts; Randomized Controlled Trials as Topic | 2016 |
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
Topics: Antipsychotic Agents; Cannabidiol; Cognition; Dronabinol; Humans; Schizophrenia | 2017 |
Cannabis and epilepsy: An ancient treatment returns to the fore.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; Europe; History, Ancient; Humans; India; Medical Marijuana; North America; Seizures | 2017 |
Pharmacology of cannabinoids in the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; Humans; Receptor, Cannabinoid, CB1; Treatment Outcome | 2017 |
Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Epilepsy; History, Ancient; Humans; Medical Marijuana | 2017 |
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
Topics: Brain; Cannabidiol; Cannabinoids; Cannabis; Comprehension; Dronabinol; Drug Combinations; Epilepsy; Humans; Marijuana Smoking; Medical Marijuana; Neuroimaging | 2017 |
The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Epilepsy; Federal Government; Humans; Marijuana Use; Medical Marijuana; State Government; United States | 2017 |
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments.
Topics: Cannabidiol; Dopamine; Dronabinol; Humans; Schizophrenia | 2017 |
Cannabinoids in treatment-resistant epilepsy: A review.
Topics: Adult; Anticonvulsants; Cannabidiol; Cannabinoids; Child; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Young Adult | 2017 |
Strokes are possible complications of cannabinoids use.
Topics: Adolescent; Adult; Brain; Brain Ischemia; Cannabidiol; Cannabinoids; Cannabis; Cohort Studies; Dronabinol; Drug Combinations; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Risk Factors; Stroke; Vasoconstriction; Young Adult | 2017 |
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Drug Combinations; Drug Design; Endocannabinoids; Humans; Plant Extracts; Signal Transduction | 2017 |
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2017 |
Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
Topics: Cannabidiol; Dronabinol; Drug Interactions; Humans; Illicit Drugs; Psychotropic Drugs; Substance-Related Disorders | 2017 |
Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Topics: Affect; Anxiety; Brain; Cannabidiol; Cognition; Depression; Dronabinol; Humans; Medical Marijuana; Sleep; Sleep Initiation and Maintenance Disorders | 2017 |
Designing microorganisms for heterologous biosynthesis of cannabinoids.
Topics: Biotechnology; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Gene Expression Regulation, Plant; Humans; Intramolecular Oxidoreductases; Intramolecular Transferases; Metabolic Engineering; Plant Proteins; Saccharomyces cerevisiae; Transgenes | 2017 |
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Drug Interactions; Humans | 2018 |
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Cannabidiol; Cannabis; Chronic Pain; Dronabinol; Drug Combinations; Humans; Medical Marijuana; Neuralgia; Pain Management; Pain, Postoperative; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation.
Topics: Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Treatment Outcome | 2017 |
Drug-drug interactions as a result of co-administering Δ
Topics: Cannabidiol; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dronabinol; Drug Interactions; Humans; Psychotropic Drugs | 2018 |
Multiple sclerosis symptoms and spasticity management: new data.
Topics: Cannabidiol; Disease Management; Dronabinol; Humans; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Oral Sprays | 2017 |
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Topics: Analgesia; Analgesics; Animals; Cancer Pain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Humans; Mice; Mice, Knockout; Neuralgia; Nociception; Pain Management; Receptor, Cannabinoid, CB1; Retrospective Studies | 2018 |
Practical considerations in medical cannabis administration and dosing.
Topics: Cannabidiol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Combinations; Humans; Inflammation; Medical Marijuana; Pain | 2018 |
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Pain; Quality of Life; Randomized Controlled Trials as Topic; Systematic Reviews as Topic | 2018 |
Cannabis-based medicines for chronic neuropathic pain in adults.
Topics: Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Cannabidiol; Chronic Pain; Codeine; Dronabinol; Humans; Medical Marijuana; Neuralgia; Numbers Needed To Treat; Randomized Controlled Trials as Topic | 2018 |
Cannabis, from plant to pill.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Plant Extracts; Secondary Metabolism; Terpenes | 2018 |
The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity.
Topics: Automobile Driving; Cannabidiol; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents | 2018 |
Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling.
Topics: Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Humans; Models, Biological | 2018 |
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Nervous System Diseases; Treatment Outcome | 2018 |
The pharmacokinetics and the pharmacodynamics of cannabinoids.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Interactions; Humans | 2018 |
A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis.
Topics: Baclofen; Cannabidiol; Disease Progression; Dronabinol; Drug Combinations; Gait Disorders, Neurologic; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Nasal Sprays; Plant Extracts; Quality of Life | 2018 |
Cannabis for the treatment of ulcerative colitis.
Topics: Cannabidiol; Capsules; Colitis, Ulcerative; Dronabinol; Humans; Marijuana Smoking; Medical Marijuana; Patient Dropouts; Phytotherapy; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Remission Induction | 2018 |
Cannabis for the treatment of Crohn's disease.
Topics: Adult; Cannabidiol; Crohn Disease; Disease Progression; Dronabinol; Humans; Marijuana Smoking; Medical Marijuana; Phytotherapy; Quality of Life; Randomized Controlled Trials as Topic; Remission Induction | 2018 |
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Topics: Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Humans; Medical Marijuana; Mental Disorders | 2019 |
Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Topics: Adolescent; Adult; Brain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Cognition Disorders; Cognitive Dysfunction; Dronabinol; Humans; Mental Disorders | 2019 |
Changing landscape of cannabis: novel products, formulations, and methods of administration.
Topics: Administration, Inhalation; Administration, Oral; Cannabidiol; Cannabis; Commerce; Dronabinol; Humans; Marijuana Smoking | 2019 |
[Progress in cannabis research from a pharmaceutical chemist's point of view].
Topics: Cannabidiol; Cannabinoids; Cannabis; Chemistry, Pharmaceutical; Dronabinol; Germany | 2019 |
Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Epilepsy; Hippocampus; Humans | 2019 |
[Cannabis for medical purposes and its prescription].
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Prescriptions; Germany; Humans; Medical Marijuana; Plant Extracts | 2019 |
Pharmacology of Medical Cannabis.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana | 2019 |
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.
Topics: Age Factors; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Brain; Cannabidiol; Cognition; Dronabinol; Endocannabinoids; Epilepsies, Myoclonic; Humans; Infant; Lennox Gastaut Syndrome; Medical Marijuana; Organ Size; Spasms, Infantile | 2019 |
A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states.
Topics: Absorption, Physiological; Administration, Oral; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Drug Delivery Systems; Fasting; Gastrointestinal Tract; Humans; Mouth Mucosa; Saliva | 2019 |
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.
Topics: Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Humans | 2019 |
Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Chronic Pain; Dronabinol; Humans; Hyperalgesia; Medical Marijuana; Pain Measurement; Pain Threshold | 2020 |
Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
Topics: Adult; Cannabidiol; Colitis, Ulcerative; Crohn Disease; Disease Progression; Dronabinol; Humans; Marijuana Smoking; Medical Marijuana; Phytotherapy; Quality of Life; Randomized Controlled Trials as Topic; Remission Induction | 2020 |
Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies.
Topics: Acute Pain; Analgesics, Non-Narcotic; Cannabidiol; Cannabinoids; Chronic Pain; Dronabinol; Humans; Marijuana Abuse; Medical Marijuana; Mental Status and Dementia Tests; Psychomotor Performance; Randomized Controlled Trials as Topic | 2019 |
Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
Topics: Animals; Brain; Cannabidiol; Cannabis; Dronabinol; Endocannabinoids; Humans; Medical Marijuana; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Swine; TRPV Cation Channels | 2019 |
A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Culture; Dronabinol; Drug Resistant Epilepsy; Evidence-Based Medicine; Humans; Lennox Gastaut Syndrome | 2020 |
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Endocannabinoids; Humans; Nervous System Diseases; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |
Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Epilepsy; Humans | 2021 |
[Cannabidiol in cancer treatment].
Topics: Animals; Anxiety; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Neoplasms | 2020 |
[E-Cigarettes - Operating Principle, Ingredients, and Associated Acute Lung Injury].
Topics: Acute Lung Injury; Cannabidiol; Disease Outbreaks; Dronabinol; Electronic Nicotine Delivery Systems; Humans; Nicotine; Risk Factors; Vaping | 2020 |
Marijuana, Lower Urinary Tract Symptoms, and Pain in the Urologic Patient.
Topics: Cancer Pain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Chronic Pain; Cystitis, Interstitial; Dronabinol; Drug Combinations; Humans; Lower Urinary Tract Symptoms; Male; Medical Marijuana; Multiple Sclerosis; Pain, Procedural; Pelvic Pain; Urinary Incontinence | 2020 |
Clinical uses of cannabis and cannabinoids in the United States.
Topics: Analgesics; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Medical Marijuana; United States | 2020 |
Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Medical Marijuana; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Swine; TRPV Cation Channels | 2019 |
Cautious Hope for Cannabidiol (CBD) in Rheumatology Care.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Pain; Rheumatology | 2023 |
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.
Topics: Administration, Inhalation; Cannabidiol; Dronabinol; Drug Combinations; Drug Interactions; Hallucinogens; Humans; Marijuana Smoking; Psychoses, Substance-Induced | 2020 |
The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Inflammation; Neuralgia; Plant Extracts | 2020 |
Terpenoids, Cannabimimetic Ligands, beyond the
Topics: Alzheimer Disease; Anxiety; Bicyclic Monoterpenes; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Cognitive Dysfunction; Dronabinol; Humans; Inflammatory Bowel Diseases; Neuralgia; Neuroprotective Agents; Nootropic Agents; Schizophrenia; Sesquiterpenes; Terpenes | 2020 |
Cannabis and cannabinoids in cancer pain management.
Topics: Analgesics, Opioid; Canada; Cancer Pain; Cannabidiol; Chronic Pain; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Evaluation, Preclinical; Humans; Medical Marijuana; Pain Management; Palliative Care; Quality of Life; Severity of Illness Index | 2020 |
Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors.
Topics: Cannabidiol; Dronabinol; Herbal Medicine; Humans; Medical Marijuana; Plant Preparations | 2020 |
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications.
Topics: Administration, Oral; Animals; Biological Availability; Cannabidiol; Dronabinol; Drug Delivery Systems; Drug Interactions; Half-Life; Humans | 2020 |
Cannabis and multiple sclerosis.
Topics: Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Humans; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Pain; Urologic Diseases | 2020 |
Psychiatric Effects of Cannabis Use.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Mental Disorders | 2020 |
Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol.
Topics: Cannabidiol; Dronabinol; Humans; Psychotropic Drugs; Receptors, Cannabinoid | 2020 |
A systematic review of minor phytocannabinoids with promising neuroprotective potential.
Topics: Cannabidiol; Dronabinol; Humans; Huntington Disease; Seizures | 2020 |
Electronic cigarettes and e-cigarette/vaping product use associated lung injury (EVALI).
Topics: Acute Lung Injury; Adolescent; Cannabidiol; Cannabinoid Receptor Agonists; Child; Disease Outbreaks; Dronabinol; E-Cigarette Vapor; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; United States; Vaping; Young Adult | 2020 |
The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials.
Topics: Cannabidiol; Dronabinol; Emotions; Facial Expression; Humans; Randomized Controlled Trials as Topic | 2020 |
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review.
Topics: Alzheimer Disease; Animals; Cannabidiol; Dronabinol; Endocannabinoids; Humans; Inflammation; Parkinson Disease | 2020 |
Effects of ∆
Topics: Affect; Anxiety; Cannabidiol; Dronabinol; Humans; Memory | 2020 |
Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
Topics: Brain; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans | 2021 |
Use of cannabidiol (CBD) for the treatment of chronic pain.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Cross-Over Studies; Dronabinol; Drug Administration Routes; Drug Combinations; Drug Therapy, Combination; Humans; Treatment Outcome | 2020 |
A critical review on the detection, occurrence, fate, toxicity, and removal of cannabinoids in the water system and the environment.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Tandem Mass Spectrometry; Water | 2021 |
Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
Topics: Cannabidiol; Cannabinoids; Cannabis; Child; Dronabinol; Electronic Nicotine Delivery Systems; Humans | 2021 |
CBD and THC: Do They Complement Each Other Like Yin and Yang?
Topics: Cannabidiol; Dronabinol; Drug Synergism; Humans | 2020 |
A Critical Review of the Role of the Cannabinoid Compounds Δ
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Baclofen; Cannabidiol; Clinical Trials as Topic; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Approval; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Multiple Sclerosis; Spinal Cord; Treatment Outcome; United States; United States Food and Drug Administration | 2020 |
Translational models of cannabinoid vapor exposure in laboratory animals.
Topics: Animals; Animals, Laboratory; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Hallucinogens | 2022 |
Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
Topics: Analgesics; Cannabidiol; Cannabis; Dronabinol; Hallucinogens; Humans | 2021 |
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
Topics: Analgesics; Cannabidiol; Cannabinoids; Dronabinol; Humans; Hyperalgesia; Neuralgia; Pain Management | 2020 |
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; China; COVID-19; Dronabinol; Female; Greece; Horses; Humans; SARS-CoV-2 | 2021 |
Cannabidiol - therapeutic and legal aspects.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Approval; Humans; Legislation, Drug; Marijuana Use; Medical Marijuana | 2020 |
Constituents of Cannabis Sativa.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Receptors, Cannabinoid | 2021 |
Neuromolecular Mechanisms of Cannabis Action.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Neurotransmitter Agents; Receptors, Cannabinoid; Synaptic Transmission | 2021 |
Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT1A; TRPV Cation Channels | 2021 |
The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
Topics: Brain; Cannabidiol; Cannabis; Dronabinol; Humans; Neuroimaging | 2021 |
A Comprehensive Review of Cannabis Potency in the United States in the Last Decade.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, Gas; Dronabinol; Humans; United States | 2021 |
Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis.
Topics: Aged; Anorexia; Antineoplastic Agents; Cancer Pain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dizziness; Dose-Response Relationship, Drug; Dronabinol; Humans; Middle Aged; Multiple Sclerosis; Nausea; Neurodegenerative Diseases; Pain; Perceptual Disorders; Randomized Controlled Trials as Topic; Regression Analysis; Self Report; Vomiting | 2021 |
Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials.
Topics: Cannabidiol; Chronic Pain; Dronabinol; Drug Combinations; Humans; Neuralgia; Randomized Controlled Trials as Topic | 2021 |
Cannabinoids, reward processing, and psychosis.
Topics: Antipsychotic Agents; Cannabidiol; Cannabinoids; Dopamine; Dronabinol; Humans; Psychotic Disorders; Reward | 2022 |
Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.
Topics: Anxiety; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Stress Disorders, Post-Traumatic | 2021 |
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19.
Topics: Analgesics; Animals; Anticonvulsants; Antiviral Agents; Cannabidiol; COVID-19 Drug Treatment; Dronabinol; Humans; SARS-CoV-2; Virus Internalization | 2021 |
Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Flavonoids; Hallucinogens; Humans; Terpenes | 2022 |
Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports.
Topics: Analgesics, Opioid; Cannabidiol; Chronic Pain; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Registries | 2021 |
Cannabis and driving ability.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans | 2021 |
A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Neuroimaging; Psychotic Disorders | 2021 |
Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana | 2021 |
Delivering therapeutic cannabinoids via skin: Current state and future perspectives.
Topics: Biological Availability; Cannabidiol; Cannabinoids; Cannabis; Dronabinol | 2021 |
Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Cannabidiol; Cannabinoids; Cannabis; Cartilage Diseases; Cytokines; Diabetes Mellitus, Type 1; Dronabinol; Humans; Immunomodulation; Lupus Erythematosus, Systemic; Mice; Multiple Sclerosis; Th17 Cells | 2021 |
A primer on medicinal cannabis safety and potential adverse effects.
Topics: Adolescent; Cannabidiol; Cannabis; Child; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Medical Marijuana | 2021 |
Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
Topics: Appetite; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Humans; Medical Marijuana; Sleep | 2021 |
Therapeutic Potential for Cannabinoids in Sports Medicine: Current Literature Review.
Topics: Athletic Performance; Brain Concussion; Cannabidiol; Cannabinoids; Cannabis; Chronic Pain; Dronabinol; Endocannabinoids; Humans; Medical Marijuana; Osteoarthritis; Receptor, Serotonin, 5-HT1A; Receptors, Cannabinoid; Sports Medicine; TRPV Cation Channels; United States | 2021 |
Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview.
Topics: Cannabidiol; Cannabis; Dronabinol | 2021 |
Topics: Analgesics; Anti-Inflammatory Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Humans; Inflammation; Obesity | 2022 |
Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Cocaine-Related Disorders; Crack Cocaine; Dronabinol; Hallucinogens | 2021 |
Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review.
Topics: Cannabidiol; Cannabis; Chronic Pain; Dronabinol; Humans; Medical Marijuana | 2021 |
The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review.
Topics: Aged; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Low Back Pain | 2022 |
Cannabis and Athletic Performance.
Topics: Athletic Performance; Cannabidiol; Cannabis; Dronabinol; Humans; Pain | 2021 |
Current review of hemp-based medicines in dogs.
Topics: Animals; Cannabidiol; Cannabis; Carrier Proteins; Dogs; Dronabinol | 2021 |
Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities.
Topics: Cannabidiol; Dronabinol; Federal Government; Humans; Legislation, Drug; Medical Marijuana; Needs Assessment; State Government; United States | 2021 |
Review of Available Data for the Efficacy and Effectiveness of Nabiximols Oromucosal Spray (Sativex®) in Multiple Sclerosis Patients with Moderate to Severe Spasticity.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Observational Studies as Topic; Plant Extracts | 2021 |
Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain.
Topics: Cannabidiol; Chronic Pain; Dronabinol; Endocannabinoids; Humans; Medical Marijuana; Nociceptive Pain | 2021 |
Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Marijuana Abuse | 2022 |
Cannabis: Chemistry, extraction and therapeutic applications.
Topics: Cannabidiol; Cannabinol; Cannabis; Dronabinol | 2022 |
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.
Topics: Animals; Anti-Inflammatory Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Evaluation, Preclinical; Eye Pain; Leukocytes; Lipid Metabolism; Rodentia; Uveitis | 2022 |
Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports.
Topics: Acute Disease; Adult; Cannabidiol; Cannabinoids; Cannabis; Cross-Sectional Studies; Dronabinol; Humans; Male; Pancreatitis | 2022 |
Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview.
Topics: Analgesics; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans | 2022 |
Effect of cannabinoids on brain metabolites: A review of animal and human studies.
Topics: Animals; Brain; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans | 2023 |
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Topics: Animals; Antineoplastic Agents; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Neoplasms; Plant Extracts | 2022 |
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Neoplasms; Pharmaceutical Preparations; Pilot Projects | 2022 |
Cannabinoids: Therapeutic Use in Clinical Practice.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Neoplasms | 2022 |
Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review.
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Hallucinogens; Obesity | 2022 |
Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity | 2022 |
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2022 |
Synthetic Strategies for Rare Cannabinoids Derived from
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol | 2022 |
Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans | 2022 |
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions.
Topics: Cannabidiol; Chronic Pain; Dronabinol; Humans; Mental Health; Sleep Initiation and Maintenance Disorders | 2022 |
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis.
Topics: Anxiety; Cannabidiol; Cannabinoids; Dronabinol; Humans; Quality of Life | 2023 |
The Origin and Biomedical Relevance of Cannabigerol.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol | 2022 |
Current Cannabidiol Safety: A Review.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Epilepsy; Female; Humans | 2023 |
Portable biosensors for rapid on-site determination of cannabinoids in cannabis, a review.
Topics: Biosensing Techniques; Cannabidiol; Cannabinoids; Cannabis; Dronabinol | 2022 |
Cannabis dosing and administration for sleep: a systematic review.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Humans; Sleep; Sleep Wake Disorders | 2022 |
Use of Cannabidiol in the Management of Insomnia: A Systematic Review.
Topics: Cannabidiol; Cross-Sectional Studies; Dronabinol; Humans; Sleep Initiation and Maintenance Disorders; United States | 2023 |
Effects of Sativex
Topics: Cannabidiol; Cognition; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
The effect of medical cannabis on cognitive functions: a systematic review.
Topics: Adult; Cannabidiol; Cannabis; Cognition; Dronabinol; Humans; Marijuana Smoking; Medical Marijuana | 2022 |
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence.
Topics: Adult; Cannabidiol; Cannabis; Child; Chronic Pain; Clinical Trials as Topic; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans | 2023 |
The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Electronic Nicotine Delivery Systems; Hallucinogens; Humans; Lung Injury; United States | 2023 |
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review.
Topics: Adolescent; Cannabidiol; Cannabinoids; Dronabinol; Female; Humans; Male; Sex Characteristics; Stress Disorders, Post-Traumatic | 2022 |
Entourage Effect and Analytical Chemistry: Chromatography as a Tool in the Analysis of the Secondary Metabolism of
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, Gas; Dronabinol; Flavonoids; Humans; Secondary Metabolism; Terpenes | 2023 |
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges.
Topics: Animals; Cannabidiol; Dronabinol; Mice; Neoplasms; Pain; Quality of Life | 2022 |
Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance.
Topics: Anxiety; Cannabidiol; Cannabinoids; Dronabinol; Humans; Sleep; Sleep Wake Disorders | 2022 |
Examining the role of cannabinoids on osteoporosis: a review.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Osteoporosis; Receptors, Cannabinoid | 2022 |
A Systematic Review of Medical Cannabinoids Dosing in Human.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Pilot Projects | 2022 |
Antitumorigenic Effect of Cannabidiol in Lung Cancer: What Do We Know So Far?–A Mini Review
Topics: Animals; Cannabidiol; Cell Line; Dronabinol; Humans; Lung Neoplasms | 2022 |
Effects of cannabinoids on resting state functional brain connectivity: A systematic review.
Topics: Adult; Brain; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans | 2023 |
Cannabidiol and Δ8-Tetrahydrocannabinol: Cannabinoids of Rising Interest and Concern.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Mammals; Vaping | 2023 |
THC and CBD: Similarities and differences between siblings.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Humans; Siblings | 2023 |
Applications of Capillary Electrophoresis for the Determination of Cannabinoids in Different Matrices.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Child; Dronabinol; Electrophoresis, Capillary; Hallucinogens; Humans | 2023 |
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review.
Topics: Cannabidiol; Cannabis; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis | 2023 |
Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Lipids; Pain | 2023 |
Cannabinoids in the Modulation of Oxidative Signaling.
Topics: Antioxidants; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2023 |
"Breaking bud": the effect of direct chemical modifications of phytocannabinoids on their bioavailability, physiological effects, and therapeutic potential.
Topics: Administration, Oral; Biological Availability; Cannabidiol; Cannabinoids; Dronabinol; Prodrugs | 2023 |
Place of therapeutic cannabis in France and safety data: A literature review.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Plant Extracts | 2023 |
Cannabinoids and the placenta: Receptors, signaling and outcomes.
Topics: Animals; Cannabidiol; Cannabinoids; Dronabinol; Female; Fetal Growth Retardation; Humans; Mice; Placenta; Pregnancy; Signal Transduction | 2023 |
Nanomaterials-Based Electrochemical Δ
Topics: Cannabidiol; Cannabinoids; Chronic Pain; Dronabinol; Humans; Quality of Life | 2023 |
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Hallucinogens; Humans | 2023 |
An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans | 2023 |
The Polypharmacological Effects of Cannabidiol.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Epilepsy; Humans; Pain | 2023 |
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Carrier Proteins; Child; Dronabinol; Endocannabinoids; Hallucinogens; Humans | 2023 |
Research Progress on Cannabinoids in
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; China; Dronabinol; Hallucinogens | 2023 |
Exosomal delivery of cannabinoids against cancer.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Neoplasms | 2023 |
Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dentistry; Dronabinol; Hallucinogens; Oral Health | 2023 |
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans | 2023 |
Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Female; Humans; Pregnancy | 2023 |
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials.
Topics: Adult; Cannabidiol; Dronabinol; Humans; Multiple Sclerosis; Muscle Spasticity; Randomized Controlled Trials as Topic; Treatment Outcome | 2023 |
A systematic review of cannabidiol trials in neurodevelopmental disorders.
Topics: Attention Deficit Disorder with Hyperactivity; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans; Randomized Controlled Trials as Topic | 2023 |
The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease.
Topics: Alzheimer Disease; Cannabidiol; Cannabinoids; Dronabinol; Humans | 2023 |
136 trial(s) available for dronabinol and cannabidiol
| Article | Year |
|---|---|
Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
Topics: Adult; Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Interactions; Euphoria; Heart Rate; Humans; Male; Motor Skills; Placebos; Postural Balance; Psychological Tests; Time Factors | 1976 |
Clinical studies on the interaction of psychopharmacologic agents with marihuana.
Topics: Animals; Barbiturates; Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Interactions; Euphoria; Humans; Male; Microsomes, Liver; Motor Skills; Postural Balance; Psychotropic Drugs; Pulse; Secobarbital; Time Factors | 1976 |
Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
Topics: Adult; Benzopyrans; Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Interactions; Eye; Herb-Drug Interactions; Humans; Male; Phytotherapy; Pulse; Time Factors; Time Perception | 1975 |
Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose repeated daily oral administration in humans.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cannabidiol; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Huntington Disease; Male; Middle Aged | 1991 |
Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man.
Topics: Adult; Biotransformation; Cannabidiol; Cannabinoids; Dronabinol; Humans; Kidney; Kinetics; Male; Models, Biological | 1981 |
In vivo cytogenetic effects of cannabinoids.
Topics: Adult; Aneuploidy; Cannabidiol; Cannabinoids; Cannabinol; Chromosome Aberrations; Chromosomes; Dronabinol; Humans; Male; Sister Chromatid Exchange | 1981 |
Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.
Topics: Adult; Anxiety; Cannabidiol; Cannabinoids; Dronabinol; Female; Humans; Male; Psychiatric Status Rating Scales; Pulse | 1982 |
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Cannabidiol; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans; Hypotension; Muscle Spasticity; Nervous System Diseases; Pain; Phytotherapy; Placebos; Plant Preparations; Severity of Illness Index; Spasm; Urination Disorders | 2003 |
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Female; Humans; Locomotion; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Outcome Assessment, Health Care; Physical Examination; Placebos; Secondary Prevention; Treatment Outcome; United Kingdom; Walking | 2003 |
Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.
Topics: Administration, Sublingual; Adult; Aged; Analgesics, Non-Narcotic; Cannabidiol; Chronic Disease; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Pain; Pain Measurement; Patient Selection; Sleep; Treatment Outcome | 2004 |
Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.
Topics: Adult; Analysis of Variance; Cannabidiol; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Electroencephalography; Female; Humans; Male; Memory; Psychomotor Performance; Sleep | 2004 |
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study.
Topics: Administration, Oral; Cannabidiol; Capsules; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans; Movement; Multiple Sclerosis; Muscle Spasticity; Sleep | 2004 |
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.
Topics: Aerosols; Cannabidiol; Cannabis; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Humans; Mouth Mucosa; Multiple Sclerosis; Muscle Spasticity; Pain; Pain Measurement; Plant Extracts; Tremor; Urinary Bladder Diseases | 2004 |
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Brachial Plexus Neuropathies; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Plant Extracts; Retrospective Studies; Sleep; Time Factors; Treatment Outcome | 2004 |
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.
Topics: Adult; Anxiety; Blood Pressure; Cannabidiol; Cannabinoids; Carbon Monoxide; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Electroencephalography; Event-Related Potentials, P300; Female; Heart Rate; Humans; Male; Marijuana Smoking; Memory; Middle Aged; Task Performance and Analysis; Time Factors | 2005 |
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Topics: Administration, Oral; Analgesics; Arthritis, Rheumatoid; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Plant Extracts; Treatment Outcome | 2006 |
Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Topics: Administration, Oral; Adolescent; Adult; Algorithms; Analgesics, Non-Narcotic; Area Under Curve; Body Mass Index; Cannabidiol; Cannabis; Capsules; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Models, Biological; Plant Extracts; Reference Standards; Sex Factors; Time Factors | 2005 |
The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS).
Topics: Analgesics, Non-Narcotic; Cannabidiol; Cannabinoids; Comorbidity; Dronabinol; Female; Humans; Middle Aged; Multiple Sclerosis; Quality of Life; Urinary Incontinence, Urge; Urination; Urodynamics | 2006 |
Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.
Topics: Administration, Sublingual; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Pilot Projects; Psychotropic Drugs; Visual Acuity | 2006 |
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.
Topics: Administration, Oral; Adult; Cannabidiol; Cannabinoids; Central Nervous System; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Placebos; Plant Extracts; Treatment Outcome | 2007 |
Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
Topics: Acoustic Stimulation; Adult; Antipsychotic Agents; Auditory Cortex; Cannabidiol; Cannabinol; Cerebral Cortex; Cognition; Contingent Negative Variation; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Prospective Studies; Psychoses, Substance-Induced; Signal Processing, Computer-Assisted; Stimulation, Chemical | 2007 |
Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Analgesics; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Hyperesthesia; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Plant Extracts; Psychomotor Performance; Time Factors; Treatment Outcome | 2007 |
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aerosols; Analgesics, Opioid; Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Pain; Plant Extracts | 2007 |
Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Topics: Acoustic Stimulation; Administration, Oral; Adult; Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Electroencephalography; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Humans; Male; Multivariate Analysis; Prospective Studies; Psychophysics; Psychotropic Drugs; Reaction Time | 2008 |
Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition.
Topics: Adult; Analysis of Variance; Brain; Brain Mapping; Cannabidiol; Decision Making; Double-Blind Method; Dronabinol; Female; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Oxygen; Photic Stimulation; Psychotropic Drugs; Reaction Time; Young Adult | 2008 |
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Topics: Adult; Amygdala; Anxiety; Arousal; Brain; Cannabidiol; Double-Blind Method; Dronabinol; Emotions; Facial Expression; Fear; Frontal Lobe; Galvanic Skin Response; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Oxygen; Parahippocampal Gyrus; Parietal Lobe; Pattern Recognition, Visual; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Psychotropic Drugs; Young Adult | 2009 |
Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
Topics: Administration, Oral; Adult; Analysis of Variance; Cannabidiol; Cannabinoids; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Fingers; Functional Laterality; Humans; Male; Neuropsychological Tests; Plant Preparations; Plant Structures; Psychomotor Performance; Reference Values | 2009 |
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
Topics: Administration, Oral; Adult; Arousal; Attention; Cannabidiol; Cannabis; Corpus Striatum; Double-Blind Method; Dronabinol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mental Recall; Oxygen; Paired-Associate Learning; Parahippocampal Gyrus; Psychoses, Substance-Induced; Temporal Lobe | 2009 |
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.
Topics: Adult; Arachidonic Acids; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Endocannabinoids; Female; Humans; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pain; Plant Extracts; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex, Stretch; Treatment Outcome; Young Adult | 2009 |
Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.
Topics: Adult; Amygdala; Cannabidiol; Double-Blind Method; Dronabinol; Emotions; Facial Expression; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Models, Neurological; Neural Pathways; Placebos; Psychotropic Drugs | 2010 |
Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor.
Topics: Adult; Aged; Cannabidiol; Depression; Diabetic Neuropathies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Placebos; Plant Extracts; Quality of Life; Treatment Outcome | 2010 |
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
Topics: Adult; Aged; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Endpoint Determination; Female; Humans; Male; Middle Aged; Neoplasms; Pain, Intractable | 2010 |
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Topics: Acoustic Stimulation; Adult; Brain; Cannabidiol; Double-Blind Method; Dronabinol; Female; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Photic Stimulation; Psychomotor Performance; Young Adult | 2010 |
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Plant Extracts; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.
Topics: Adolescent; Analysis of Variance; Appetitive Behavior; Cannabidiol; Choice Behavior; Chromatography, Liquid; Dronabinol; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Marijuana Smoking; Mass Spectrometry; Neuropsychological Tests; Reaction Time; Young Adult | 2010 |
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Plant Extracts; Urinary Bladder, Overactive | 2010 |
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Pilot Projects; Vomiting | 2010 |
Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.
Topics: Adult; Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Mouth Mucosa; Plant Extracts; Young Adult | 2011 |
Subjective and physiological effects after controlled Sativex and oral THC administration.
Topics: Administration, Oral; Adult; Anxiety; Brain; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Female; Heart Rate; Humans; Male; Mouth Mucosa; Plant Extracts; Psychotropic Drugs; Tissue Distribution; Young Adult | 2011 |
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.
Topics: Adult; Aged; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2011 |
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
Topics: Acoustic Stimulation; Adult; Afferent Pathways; Brain; Brain Mapping; Cannabidiol; Double-Blind Method; Dronabinol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Oxygen; Photic Stimulation; Young Adult | 2011 |
Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety.
Topics: Adult; Aged; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Dyspnea; Female; Humans; Male; Middle Aged; Pilot Projects; Psychotropic Drugs; Pulmonary Disease, Chronic Obstructive; Pulmonary Ventilation; Respiratory Rate; Sensation | 2011 |
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use.
Topics: Adult; Cannabidiol; Cannabinoids; Cognition; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Drug Evaluation; Female; Humans; Illicit Drugs; Male; Marijuana Abuse; Middle Aged; Mouth Mucosa; Oral Sprays; Plant Extracts; Young Adult | 2011 |
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols).
Topics: Aged; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Muscle Spasticity; Placebos; Plant Extracts; Substance Withdrawal Syndrome | 2012 |
Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
Topics: Adult; Area Under Curve; Cannabidiol; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Hot Temperature; Humans; Male; Metabolome; Phytotherapy; Plant Extracts; Psychotropic Drugs; Reference Values; Young Adult | 2012 |
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.
Topics: Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Cannabidiol; Chronic Pain; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Pain Measurement; Time Factors | 2012 |
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans; Male; Placebos; Reference Values | 2012 |
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Electrocardiography; Female; Humans; Longitudinal Studies; Male; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Pain Measurement; Phytotherapy; Plant Extracts; Sleep | 2013 |
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.
Topics: Adult; Cannabidiol; Cannabis; Cognitive Dysfunction; Double-Blind Method; Dronabinol; Drug Interactions; Female; Hippocampus; Humans; Learning; Male; Memory Disorders; Paranoid Disorders | 2013 |
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Breakfast; Cannabidiol; Cross-Over Studies; Dietary Fats; Dronabinol; Drug Combinations; Fasting; Food-Drug Interactions; Humans; Male; Middle Aged; Mouth Mucosa; Oral Sprays; Young Adult | 2013 |
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Topics: Administration, Oral; Administration, Sublingual; Adult; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Smoking; Medication Adherence; Mouth Mucosa; Plant Extracts; Saliva; Substance Abuse Detection; Young Adult | 2013 |
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray.
Topics: Adolescent; Adult; Biological Availability; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Humans; Male; Middle Aged; Oral Sprays; Plant Extracts | 2013 |
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Topics: Administration, Mucosal; Administration, Oral; Adult; Analgesics, Non-Narcotic; Analysis of Variance; Cannabidiol; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Sclerosis; Neuralgia; Pain Measurement; Treatment Outcome | 2013 |
A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.
Topics: Analgesics; Antineoplastic Agents; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Neuralgia; Oral Sprays; Pain Measurement; Pilot Projects; Treatment Outcome | 2014 |
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Treatment Outcome | 2014 |
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Topics: Adult; Australia; Cannabidiol; Cannabinoid Receptor Agonists; Combined Modality Therapy; Double-Blind Method; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; Middle Aged; Placebo Effect; Placebos; Psychotherapy; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome | 2014 |
Quantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Gas Chromatography-Mass Spectrometry; Humans; Plant Extracts; Saliva; Sensitivity and Specificity; Substance Abuse Detection; Tandem Mass Spectrometry | 2014 |
The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
Topics: Adult; Australia; Cannabidiol; Cannabinol; Chromatography, Liquid; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Multiple Sclerosis; Muscle Relaxants, Central; Oral Sprays; Pilot Projects; Plant Extracts; Saliva; Substance Abuse Detection; Tandem Mass Spectrometry | 2014 |
Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
Topics: Administration, Oral; Adult; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Female; Humans; Male; Marijuana Smoking; Middle Aged; Saliva; Self Administration; Substance Abuse Detection; Time Factors | 2015 |
A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain.
Topics: Adult; Aged; Analgesics; Cannabidiol; Diabetic Neuropathies; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Oral Sprays; Pain Management; Treatment Outcome | 2015 |
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Topics: Administration, Inhalation; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Drug Interactions; Emotions; Facial Recognition; Female; Humans; Longitudinal Studies; Male; Marijuana Smoking; Photic Stimulation; Psychotropic Drugs; Schizotypal Personality Disorder; Surveys and Questionnaires; Visual Analog Scale; Young Adult | 2015 |
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Topics: Adult; Cannabidiol; Cerebral Cortex; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Electric Stimulation; Electromyography; Evoked Potentials, Motor; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Muscle Spasticity; Outcome Assessment, Health Care; Plant Extracts; Severity of Illness Index; Transcranial Magnetic Stimulation | 2015 |
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Topics: Administration, Oral; Adolescent; Adult; Affect; Cannabidiol; Double-Blind Method; Dronabinol; Female; Heart Rate; Humans; Male; Marijuana Smoking; Middle Aged; Reinforcement, Psychology; Self Administration; Young Adult | 2016 |
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Topics: Adult; Brain; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Laser-Evoked Potentials; Male; Middle Aged; Multiple Sclerosis; Neuralgia; Pain Management; Pain Measurement; Plant Extracts; Transcranial Magnetic Stimulation | 2016 |
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.
Topics: Adult; Cannabidiol; Cannabis; Craving; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Marijuana Smoking; Middle Aged; Plant Extracts; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome; Young Adult | 2016 |
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.
Topics: Adult; Amino Acids; Amyloid beta-Peptides; Biogenic Monoamines; Cannabidiol; Cross-Over Studies; Dronabinol; Drug Combinations; Endocannabinoids; Female; Fibroblasts; Follow-Up Studies; Gene Expression Regulation; Humans; Huntington Disease; Male; Mental Status Schedule; MicroRNAs; Middle Aged; Outcome Assessment, Health Care; Peptide Fragments; Pilot Projects; Plant Extracts; Plant Structures; Severity of Illness Index; tau Proteins | 2016 |
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Topics: Adult; Baclofen; Cannabidiol; Clonidine; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts | 2016 |
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Motor Neurons; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Pyramidal Tracts | 2017 |
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
Topics: Aged; Blood Glucose; Body Mass Index; Body Weight; Cannabidiol; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Endpoint Determination; Female; Gastric Inhibitory Polypeptide; Glycated Hemoglobin; Humans; Male; Middle Aged; Pilot Projects; Triglycerides | 2016 |
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
Topics: Administration, Inhalation; Adult; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Choice Behavior; Decision Making; Depression; Double-Blind Method; Dronabinol; Female; Humans; Learning; Male; Marijuana Abuse; Marijuana Smoking; Motivation; Reward; Young Adult | 2016 |
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Interferon beta-1b; Leukocytes, Mononuclear; Male; Methylation; Middle Aged; Multiple Sclerosis, Chronic Progressive; Promoter Regions, Genetic; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2017 |
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity.
Topics: Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Italy; Muscle Spasticity; Pilot Projects; Research Design; Stroke; Treatment Outcome | 2017 |
Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
Topics: Administration, Buccal; Administration, Oral; Adult; Alkaloids; Benzodioxoles; Biological Availability; Cannabidiol; Cross-Over Studies; Dronabinol; Drug Delivery Systems; Fasting; Healthy Volunteers; Humans; Male; Nanospheres; Piperidines; Polyunsaturated Alkamides; Young Adult | 2017 |
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain.
Topics: Analgesics; Analgesics, Opioid; Cancer Pain; Cannabidiol; Chemotherapy, Adjuvant; Chronic Pain; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Oral Sprays; Pain Measurement; Quality of Life; Treatment Outcome | 2018 |
Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology.
Topics: Administration, Oral; Adult; Biological Availability; Cannabidiol; Cross-Over Studies; Dronabinol; Drug Combinations; Gelatin; Healthy Volunteers; Humans; Male; Oral Sprays; Young Adult | 2018 |
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology.
Topics: Adolescent; Adult; Analgesics; Biomechanical Phenomena; Cannabidiol; Clinical Protocols; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neurological Rehabilitation; Oral Sprays; Robotics; Single-Blind Method; Treatment Outcome; Young Adult | 2017 |
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.
Topics: Adult; Cannabidiol; Cognitive Behavioral Therapy; Craving; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Middle Aged; Motivation; Pilot Projects; Placebos; Substance Withdrawal Syndrome; Young Adult | 2018 |
Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study.
Topics: Adult; Analgesics; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth; Multiple Sclerosis; Muscle Spasticity; Pilot Projects; Prospective Studies; Stomatitis; Taste; Taste Perception; Treatment Outcome | 2018 |
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
Topics: Adult; Australia; Cannabidiol; Cannabinoids; Cognition; Cognitive Behavioral Therapy; Combined Modality Therapy; Craving; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; New South Wales; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Treatment Outcome | 2018 |
Sativex
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Prospective Studies; Treatment Outcome | 2019 |
Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity.
Topics: Cannabidiol; Corpus Striatum; Cross-Over Studies; Double-Blind Method; Dronabinol; Frontal Lobe; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Neuroimaging | 2018 |
Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adult; Biological Availability; Bronchodilator Agents; Cannabidiol; Double-Blind Method; Dronabinol; Dyspnea; Exercise Test; Female; Humans; Lung; Male; Nebulizers and Vaporizers; Physical Endurance; Psychotropic Drugs; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Treatment Outcome | 2018 |
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.
Topics: Administration, Inhalation; Brief Psychiatric Rating Scale; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Drug Interactions; Female; Hallucinogens; Humans; Male; Marijuana Smoking; Memory; Psychoses, Substance-Induced; United Kingdom; Young Adult | 2018 |
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).
Topics: Administration, Oral; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cost-Benefit Analysis; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Multicenter Studies as Topic; Nausea; Patient Reported Outcome Measures; Phytotherapy; Pilot Projects; Randomized Controlled Trials as Topic; Secondary Prevention; Vomiting | 2018 |
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Topics: Adult; Aged; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Motor Neuron Disease; Muscle Spasticity; Quality of Life; Treatment Outcome | 2019 |
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.
Topics: Adult; Aged; Analgesics; Cannabidiol; Chronic Pain; Cross-Over Studies; Dronabinol; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain Measurement; Surveys and Questionnaires; Time Factors; Young Adult | 2019 |
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.
Topics: Anti-Retroviral Agents; Cannabidiol; Dronabinol; Drug Therapy, Combination; Gastrointestinal Microbiome; HIV Infections; Humans; Pilot Projects; Quality of Life; Randomized Controlled Trials as Topic | 2019 |
A randomised controlled trial of vaporised Δ
Topics: Adolescent; Adult; Blood Pressure; Cannabidiol; Cannabinoid Receptor Modulators; Cannabis; Dissociative Disorders; Dronabinol; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Heart Rate; Humans; Male; Middle Aged; Perceptual Disorders; Self Report; Young Adult | 2019 |
Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
Topics: Adult; Brain; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Hallucinogens; Humans; Magnetic Resonance Imaging; Male; Marijuana Smoking; Young Adult | 2019 |
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Topics: Adult; Automobile Driving; Cannabidiol; Cognition; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Hallucinogens; Humans; Male; Marijuana Smoking; Psychotropic Drugs; Vaping; Young Adult | 2019 |
Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study
Topics: Arthritis, Rheumatoid; Cannabidiol; Chronic Pain; Double-Blind Method; Dronabinol; Humans; Multicenter Studies as Topic; Pain Management; Placebos; Randomized Controlled Trials as Topic; Research Design; Spondylitis, Ankylosing | 2019 |
Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
Topics: Cannabidiol; Cannabinoids; Cannabis; Cross-Over Studies; Dronabinol; Humans | 2020 |
Detection of Δ
Topics: Adult; Cannabidiol; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Smoking; Psychotropic Drugs; Reproducibility of Results; Saliva; Specimen Handling; Substance Abuse Detection; Tandem Mass Spectrometry; Volatilization; Young Adult | 2019 |
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Topics: Adult; Analgesics; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Myalgia; Oral Sprays; Outcome Assessment, Health Care; Severity of Illness Index | 2020 |
Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Hallucinogens; Humans; Illusions | 2021 |
Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial.
Topics: Administration, Oral; Adolescent; Brain Injuries, Traumatic; Cannabidiol; Cerebral Palsy; Child; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Muscle Spasticity; Treatment Outcome | 2020 |
Cannabidiol (CBD) and Δ
Topics: Adult; Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Humans; Middle Aged; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders | 2020 |
Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (
Topics: Administration, Oral; Cannabidiol; Double-Blind Method; Dronabinol; Humans; Multicenter Studies as Topic; Neoplasms; Palliative Care; Quality of Life; Queensland; Randomized Controlled Trials as Topic; Syndrome | 2020 |
Cannabinoids in multiple sclerosis: A neurophysiological analysis.
Topics: Administration, Oral; Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Muscle Spasticity; Muscle, Skeletal; Pain; Pilot Projects; Treatment Outcome | 2020 |
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.
Topics: Adolescent; Adult; Bayes Theorem; Cannabidiol; Double-Blind Method; Dronabinol; Female; Hallucinogens; Humans; London; Male; Marijuana Abuse; Marijuana Smoking; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2020 |
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial.
Topics: Australia; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Marijuana Smoking; Substance-Related Disorders; Treatment Outcome | 2020 |
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Australia; Cannabidiol; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Nausea; Plant Extracts; Vomiting | 2020 |
A validated method for the simultaneous quantification of cannabidiol, Δ
Topics: Administration, Oral; Adolescent; Adult; Cannabidiol; Child; Chromatography, Liquid; Dronabinol; Humans; Reproducibility of Results; Tandem Mass Spectrometry; Young Adult | 2021 |
Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical Trial.
Topics: Adult; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Female; Humans; Male; Substance Abuse Detection; Urinalysis | 2021 |
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Topics: Adult; Automobile Driver Examination; Cannabidiol; Cognition; Cross-Over Studies; Double-Blind Method; Driving Under the Influence; Dronabinol; Female; Healthy Volunteers; Humans; Male; Psychomotor Performance; Vaping; Young Adult | 2020 |
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oral Sprays; Precision Medicine; Survival Analysis; Temozolomide; Treatment Outcome | 2021 |
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants.
Topics: Analgesics; Cannabidiol; Cannabis; Dronabinol; Healthy Volunteers; Humans | 2022 |
Safety and tolerability of escalating cannabinoid doses in healthy cats.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Cats; Dronabinol | 2021 |
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants.
Topics: Analgesics; Cannabidiol; Cannabis; Dronabinol; Healthy Volunteers; Humans | 2022 |
Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Gait Analysis; Humans; Multiple Sclerosis; Muscle Spasticity; Walking | 2021 |
Orally administered cannabidiol does not produce false-positive tests for Δ
Topics: Administration, Oral; Adult; Cannabidiol; Chromatography, High Pressure Liquid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; False Positive Reactions; Female; Humans; Male; Substance Abuse Detection; Tandem Mass Spectrometry; Young Adult | 2022 |
Effects of cannabidiol in cannabis flower: Implications for harm reduction.
Topics: Adult; Cannabidiol; Cannabis; Dronabinol; Female; Flowers; Harm Reduction; Humans; Male; Middle Aged | 2022 |
Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial.
Topics: Adult; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans; Memory, Episodic; Young Adult | 2021 |
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ
Topics: Area Under Curve; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Humans; Medical Marijuana; Pilot Projects | 2022 |
Acute effects of Δ
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans | 2022 |
Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials.
Topics: Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Sex Characteristics | 2022 |
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Leukemia, Lymphocytic, Chronic, B-Cell | 2022 |
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Comorbidity; Double-Blind Method; Dronabinol; Drug Combinations; Hallucinogens; Humans; Marijuana Abuse; Medical Marijuana; Pain; Sleep; Treatment Outcome | 2022 |
Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.
Topics: Administration, Oral; Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Eating; Hallucinogens; Humans; Volatilization | 2022 |
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial.
Topics: Adult; Blood Alcohol Content; Cannabidiol; Cannabis; Cognition; Cross-Over Studies; Double-Blind Method; Dronabinol; Humans | 2022 |
Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
Topics: Administration, Oral; Analgesics; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Female; Hallucinogens; Humans; Male; Substance Abuse Detection | 2022 |
A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Research Design; Smoking | 2022 |
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol.
Topics: Aged; Cannabidiol; Chronic Pain; Dementia; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Oral Sprays; Psychomotor Agitation; Randomized Controlled Trials as Topic | 2022 |
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.
Topics: Australia; Bayes Theorem; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Humans; Male; Marijuana Abuse; Pain; Substance-Related Disorders | 2022 |
Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.
Topics: Anti-Anxiety Agents; Anxiety; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Hallucinogens; Humans | 2022 |
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Hallucinogens; Humans | 2023 |
The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.
Topics: Adult; Cannabidiol; Chronic Pain; Cross-Over Studies; Double-Blind Method; Dronabinol; Epidermolysis Bullosa; Humans; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment.
Topics: Cannabidiol; Cannabinol; Dronabinol; Humans; Neuralgia | 2023 |
The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents.
Topics: Adolescent; Adult; Bayes Theorem; Cannabidiol; Cannabis; Cross-Over Studies; Dronabinol; Female; Hallucinogens; Humans; Reward | 2023 |
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.
Topics: Adolescent; Adult; Bayes Theorem; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Hallucinogens; Humans; Marijuana Smoking | 2023 |
Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
Topics: Adult; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Hallucinogens; Humans; Male; Plant Extracts | 2023 |
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder.
Topics: Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Endocannabinoids; Hallucinogens; Humans; Marijuana Abuse | 2023 |
Effect of CannEpil
Topics: Adult; Australia; Automobile Driving; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Double-Blind Method; Dronabinol; Female; Hallucinogens; Humans; Male; Medical Marijuana; Middle Aged; Young Adult | 2023 |
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Muscle Tonus; Randomized Controlled Trials as Topic; Spasm | 2023 |
Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms.
Topics: Cannabidiol; Cannabis; Cognition; Double-Blind Method; Dronabinol; Parkinson Disease | 2023 |
Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study.
Topics: Body Fluids; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male | 2023 |
790 other study(ies) available for dronabinol and cannabidiol
| Article | Year |
|---|---|
Hashish: synthesis and central nervous system activity of some novel analogues of cannabidiol and oxepin derivatives of delta 9-tetrahydrocannabinol.
Topics: Analgesics; Animals; Body Temperature; Cannabidiol; Central Nervous System; Dogs; Dronabinol; Female; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxepins; Structure-Activity Relationship | 1985 |
Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids.
Topics: Animals; Behavior, Animal; Cannabinoids; Columbidae; Dogs; Macaca mulatta; Mice; Models, Psychological; Rabbits; Rats; Structure-Activity Relationship | 1982 |
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
Topics: Arachidonic Acids; Cannabinoids; Drug Design; Endocannabinoids; Indoles; Ligands; Models, Biological; Models, Molecular; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 2000 |
The orphan receptor GPR55 is a novel cannabinoid receptor.
Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Cannabidiol; Cannabinoids; Cell Line; Cloning, Molecular; Cyclohexanols; Down-Regulation; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Molecular Sequence Data; Organ Specificity; Polymerase Chain Reaction; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Structure-Activity Relationship | 2007 |
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons.
Topics: Animals; Benzoxazines; Calcitonin Gene-Related Peptide; Calcium; Cannabidiol; Cells, Cultured; Drug Interactions; Enzyme Inhibitors; Ganglia, Spinal; Gene Expression Regulation; Humans; Morpholines; Naphthalenes; Neurons; Radioimmunoassay; Rats; Receptor, Cannabinoid, CB1; RNA, Small Interfering; TRPV Cation Channels | 2008 |
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
Topics: Acetylation; Anti-Bacterial Agents; Cannabinoids; Cannabis; Magnetic Resonance Spectroscopy; Methicillin Resistance; Methylation; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Staphylococcus aureus; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.
Topics: Arachidonic Acids; Cell Line, Tumor; Cell Movement; Dronabinol; Endometrium; Female; Glycine; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, G-Protein-Coupled; RNA, Messenger; Transfection | 2012 |
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.
Topics: Animals; Endocannabinoids; Fatty Acid-Binding Proteins; Female; Fluorescent Dyes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cannabinoid | 2016 |
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
Topics: Animals; Cannabinoids; Cannabis; Cell Line, Tumor; Cell Proliferation; Humans; Neuralgia; Plant Leaves; Wnt Signaling Pathway | 2019 |
Cannabichromene and Δ
Topics: Cannabinoids; Cannabis; Databases, Chemical; Dronabinol; Enzyme Inhibitors; Lactate Dehydrogenase 5; Molecular Docking Simulation; Molecular Structure | 2021 |
THC shows activity against cultured Plasmodium falciparum.
Topics: Antimalarials; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Hemeproteins; HL-60 Cells; Humans; Malaria; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2021 |
High pressure liquid chromatography on cannabis. Identification of separated constituents.
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Hydrogen-Ion Concentration; Mass Spectrometry; Solvents | 1975 |
Proceedings: Cannabinoid pattern in Cannabis sativa L. seedlings as an indication of chemical race.
Topics: Cannabidiol; Cannabis; Chemical Phenomena; Chemistry; Dronabinol; Seeds | 1975 |
The stability of cannabis and its preparations on storage.
Topics: Air; Cannabidiol; Cannabis; Chemical Phenomena; Chemistry; Dronabinol; Drug Stability; Drug Storage; Light; Oxidation-Reduction; Resins, Plant; Temperature | 1976 |
Characterization of the butyl homologues of delta1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of cannabis by combined gas chromatography and mass spectrometry.
Topics: Cannabidiol; Cannabis; Chromatography, Gas; Decarboxylation; Dronabinol; Mass Spectrometry | 1976 |
Cannabinoid patterns in seedlings of Cannabis sativa L. and their use in the determination of chemical race.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chemical Phenomena; Chemistry; Dronabinol; Species Specificity; Time Factors | 1977 |
Evidence for highly specific interactions between delta8- and delta9- tetrahydrocannabinol and hydrocortisone in the rodent tyrosine aminotransferase system.
Topics: Adrenalectomy; Animals; Cannabidiol; Dronabinol; Drug Interactions; Enzyme Activation; Estradiol; Female; Glucagon; Hydrocortisone; In Vitro Techniques; Liver; Male; Mice; Mice, Inbred ICR; Rats; Tyrosine Transaminase | 1978 |
The effects of delta 9-tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats.
Topics: Animals; Cannabidiol; Cannabinoids; Corticosterone; Dronabinol; Drug Interactions; Electroshock; Male; Rats | 1979 |
Effects of delta 1-tetrahydrocannabinol on cyclic AMP in cultured human diploid fibroblasts.
Topics: 1-Methyl-3-isobutylxanthine; Cannabidiol; Cannabinoids; Cells, Cultured; Contact Inhibition; Cyclic AMP; Dronabinol; Fibroblasts; Humans; Prostaglandins E | 1979 |
Effects of delta9-tetrahydrocannabinol and cannabidiol on a Mg2+-ATPase of synaptic vesicles prepared from rat cerebral cortex.
Topics: Adenosine Triphosphatases; Animals; Cannabidiol; Cannabinoids; Cerebral Cortex; Dronabinol; Drug Interactions; Ethanol; In Vitro Techniques; Magnesium; Male; Phenytoin; Rats; Synaptic Vesicles | 1977 |
Effects of cannabinoids on cardiac microsomal CaATPase activity and calcium uptake.
Topics: Animals; Calcium; Calcium-Transporting ATPases; Cannabidiol; Cannabinoids; Dronabinol; In Vitro Techniques; Male; Mice; Microsomes; Myocardium | 1979 |
The value of the Duquénois test for cannabis--a survey.
Topics: Benzopyrans; Cannabidiol; Cannabinoids; Cannabis; Catechols; Chemical Phenomena; Chemistry; Color; Dronabinol; Indicators and Reagents; Magnoliopsida; Phenols; Plant Extracts; Resorcinols; Terpenes | 1979 |
The effect of delta9-tetrahydrocannabinol, cannabidiol and cannabinol on ether anaesthesia in mice.
Topics: Anesthesia, Inhalation; Animals; Cannabidiol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Ether; Ethyl Ethers; Female; Mice; Phytotherapy | 1975 |
delta1-tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dose-Response Relationship, Drug; Dronabinol; Hemagglutination; Hemolytic Plaque Technique; Immunity; Immunosuppressive Agents; Male; Mice; Organ Size; Spleen; T-Lymphocytes | 1977 |
Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Evoked Potentials; Male; Pentylenetetrazole; Photic Stimulation; Rats; Time Factors | 1977 |
Effects of cannabinoids on sperm morphology.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Male; Mice; Sperm Head; Spermatozoa | 1979 |
Acute and subacute inhalation toxicity of Turkish marihuana, cannabichromene, and cannabidiol in rats.
Topics: Animals; Behavior, Animal; Benzopyrans; Body Weight; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Female; Male; Mexico; Rats; Sex Factors; Testis; Turkey | 1979 |
Cannabidiol and delta 9-tetrahydrocannabinol metabolism. In vitro comparison of mouse and rat liver crude microsome preparations.
Topics: Animals; Cannabidiol; Cannabinoids; Dronabinol; In Vitro Techniques; Kinetics; Male; Mice; Microsomes, Liver; Mixed Function Oxygenases; Rats; Species Specificity; Time Factors | 1979 |
Effects of marijuana extract distillate and cannabidiol on variable interval performance as a function of food deprivation.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Conditioning, Operant; Dronabinol; Food Deprivation; Male; Rats; Task Performance and Analysis | 1978 |
The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2.
Topics: Animals; Cannabidiol; Catalepsy; Chlorpromazine; Dronabinol; Drug Interactions; Humans; Male; Mice; Prostaglandin Antagonists; Prostaglandins E; Time Factors | 1979 |
In vivo metabolism of cannabinol by the mouse and rat and a comparison with a metabolism of delta 1-tetrahydrocannabinol and cannabidiol.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Liver; Male; Mice; Rats | 1977 |
In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas.
Topics: Animals; Cannabidiol; Cannabinoids; DNA, Neoplasm; Dronabinol; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Proteins; Neoplasms, Experimental; RNA, Neoplasm; Tissue Distribution | 1977 |
The effects of SP-111, a water-soluble THC derivative, on neuronal activity in the rat brain.
Topics: Action Potentials; Afferent Pathways; Animals; Cannabidiol; Cerebellum; Dronabinol; Hippocampus; Male; Motor Activity; Neurons; Purkinje Cells; Rats | 1978 |
Effect of cannabinoids on the turnover rate of acetylcholine in rat hippocampus, striatum and cortex.
Topics: Acetylcholine; Animals; Cannabidiol; Cannabinoids; Cerebral Cortex; Corpus Striatum; Dronabinol; Hippocampus; Kinetics; Male; Rats | 1978 |
An investigation of procedures reported to increase potency of marijuana: a chemical analysis and psychological interpretation.
Topics: Cannabidiol; Cannabinol; Cannabis; Cognitive Dissonance; Dronabinol; Humans; Spectrophotometry; Substance-Related Disorders | 1978 |
A contribution to the content of the psychotomimetically active delta9-tetrahydrocannabinol in female (Marijuana) and male flowering tops of Cannabis sativa L. cultivated in climatic conditions of Czechoslovakia.
Topics: Cannabidiol; Cannabis; Czechoslovakia; Dronabinol | 1978 |
New approaches to assay of cannabinoids in biological extracts.
Topics: Animals; Cannabidiol; Cannabis; Dansyl Compounds; Dronabinol; Feces; Haplorhini; Methods; Papio | 1975 |
Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Heroin Dependence; Humans; Male; Mice; Morphine Dependence; Naloxone; Substance Withdrawal Syndrome | 1976 |
Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinol; Carbamazepine; Diazepam; Dose-Response Relationship, Drug; Dronabinol; Ethosuximide; Female; Male; Phenobarbital; Phenytoin; Rabbits; Seizures; Time Factors | 1977 |
Identification of glucuronides as in vivo liver conjugates of seven cannabinoids and some of their hydroxy and acid metabolites.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Chromatography, Gas; Dronabinol; Glucuronates; Hydroxylation; Liver; Male; Mass Spectrometry; Mice | 1977 |
Comparative diuretic activity of delta9-tetrahydrocannabinol, cannabidiol, cannabinol and hydrochlorothiazide in the rat.
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoids; Cannabinol; Chlorides; Diuretics; Dronabinol; Hydrochlorothiazide; Male; Potassium; Rats; Sodium; Time Factors | 1977 |
Effects of chronic administration of delta-9-tetrahydrocannabinol and cannabidiol on rat testicular esterase isozymes.
Topics: Animals; Cannabidiol; Cannabinoids; Dronabinol; Esterases; Isoenzymes; Leydig Cells; Male; Naphthaleneacetic Acids; Rats; Testis | 1977 |
Storage of cannabinoids by Arctia caja and Zonocerus elegans fed on chemically distinct strains of Cannabis sativa.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Diet; Dronabinol; Grasshoppers; Larva; Lepidoptera; Moths; Skin | 1977 |
Synthesis and characterization of glucuronides of Cannabinol, cannabidiol, delta9-tetrahydrocannabinol and delta8-tetrahydrocannabinol.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Chemical Phenomena; Chemistry; Chromatography, Gas; Dronabinol; Glucuronates; Mass Spectrometry | 1977 |
A cannabinoid with cardiovascular activity but no overt behavioral effects.
Topics: Animals; Behavior, Animal; Blood Pressure; Cannabidiol; Cannabinoids; Dogs; Dronabinol; Female; Heart Rate; Male; Mice; Motor Activity; Structure-Activity Relationship | 1977 |
Marihuana metabolites in urine of man. VII. Excretion patterns of acidic metabolites detected by sequential thin layer chromatography.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Chromatography, Thin Layer; Dronabinol; Humans; Time Factors | 1977 |
Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Columbidae; Cues; Discrimination, Psychological; Dronabinol; Male; Time Factors | 1977 |
Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components.
Topics: Animals; Brain; Cannabidiol; Cannabis; Dronabinol; In Vitro Techniques; Mitochondria; Mitochondria, Liver; Monoamine Oxidase Inhibitors; Swine; Time Factors | 1976 |
The interaction of hashish compounds with planar lipid bilayer membranes (BLM).
Topics: Cannabidiol; Cannabis; Dronabinol; Membrane Potentials; Membranes, Artificial; Phosphatidylcholines; Phosphatidylethanolamines; Time Factors | 1976 |
Delta9-tetrahydrocannabinol: depression of ventilatory regulation; other respiratory and cardiovascular effects.
Topics: Airway Resistance; Animals; Blood Pressure; Cannabidiol; Cannabis; Carbon Dioxide; Dogs; Dronabinol; Heart Rate; Male; Respiration | 1976 |
Total synthesis of cannabidiol and delta1-tetrahydrocannabinol metabolites.
Topics: Cannabidiol; Cannabis; Dronabinol; Methods; Oxidation-Reduction | 1976 |
Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats.
Topics: Animals; Cannabidiol; Cannabis; Depression, Chemical; Dextroamphetamine; Drinking Behavior; Dronabinol; Feeding Behavior; Male; Rats; Sucrose; Time Factors | 1976 |
Delta 9-Tetrahydrocannabinol, ethanol, and amphetamine as discriminative stimuli-generalization tests with other drugs.
Topics: Animals; Cannabidiol; Cannabis; Cues; Dextroamphetamine; Discrimination, Psychological; Dronabinol; Ethanol; Generalization, Stimulus; Male; Rats | 1976 |
The effect of hashish compounds on pphospholipid phase transition.
Topics: Binding Sites; Cannabidiol; Cannabis; Dronabinol; Membranes, Artificial; Models, Biological; Phospholipids; Structure-Activity Relationship; Temperature; Thermodynamics | 1976 |
Marihuana-induced antibody response.
Topics: Adolescent; Adult; Antibody Formation; Antibody Specificity; Antigens; Cannabidiol; Cannabis; Coombs Test; Dronabinol; Humans; Male | 1976 |
Effects of cannabinoids on the perfused rat heart.
Topics: Animals; Cannabidiol; Cannabis; Depression, Chemical; Dronabinol; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Perfusion; Rats; Stimulation, Chemical; Time Factors | 1976 |
Detection and quantification of tetrahydrocannabinol in blood plasma.
Topics: Cannabidiol; Cannabis; Chromatography; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans | 1976 |
Impairment of ADP-induced platelet aggregation by hashish components.
Topics: Adenosine Diphosphate; Cannabidiol; Cannabinoids; Dronabinol; Humans; Platelet Aggregation | 1976 |
Influence of anticonvulsant cannabinoids on posttetanic potentiation at isolated bullfrog ganglia.
Topics: Animals; Anticonvulsants; Anura; Cannabidiol; Cannabis; Depression, Chemical; Detergents; Dose-Response Relationship, Drug; Dronabinol; Ganglia, Autonomic; In Vitro Techniques; Membrane Potentials; Rana catesbeiana; Structure-Activity Relationship | 1975 |
Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol.
Topics: Cannabidiol; Cannabis; Cell Division; Dronabinol; Enterobacteriaceae; Species Specificity; Staphylococcus; Streptococcus | 1976 |
Constituents of Cannabis sativa L. XI: Cannabidiol and cannabichromene in samples of known geographical origin.
Topics: Africa; Asia; Benzopyrans; Cannabidiol; Cannabinoids; Cannabis; Chromatography, Gas; Computers; Costa Rica; Dronabinol; Europe; Geography; Iowa; Mexico; Mississippi; Sex Factors; South America | 1975 |
Plasma cannabinoids measured by radioimmunoassay in rabbits after intravenous injection of tetrahydrocannibinol, 11-hydroxy-tetrahydrocannabinol, cannabinol and cannabidiol.
Topics: Animals; Antibody Specificity; Cannabidiol; Cannabis; Dronabinol; Half-Life; Hydroxylation; Rabbits; Radioimmunoassay; Time Factors | 1975 |
Effects of 7-hydroxy-delta-6-tetrahydrocannabinol and some related cannabinoids on the guinea pig isolated ileum.
Topics: Acetylcholine; Animals; Cannabidiol; Cannabis; Depression, Chemical; Dronabinol; Guinea Pigs; Ileum; Muscle, Smooth; Stimulation, Chemical | 1975 |
Antineoplastic activity of cannabinoids.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cannabidiol; Cannabis; Dactinomycin; Dose-Response Relationship, Drug; Dronabinol; Friend murine leukemia virus; In Vitro Techniques; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Phytotherapy; Splenomegaly; Thymidine; Uridine | 1975 |
Absence of interaction between delta9-tetrahydrocannabinol (delta-THC) and cannabidiol (CBD) in aggression, muscle control and body temperature experiments in mice.
Topics: Aggression; Analysis of Variance; Animals; Body Temperature; Cannabidiol; Cannabis; Depression, Chemical; Dronabinol; Drug Interactions; Humans; Male; Mice; Motor Skills | 1975 |
The anticonvulsant activity of cannabinoids in seizure sensitive gerbils.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabis; Dronabinol; Female; Gerbillinae; Male; Motor Activity; Seizures | 1975 |
The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption.
Topics: Animals; Body Temperature; Brain; Cannabidiol; Cannabis; Depression, Chemical; Dose-Response Relationship, Drug; Dronabinol; In Vitro Techniques; Liver; Male; Mice; Mice, Inbred ICR; Mitochondria; Mitochondria, Muscle; Muscles; Myocardium; Oxygen Consumption; Pharmaceutical Vehicles; Time Factors | 1975 |
Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol.
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Drug Interactions; Kinetics; Male; Rats | 1975 |
Proceedings: Effect of hashish compounds on mouse peritoneal macrophages.
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Macrophages; Mice; Peritoneum | 1975 |
Proceedings: Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components.
Topics: Animals; Brain; Cannabidiol; Cannabis; Dronabinol; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Serotonin | 1975 |
Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
Topics: Animals; Cannabidiol; Cannabis; Depression, Chemical; Dronabinol; Drug Synergism; Humans; Male; Morphine Dependence; Rats; Stereotyped Behavior; Substance Withdrawal Syndrome | 1975 |
Interactions between cannabidiol and delta9-THC during abstinence in morphine-dependent rats.
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Drug Synergism; Herb-Drug Interactions; Humans; Male; Morphine; Phytotherapy; Rats; Substance Withdrawal Syndrome | 1975 |
Effect of hashish compounds on mouse peritoneal macrophages.
Topics: Animals; Cannabidiol; Cannabis; Cattle; Cells, Cultured; Dronabinol; Macrophages; Male; Mice; Mice, Inbred BALB C; Peritoneum; Phagocytosis; Time Factors | 1976 |
The inhibition of DNA synthesis by cannabinoids.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cannabidiol; Cannabis; Cyclophosphamide; Cytarabine; DNA; DNA, Neoplasm; Dronabinol; Fluorouracil; Idoxuridine; Leukemia L1210; Lung Neoplasms; Mice; Neoplasms, Experimental; Semustine | 1976 |
Antitussive activity of some naturally occurring cannabinoids in anesthetized cats.
Topics: Animals; Antitussive Agents; Cannabidiol; Cannabis; Cats; Codeine; Cough; Dextromethorphan; Dronabinol; Electric Stimulation; Female; Injections, Intravenous; Laryngeal Nerves; Male; Physical Stimulation; Phytotherapy; Respiration; Trachea | 1976 |
Combined effect of methaqualone and two cannabinoids.
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Drug Synergism; Male; Methaqualone; Mice; Sleep | 1976 |
Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions.
Topics: Abdomen; Analgesia; Animals; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Formates; Mice; Pain | 1976 |
Mode of action of hashish compounds in reducing blood platelet count.
Topics: Adenosine Diphosphate; Blood Cell Count; Blood Platelets; Cannabidiol; Cannabis; Depression, Chemical; Dronabinol; Erythrocytes; Humans; In Vitro Techniques; Platelet Aggregation | 1976 |
Chromatographic separation of cannabinoids and their monooxygenated derivatives.
Topics: Cannabidiol; Cannabis; Chemical Phenomena; Chemistry; Chromatography; Chromatography, Gas; Chromatography, Liquid; Chromatography, Thin Layer; Dronabinol; Methods; Oxidation-Reduction | 1976 |
Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marihuana. I. Inhibition of the acrosome reaction induced by egg jelly.
Topics: Acrosome; Ammonia; Animals; Calcimycin; Cannabidiol; Cannabinol; Dronabinol; Female; Fertilization; Ionomycin; Kinetics; Male; Monensin; Nigericin; Sea Urchins; Sperm-Ovum Interactions; Spermatozoa; Zona Pellucida | 1991 |
Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marihuana. II. Ultrastructural changes associated with inhibition of the acrosome reaction.
Topics: Acrosome; Animals; Cannabidiol; Cannabinol; Dronabinol; Fertilization; Kinetics; Male; Membrane Fusion; Microscopy, Electron; Sea Urchins; Spermatozoa; Vacuoles; Zona Pellucida | 1991 |
Influence of marijuana components (THC and CBD) on human mononuclear cell cytokine secretion in vitro.
Topics: Adult; Aged; Cannabidiol; Cytokines; Dimethyl Sulfoxide; Dronabinol; Humans; Interferon-gamma; Interleukin-1; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Middle Aged; Mitogens; Tumor Necrosis Factor-alpha | 1991 |
An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol.
Topics: Amino Acids; Amino Acids, Neutral; Analgesics; Animals; Anticonvulsants; Body Temperature; Cannabidiol; Dronabinol; Electric Stimulation; Flurazepam; gamma-Aminobutyric Acid; Guinea Pigs; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Nipecotic Acids; Pentylenetetrazole; Seizures; Tiagabine | 1991 |
Chronic marijuana smoke exposure in the rhesus monkey. IV: Neurochemical effects and comparison to acute and chronic exposure to delta-9-tetrahydrocannabinol (THC) in rats.
Topics: Animals; Biogenic Amines; Brain Chemistry; Cannabidiol; Cannabinol; Caudate Nucleus; Cerebral Cortex; Dopamine; Dronabinol; Frontal Lobe; Hippocampus; Macaca mulatta; Male; Marijuana Smoking; Nerve Tissue Proteins; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Serotonin; Time Factors | 1991 |
Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro.
Topics: Adult; Cannabidiol; Cell Adhesion; Dronabinol; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-1; Interleukin-2; Leukocytes, Mononuclear; Middle Aged; Tumor Necrosis Factor-alpha | 1991 |
Cannabinoid interactions with glucocorticoid receptors in rat hippocampus.
Topics: Androstanols; Animals; Binding, Competitive; Cannabidiol; Centrifugation, Density Gradient; Cytosol; Dexamethasone; Down-Regulation; Dronabinol; Hippocampus; Kinetics; Male; Rats; Rats, Inbred F344; Receptors, Glucocorticoid | 1990 |
Effects of psychoactive and nonpsychoactive cannabinoids on the hypothalamic-pituitary axis of the adult male rat.
Topics: Animals; Cannabidiol; Cannabinol; Dronabinol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Male; Norepinephrine; Rats; Rats, Inbred Strains; Testosterone | 1990 |
The effects of pH and temperature on the in vitro bindings of delta-9-tetrahydrocannabinol and other cannabinoids to bovine serum albumin.
Topics: Binding Sites; Cannabidiol; Cannabinoids; Cannabinol; Carrier Proteins; Chromatography, High Pressure Liquid; Dronabinol; Hydrogen-Ion Concentration; Kinetics; Serum Albumin, Bovine; Temperature; Ultrafiltration | 1990 |
Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
Topics: Animals; Cannabidiol; Cannabinol; Dopamine; Dronabinol; Hypothalamus; Hypothalamus, Middle; Kinetics; Luteinizing Hormone; Male; Median Eminence; Neurotransmitter Agents; Norepinephrine; Prolactin; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Dronabinol; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Motor Activity; Respiration; Structure-Activity Relationship | 1990 |
Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Conditioning, Operant; Dronabinol; Drug Interactions; Male; Rats; Rats, Inbred Strains; Reference Values; Reinforcement, Psychology | 1989 |
Effect of cannabidiol on cytochrome P-450 isozymes.
Topics: Animals; Blotting, Western; Cannabidiol; Cannabinoids; Cytochrome P-450 Enzyme System; Dronabinol; In Vitro Techniques; Isoenzymes; Male; Mice; Microsomes, Liver; Mixed Function Oxygenases | 1989 |
Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Benzyl Alcohol; Benzyl Alcohols; Cannabidiol; Cannabinoids; Carbachol; Dronabinol; Membrane Fluidity; Neuroblastoma; Thermodynamics; Tumor Cells, Cultured | 1989 |
The actions of THC on the intact hippocampus: a comparison of dentate and CA1 responses.
Topics: Animals; Cannabidiol; Dronabinol; Electric Stimulation; Hippocampus; Membrane Potentials; Neural Pathways; Rats; Rats, Inbred Strains; Reaction Time | 1987 |
Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
Topics: Acetylcholine; Animals; Brain; Cannabidiol; Dronabinol; Guinea Pigs; In Vitro Techniques; Kinetics; Male; Organ Specificity; Prostaglandins; Stereoisomerism | 1987 |
Diazotized dapsone as a reagent for the detection of cannabinoids on thin-layer chromatographic plates.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Chromatography, Thin Layer; Dapsone; Dronabinol; Indicators and Reagents; Naphthols; Spectrophotometry, Ultraviolet | 1988 |
Changes in neurotransmitter release at a neuromuscular junction of the lobster caused by cannabinoids.
Topics: Animals; Cannabidiol; Cannabinoids; Dronabinol; Evoked Potentials; In Vitro Techniques; Membrane Potentials; Nephropidae; Neuromuscular Junction; Neurotransmitter Agents | 1988 |
Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
Topics: Animals; Brain Chemistry; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Fluorescence Polarization; Lipid Bilayers; Male; Membrane Fluidity; Membrane Lipids; Mice; Mice, Inbred DBA; Phospholipids; Rats; Rats, Inbred Strains; Synaptic Membranes | 1985 |
The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Humans; Morphine; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1985 |
Prostaglandins and cannabis XIV. Tolerance to the stimulatory actions of cannabinoids on arachidonate metabolism.
Topics: Arachidonic Acid; Arachidonic Acids; Calcimycin; Cannabidiol; Cannabinoids; Cell Line; Cell Survival; Cells, Cultured; Dinoprostone; Dronabinol; Drug Tolerance; Fibroblasts; Humans; Lung; Prostaglandins E; Time Factors | 1985 |
Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients.
Topics: Blood Platelets; Cannabidiol; Cannabinoids; Dronabinol; Humans; Migraine Disorders; Plasma; Serotonin | 1985 |
Alteration of electrical correlates of sensory processing by tetrahydrocannabinol.
Topics: Animals; Cannabidiol; Cats; Cerebral Cortex; Dronabinol; Evoked Potentials, Auditory; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Male; Time Factors | 1986 |
Interactions between delta 9-tetrahydrocannabinol and cannabidiol as evaluated by drug discrimination procedures in rats and pigeons.
Topics: Animals; Cannabidiol; Cannabinoids; Columbidae; Discrimination Learning; Discrimination, Psychological; Dronabinol; Male; Piperidines; Rats; Rats, Inbred Strains; Species Specificity; Time Factors | 1986 |
Effects of two cannabinoids on hepatic microsomal cytochrome P-450.
Topics: 5-Aminolevulinate Synthetase; Animals; Cannabidiol; Cannabinoids; Cytochrome P-450 Enzyme System; Dronabinol; Heme Oxygenase (Decyclizing); Lipid Peroxides; Male; Malondialdehyde; Methylcholanthrene; Mice; Microsomes, Liver; Phenobarbital | 1986 |
Perinatal cannabinoid exposure: effects on hepatic cytochrome P-450 and plasma protein levels in male mice.
Topics: Androgens; Animals; Animals, Newborn; Blood Proteins; Cannabidiol; Cannabinoids; Cannabinol; Cytochrome P-450 Enzyme System; Dronabinol; Female; Gestational Age; Male; Maternal-Fetal Exchange; Mice; Microsomes, Liver; Pregnancy | 1986 |
Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Generalization, Stimulus; Male; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Cannabimimetic activity (delta 1-THC cue) of cannabidiol monomethyl ether and two stereoisomeric hexahydrocannabinols in rats and pigeons.
Topics: Animals; Cannabidiol; Cannabinoids; Chemical Phenomena; Chemistry; Columbidae; Cues; Discrimination Learning; Dronabinol; Male; Rats; Rats, Inbred Strains; Species Specificity; Stereoisomerism | 1986 |
Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog.
Topics: Animals; Cannabidiol; Cannabinoids; Dronabinol; In Vitro Techniques; Membrane Potentials; Motor Endplate; Neuromuscular Junction; Rana pipiens; Stimulation, Chemical; Synaptic Transmission | 1986 |
Maternal cannabinoid exposure. Effects on spermatogenesis in male offspring.
Topics: Animals; Cannabidiol; Cannabinol; Dronabinol; Female; Follicle Stimulating Hormone; Infertility, Male; Luteinizing Hormone; Male; Mice; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Spermatogenesis; Spermatozoa; Testis | 1986 |
Cannabinoids reduce fertility of sea urchin sperm.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Female; Fertility; Male; Sea Urchins; Sperm-Ovum Interactions; Spermatozoa | 1987 |
Cannabinoids induce incomplete maturation of cultured human leukemia cells.
Topics: Calcitriol; Cannabidiol; Cannabinoids; Cannabinol; Cell Differentiation; Cells, Cultured; Dronabinol; Humans; Leukemia, Myeloid, Acute; Lymphocyte Activation; Monocytes; Tetradecanoylphorbol Acetate | 1987 |
[Identification of potential cannalis containing substance metabolites: nuclear resonance and mass spectroscopic studies on side chain hydroxylation of cannabinoids].
Topics: Cannabidiol; Cannabis; Dronabinol; Hydroxylation; Magnetic Resonance Spectroscopy; Mass Spectrometry | 1974 |
Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
Topics: Animals; Cannabidiol; Cannabinoids; Corticosterone; Dronabinol; Drug Interactions; Kinetics; Male; Rats; Rats, Inbred Strains | 1984 |
Marijuana. Health and treatment issues.
Topics: Brain; Cannabidiol; Cannabinoids; Cardiovascular System; Digestive System; Dronabinol; Drug Interactions; Humans; Immune System; Lung; Marijuana Abuse; Motivation; Paraquat; Psychoses, Substance-Induced; Reproduction | 1984 |
Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Cats; Cerebral Cortex; Dronabinol; Electroencephalography; Eye; Female; Intraocular Pressure; Male; Plant Extracts; Polyethylene Glycols; Rats; Rats, Inbred Strains; Sleep; Sleep, REM | 1984 |
delta 1-Tetrahydrocannabinol-induced circling behavior in rats: a possible measure of psychotomimetic activity?
Topics: Animals; Cannabidiol; Defecation; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Humans; Male; Motor Activity; Phencyclidine; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1984 |
delta 1-Tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behavior of rats tested in dyadic encounters.
Topics: Aggression; Animals; Cannabidiol; Cannabinoids; Dronabinol; Humans; Male; Rats; Rats, Inbred Strains; Social Behavior; Social Isolation | 1984 |
Identification of in vivo liver metabolites of delta 1-tetra-hydrocannabinol, cannabidiol, and cannabinol produced by the guninea-pig.
Topics: Animals; Biotransformation; Cannabidiol; Cannabinoids; Cannabinol; Chemical Phenomena; Chemistry; Chromatography, Gas; Dronabinol; Gas Chromatography-Mass Spectrometry; Guinea Pigs; Liver; Male | 1980 |
Effect of cannabinoids on human Sertoli cell function in vitro.
Topics: Acyltransferases; Cannabidiol; Cannabinoids; Cannabinol; Cells, Cultured; Dose-Response Relationship, Drug; Dronabinol; Follicle Stimulating Hormone; Humans; In Vitro Techniques; Iron; Kinetics; Male; Sertoli Cells; Testosterone; Transferrin; Transglutaminases | 1983 |
Effect of cannabinoids on the activity of monoamine oxidase in normal human platelets.
Topics: Adolescent; Adult; Aged; Blood Platelets; Cannabidiol; Cannabinoids; Dronabinol; Humans; In Vitro Techniques; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 1982 |
Effects of cannabinoids on macromolecular synthesis in isolated spermatogenic cells.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Cells, Cultured; Dronabinol; In Vitro Techniques; Macromolecular Substances; Male; Mice; RNA; Solubility; Spermatids; Spermatocytes; Spermatogenesis; Spermatozoa; Uridine | 1984 |
Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
Topics: Animals; Anticonvulsants; Biological Transport, Active; Brain; Cannabidiol; Cannabinoids; Choline; Dronabinol; Electroshock; Hippocampus; In Vitro Techniques; Kinetics; Male; Rats; Sodium | 1980 |
3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
Topics: Animals; Brain; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Drug Interactions; Kinetics; Male; Rats; Time Factors | 1980 |
Cannabinoid-induced hormone changes in monkeys and rats.
Topics: Administration, Oral; Aerosols; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocrine Glands; Female; Haplorhini; Hormones; Lactation; Macaca mulatta; Male; Pregnancy; Rats; Rats, Inbred F344 | 1980 |
Effects of delta 9-tetrahydrocannabinol and cannabidiol on phospholipase and other enzymes regulating arachidonate metabolism.
Topics: Animals; Arachidonate Lipoxygenases; Arachidonic Acids; Blood Platelets; Cannabidiol; Cannabinoids; Dronabinol; Humans; Lipoxygenase; Mice; Neuroblastoma; Phospholipases; Phospholipases A; Phospholipases A2; Prostaglandin-Endoperoxide Synthases; Thromboxane-A Synthase | 1980 |
Marihuana: a forensic problem.
Topics: Automobile Driving; Body Fluids; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Drug and Narcotic Control; Forensic Medicine; Health; Humans; Legislation, Medical; Marijuana Abuse; Research; United States | 1980 |
Influence of cannabinoids on somatic cells in vivo.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cannabidiol; Cannabinoids; Cell Nucleus; Chromosome Aberrations; Dronabinol; Male; Mice; Mitosis; Mutagens | 1980 |
Lack of effect of cannabinoids on carbonic anhydrase.
Topics: Animals; Cannabidiol; Cannabinoids; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cattle; Dronabinol; Erythrocytes; Kinetics | 1980 |
The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
Topics: Animals; Cannabidiol; Cannabinoids; Conditioning, Operant; Dose-Response Relationship, Drug; Dronabinol; Macaca mulatta; Male; Reinforcement Schedule | 1980 |
Post-column derivatization procedure for the colorimetric analysis of tissue cannabinoids separated by high-performance liquid chromatography.
Topics: Animals; Brain Chemistry; Cannabidiol; Cannabinoids; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Colorimetry; Dronabinol; Drug Stability; Mice; Nitrites | 1981 |
Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
Topics: Animals; Cannabidiol; Cannabinoids; Discrimination Learning; Dronabinol; Drug Interactions; Generalization, Stimulus; Male; Rats | 1981 |
Toxicity of short-term administration of cannabinoids to rhesus monkeys.
Topics: Animals; Cannabidiol; Cannabinoids; Dronabinol; Female; Macaca mulatta; Male; Organ Size | 1981 |
Cannabinoid-induced enhancement and depression of cat monosynaptic reflexes.
Topics: Animals; Cannabidiol; Cannabinoids; Cats; Dronabinol; Phenytoin; Reflex, Monosynaptic; Spinal Cord; Synapses | 1981 |
Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content.
Topics: Animals; Aspirin; Biological Assay; Cannabidiol; Cannabinoids; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Female; Hypnotics and Sedatives; Mice; Plant Extracts; Time Factors | 1981 |
Rabbit behavioral model of marijuana psychoactivity in humans.
Topics: Animals; Behavior, Animal; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Tolerance; Electroencephalography; Humans; Models, Biological; Rabbits; Seizures | 1981 |
Identification and differentiation of resinous cannabis and textile cannabis: combined use of HPLC and high-resolution GLC.
Topics: Cannabidiol; Cannabinol; Cannabis; Chromatography, Gas; Chromatography, High Pressure Liquid; Dronabinol; Resins, Plant; Textiles | 1981 |
Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.
Topics: Administration, Oral; Adolescent; Adult; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Male | 1981 |
[Hashish].
Topics: Cannabidiol; Cannabis; Chromatography, Gas; Chromatography, Thin Layer; Dronabinol; Drug and Narcotic Control; Hungary; Microscopy, Electron, Scanning; Spectrophotometry, Infrared | 1981 |
Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Cerebral Cortex; Convulsants; Dronabinol; Ethosuximide; Evoked Potentials; Pentylenetetrazole; Phenytoin; Rats; Rats, Inbred Strains | 1981 |
Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats.
Topics: Animals; Cannabidiol; Central Nervous System; Dronabinol; Electrophysiology; Epilepsy; Iron; Male; Phenytoin; Rats; Rats, Inbred Strains | 1982 |
Cannabinoids inhibit calcium uptake by brain synaptosomes.
Topics: Animals; Brain Stem; Calcium; Cannabidiol; Cannabinoids; Cannabinol; Cerebellum; Cerebral Cortex; Dronabinol; Male; Membrane Potentials; Mice; Mice, Inbred BALB C; Onium Compounds; Organophosphorus Compounds; Rats; Synaptosomes | 1982 |
Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
Topics: Animals; Cannabidiol; Cannabinoids; Cerebral Cortex; Cobalt; Dronabinol; Evoked Potentials; Male; Rats; Rats, Inbred Strains; Seizures; Sleep, REM | 1982 |
Cannabinoid induced degranulation of rabbit neutrophils.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Chemotactic Factors; Cytochalasin B; Cytoplasmic Granules; Dronabinol; Muramidase; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phenanthridines; Rabbits | 1982 |
Influence of 22-day treatment on the anticonvulsant properties of cannabinoids.
Topics: Animals; Anticonvulsants; Brain; Cannabidiol; Cannabinoids; Dronabinol; Electroshock; Kinetics; Male; Mice; Phenytoin | 1982 |
Prostaglandins and cannabis--IX. Stimulation of prostaglandin E2 synthesis in human lung fibroblasts by delta 1-tetrahydrocannabinol.
Topics: Arachidonic Acid; Arachidonic Acids; Cannabidiol; Cells, Cultured; Dinoprostone; Dronabinol; Fibroblasts; Humans; Lung; Prostaglandins E | 1982 |
Influence of hashish extract on the social behaviour of encountering male baboons (Papio c. anubis).
Topics: Aggression; Agonistic Behavior; Animals; Behavior, Animal; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Humans; Male; Motor Activity; Papio; Social Behavior | 1982 |
Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. I. In vivo investigation of the primary and secondary immune response.
Topics: Animals; Antibody Formation; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Electrophoresis; Erythrocytes; Hemagglutination; Immunity; Male; Mice; Sheep; Thymus Gland | 1983 |
Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. II. In vitro investigation using cultured mouse splenocytes.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Cells, Cultured; Dronabinol; Hemolytic Plaque Technique; Immunity; Male; Mice; Spleen | 1983 |
Influence of different barbiturate anesthetics on delta-9-tetrahydrocannabinol effects on spinal monosynaptic reflexes.
Topics: Anesthetics; Animals; Blood Pressure; Cannabidiol; Cats; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Male; Methohexital; Pentobarbital; Reflex, Monosynaptic; Spinal Cord | 1983 |
Cannabinoids stimulate and inhibit testosterone production in vitro and in vivo.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Chorionic Gonadotropin; Dronabinol; In Vitro Techniques; Male; Mice; Testis; Testosterone | 1983 |
Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
Topics: Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Dronabinol; Drug Tolerance; Electroshock; Humans; Male; Mice; Mice, Inbred ICR; Substance Withdrawal Syndrome | 1980 |
delta 9-Tetrahydrocannabinol and cannabidiol: dose-dependent effects on evoked potentials in the hippocampal slice.
Topics: Anesthetics; Animals; Anticonvulsants; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Evoked Potentials; Guinea Pigs; Hippocampus; In Vitro Techniques; Male | 1983 |
The properties of UDP-glucuronyltransferase for cannabinoids in rat liver microsomes.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Glucuronosyltransferase; In Vitro Techniques; Kinetics; Methylcholanthrene; Microsomes, Liver; Octoxynol; Phenobarbital; Polyethylene Glycols; Rats; Uridine Diphosphate N-Acetylglucosamine | 1983 |
Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
Topics: Animals; Cannabidiol; Cannabinoids; Conditioning, Operant; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Humans; Male; Rats; Rats, Inbred Strains; Substance-Related Disorders | 1983 |
[Antagonistic effects of two natural cannabinoids on the isolated heart].
Topics: Animals; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Drug Antagonism; Heart; Heart Rate; Myocardial Contraction; Rats | 1983 |
[Detection of intake of hashish in biological material].
Topics: Cannabidiol; Cannabinol; Cannabis; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans | 1983 |
Early cannabinoid exposure influences neuroendocrine and reproductive functions in male mice: I. Prenatal exposure.
Topics: Animals; Biogenic Amines; Brain; Cannabidiol; Cannabinoids; Cannabinol; Castration; Dronabinol; Female; Fetus; Follicle Stimulating Hormone; Genitalia, Male; Luteinizing Hormone; Male; Maternal-Fetal Exchange; Mice; Pregnancy; Reproduction; Seminal Vesicles; Testis; Testosterone | 1984 |
Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
Topics: Animals; Biogenic Amines; Brain; Cannabidiol; Cannabinoids; Cannabinol; Castration; Dronabinol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Maternal-Fetal Exchange; Mice; Pregnancy; Reproduction; Sex Factors; Testis; Testosterone | 1984 |
Interactions of cannabinoids with bovine serum albumin.
Topics: Anilino Naphthalenesulfonates; Animals; Cannabidiol; Cannabinoids; Cannabinol; Cattle; Dronabinol; Fluorescent Dyes; Kinetics; Protein Binding; Serum Albumin, Bovine; Spectrometry, Fluorescence | 1984 |
delta 9-Tetrahydrocannabinol-induced changes in beta-adrenergic receptor binding in mouse cerebral cortex.
Topics: Animals; Cannabidiol; Cerebral Cortex; Dihydroalprenolol; Dronabinol; Male; Mice; Mice, Inbred ICR; Receptors, Adrenergic, beta | 1982 |
[Sex difference in the effects of delta 9-tetrahydrocannabinol and cannabidiol on pentobarbital-induced sleeping time and hepatic microsomal drug metabolizing enzyme systems in mice].
Topics: Aniline Hydroxylase; Animals; Aryl Hydrocarbon Hydroxylases; Cannabidiol; Cannabinoids; Dronabinol; Drug Synergism; Female; Inactivation, Metabolic; Male; Mice; Microsomes, Liver; Nitroanisole O-Demethylase; Oxidoreductases; Pentobarbital; Sex Factors; Sleep | 1983 |
Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
Topics: Animals; Biotransformation; Brain; Cannabidiol; Dronabinol; Half-Life; Liver; Male; Mice | 1995 |
Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.
Topics: Biomarkers; Cannabidiol; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans | 1995 |
The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
Topics: Animals; Arachidonic Acids; Base Sequence; Binding Sites; Blastocyst; Cannabidiol; Cannabinoids; Colforsin; Cyclic AMP; Dronabinol; Endocannabinoids; Fallopian Tubes; Female; Hallucinogens; Mice; Molecular Sequence Data; Polyunsaturated Alkamides; Pregnancy; Receptors, Cannabinoid; Receptors, Drug; RNA, Messenger; Signal Transduction; Uterus | 1995 |
Formation of carbon monoxide during mouse hepatic microsomal oxidative metabolism of cannabidiol; identification and determination.
Topics: Animals; Cannabidiol; Carbon Monoxide; Dronabinol; Enzyme Induction; Free Radical Scavengers; Gas Chromatography-Mass Spectrometry; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Oxidation-Reduction; Oxygen Consumption; Proteins | 1995 |
Cannabinoid ligand-receptor signaling in the mouse uterus.
Topics: Animals; Arachidonic Acids; Autoradiography; Base Sequence; Blotting, Northern; Calcium Channel Blockers; Cannabidiol; Cannabinoids; Cannabis; Colforsin; Cyclic AMP; DNA Primers; Dronabinol; Endocannabinoids; Female; Gene Expression; GTP-Binding Proteins; Mice; Mice, Inbred Strains; Molecular Sequence Data; Pertussis Toxin; Polymerase Chain Reaction; Polyunsaturated Alkamides; Pregnancy; Receptors, Cannabinoid; Receptors, Drug; RNA, Messenger; Signal Transduction; Tritium; Uterus; Virulence Factors, Bordetella | 1995 |
Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol.
Topics: Amino Acid Sequence; Animals; Base Sequence; Cannabidiol; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Dronabinol; Enzyme Induction; Gene Expression Regulation, Enzymologic; Liver; Mice; Mice, Inbred C57BL; Molecular Sequence Data | 1994 |
In vitro effects of psychoactive and non-psychoactive cannabinoids on immature rat Sertoli cell function.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Cells, Cultured; Culture Media, Serum-Free; DNA; Dronabinol; Female; Lactates; Male; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Sertoli Cells; Stimulation, Chemical; Transferrin | 1993 |
Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC.
Topics: Analgesics; Animals; Body Temperature; Cannabidiol; Cannabinoids; Cyclohexanols; Dronabinol; Male; Mice; Mice, Inbred ICR; Models, Molecular; Molecular Conformation; Motor Activity; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 1993 |
In vitro metabolic formation of a new metabolite, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol from cannabidiol through an epoxide intermediate and its pharmacological effects on mice.
Topics: Analgesics; Animals; Biotransformation; Body Temperature; Cannabidiol; Catalepsy; Dronabinol; Epoxy Compounds; Guinea Pigs; In Vitro Techniques; Male; Mice; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Sleep | 1993 |
Suppression of liver microsomal drug-metabolizing enzyme activities in adult female rats pretreated with cannabidiol.
Topics: Animals; Benzphetamine; Cannabidiol; Dronabinol; Female; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Sex Characteristics | 1993 |
A novel metabolite, an oxepin formed from cannabidiol with guinea-pig hepatic microsomes.
Topics: Animals; Cannabidiol; Catalepsy; Dibenzoxepins; Dronabinol; Gas Chromatography-Mass Spectrometry; Guinea Pigs; Hypothermia; Male; Mice; Microsomes, Liver; Oxepins; Sleep | 1995 |
Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes.
Topics: Animals; Cannabidiol; Cyclosporine; Dronabinol; Drug Interactions; Hallucinogens; Humans; Immunosuppressive Agents; Male; Mice; Microsomes, Liver | 1996 |
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Topics: Animals; Antioxidants; Cannabidiol; Cell Death; Cells, Cultured; Dronabinol; Drug Antagonism; Glutamic Acid; Neurons; Oxidative Stress; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug | 1998 |
Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
Topics: Analgesics; Animals; Binding, Competitive; Brain; Cannabidiol; Cell Membrane; Cerebellar Cortex; Cyclohexanols; Dronabinol; Guanosine Triphosphate; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1998 |
Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.
Topics: Antiemetics; Cannabidiol; Cell Line; Cytokines; Dronabinol; Eosinophils; Humans; Lymphocytes; Psychotropic Drugs | 1998 |
Are cannabinoids detected in hair after washing with Cannabio shampoo?
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Hair; Hair Preparations; Humans; Hygiene; Male; Sensitivity and Specificity; Substance Abuse Detection | 1999 |
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Topics: Animals; Arachidonic Acids; Cannabidiol; Cannabinoids; Dronabinol; Endocannabinoids; Endothelium, Vascular; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Nitric Oxide; Piperidines; Polyunsaturated Alkamides; Potassium Channels; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vasodilation; Vasodilator Agents | 1999 |
Cannabinoid ligands and their effects on learning and performance in rhesus monkeys.
Topics: Animals; Brain; Cannabidiol; Cannabinoids; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Erythrocebus patas; Female; Macaca fascicularis; Macaca mulatta; Male; Mental Recall; Receptors, Cannabinoid; Receptors, Drug; Reinforcement Schedule | 1999 |
Different effects of nabilone and cannabidiol on binocular depth inversion in Man.
Topics: Adult; Affect; Anti-Anxiety Agents; Cannabidiol; Depth Perception; Dronabinol; Humans; Male | 2000 |
Stability of cannabinoids in hair samples exposed to sunlight.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Hair; Humans; Specimen Handling; Substance Abuse Detection; Sunlight | 2000 |
[Cannabis arteriopathy].
Topics: Arteritis; Cannabidiol; Cannabis; Dronabinol; France; Humans; Marijuana Abuse; Morocco; Population Surveillance; Registries; Residence Characteristics | 2000 |
[Analysis of the major components in cannabis by capillary gas chromatography].
Topics: Cannabidiol; Cannabinol; Cannabis; Chromatography, Gas; Dronabinol | 1998 |
Other therapies for wasting.
Topics: Acquired Immunodeficiency Syndrome; Anabolic Agents; Cannabidiol; Dronabinol; Female; Humans; Ketotifen; Male; Marijuana Smoking; National Institutes of Health (U.S.); Quality of Life; Tumor Necrosis Factor-alpha; Weight Gain | 1995 |
Cannabis and cannabidiol: interview with Robert Gorter, M.D. Interview by Fred Gardner.
Topics: Appetite Stimulants; Cachexia; Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Europe; HIV Infections; Humans; Neoplasms; Phytotherapy; Plant Extracts; United States | 1998 |
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
Topics: Animals; Anticonvulsants; Behavior, Animal; Benzoxazines; Cannabidiol; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Electroshock; Male; Mice; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2001 |
DNA fingerprinting of Cannabis sativa using inter-simple sequence repeat (ISSR) amplification.
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; DNA Fingerprinting; Dronabinol; Nucleic Acid Amplification Techniques; Repetitive Sequences, Nucleic Acid | 2002 |
Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Disease Models, Animal; Dronabinol; Male; Nausea; Phytotherapy; Plant Preparations; Psychotropic Drugs; Rats; Rats, Sprague-Dawley | 2002 |
The inheritance of chemical phenotype in Cannabis sativa L.
Topics: Cannabidiol; Cannabis; Crosses, Genetic; Dronabinol; Genetic Markers; Genetic Variation | 2003 |
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Topics: Administration, Oral; Affect; Appetite; Cannabidiol; Cannabinoids; Cannabis; Clinical Trials, Phase III as Topic; Double-Blind Method; Dronabinol; Humans; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Plant Extracts; Reflex, Abnormal; Safety; Sleep; Switzerland; Treatment Outcome; United Kingdom | 2003 |
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Female; Injections, Intraperitoneal; Lithium Chloride; Male; Piperidines; Pyrazoles; Rimonabant; Shrews; Vomiting | 2004 |
Neuroscience. Stout guards of the central nervous system.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Brain; Brain Diseases; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Convulsants; Dronabinol; Endocannabinoids; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Glycerides; Humans; Kainic Acid; Mice; Neurons; Neuroprotective Agents; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction | 2003 |
Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite.
Topics: Animals; Apoptosis; Cannabidiol; Cyclic N-Oxides; Dose-Response Relationship, Drug; Dronabinol; In Situ Nick-End Labeling; Male; N-Methylaspartate; Neurons; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Oxidative Stress; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Retina; Reverse Transcriptase Polymerase Chain Reaction; Spin Labels; Time Factors | 2003 |
Oral cannabinoids for spasticity in multiple sclerosis: will attitude continue to limit use?
Topics: Administration, Oral; Cannabidiol; Cannabinoids; Double-Blind Method; Dronabinol; Drug and Narcotic Control; Humans; Multicenter Studies as Topic; Multiple Sclerosis; Muscle Spasticity; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; United States | 2003 |
Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Body Temperature; Brain; Brain Chemistry; Cannabidiol; Chromatography, High Pressure Liquid; Corticosterone; Disease Models, Animal; Dronabinol; Drug Interactions; Formaldehyde; Male; Morphine; Motor Activity; Narcotics; Pain; Pain Measurement; Psychotropic Drugs; Radioimmunoassay; Rats; Time Factors | 2004 |
Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.
Topics: Abdomen; Cannabidiol; Cannabinol; Diffusion Chambers, Culture; Dronabinol; Humans; In Vitro Techniques; Permeability; Skin; Tissue and Organ Harvesting | 2004 |
Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Topics: Amphetamine; Animals; Cannabidiol; Cocaine; Conditioning, Operant; Dronabinol; Extinction, Psychological; Learning; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2004 |
GW-1000. GW Pharmaceuticals.
Topics: Administration, Oral; Analgesics; Animals; Biological Availability; Canada; Cannabidiol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dronabinol; Drug Approval; Drug Combinations; Drug Evaluation, Preclinical; Drug Industry; Humans; Hyperalgesia; Investigational New Drug Application; Mice; Molecular Structure; Multiple Sclerosis; Patents as Topic; Peripheral Nervous System Diseases; Phytotherapy; Plant Extracts; Plant Preparations; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Structure-Activity Relationship | 2004 |
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.
Topics: Adult; Cannabidiol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Follow-Up Studies; Humans; Medical Records; Middle Aged; Multiple Sclerosis; Pilot Projects; Plant Extracts; Sensation; Surveys and Questionnaires; Treatment Outcome; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination; Urodynamics | 2004 |
Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.
Topics: Animals; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Male; Maze Learning; Memory; Plant Extracts; Rats; Receptor, Cannabinoid, CB1 | 2004 |
Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cannabidiol; Clinical Trials, Phase I as Topic; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dronabinol; Humans; Pain; Psychotropic Drugs | 2004 |
Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism.
Topics: Analysis of Variance; Animals; Body Temperature; Brain Infarction; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fever; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Tetrazolium Salts; Time Factors | 2004 |
Effect of cannabis use in human brain activity.
Topics: Brain; Cannabidiol; Cannabis; Dronabinol; Humans | 2005 |
Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
Topics: Administration, Oral; Administration, Sublingual; Animals; beta-Cyclodextrins; Biological Availability; Cannabidiol; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Male; Methylation; Rabbits; Solubility; Time Factors | 2005 |
Conditional okay for cannabis prescription drug.
Topics: Canada; Cannabidiol; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Humans; Multiple Sclerosis; Neuralgia; Phytotherapy; Plant Extracts | 2005 |
Sublingual drug delivery during functional magnetic resonance imaging.
Topics: Administration, Sublingual; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Drug Delivery Systems; Humans; Magnetic Resonance Imaging; Plant Extracts | 2005 |
Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: An animal model of anticipatory nausea and vomiting.
Topics: Analysis of Variance; Animals; Antiemetics; Association Learning; Cannabidiol; Cannabinoids; Conditioning, Classical; Disease Models, Animal; Dronabinol; Female; Lithium Chloride; Male; Nausea; Ondansetron; Serotonin Antagonists; Shrews; Vomiting, Anticipatory | 2006 |
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.
Topics: Animals; Cannabidiol; Clinical Trials as Topic; Dronabinol; Drug Therapy, Combination; Humans; Neoplasms | 2006 |
Simultaneous determination of cannabidiol, cannabinol, and delta9-tetrahydrocannabinol in human hair by gas chromatography-mass spectrometry.
Topics: Adult; Cannabidiol; Cannabinol; Dronabinol; Drug Stability; Gas Chromatography-Mass Spectrometry; Hair; Humans | 2005 |
Sativex for the management of multiple sclerosis symptoms.
Topics: Administration, Oral; Administration, Sublingual; Aerosols; Analgesics; Canada; Cannabidiol; Dronabinol; Drug Approval; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Sleep Wake Disorders; Tremor; United Kingdom | 2005 |
Extraction and analysis of different Cannabis samples by headspace solid-phase microextraction combined with gas chromatography-mass spectrometry.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Cluster Analysis; Dronabinol; Gas Chromatography-Mass Spectrometry; Molecular Structure; Principal Component Analysis; Switzerland | 2005 |
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.
Topics: Allosteric Regulation; Analgesics, Opioid; Animals; Cannabidiol; Cerebral Cortex; Dose-Response Relationship, Drug; Dronabinol; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu | 2006 |
Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Topics: Animals; Body Temperature Regulation; Brain; Cannabidiol; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Inhalation Exposure; Injections, Intravenous; Male; Marijuana Smoking; Mice; Mice, Inbred ICR; Models, Animal; Motor Activity; Pain Threshold | 2006 |
The use of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Topics: Analgesics; Arthritis, Rheumatoid; Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Humans; Pain; Plant Extracts; Treatment Outcome | 2006 |
Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.
Topics: Adenosine; Animals; Camphanes; Cannabidiol; Cell Line; Cell Proliferation; DNA; Dronabinol; Equilibrative Nucleoside Transporter 1; Immunosuppression Therapy; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Nucleoside Transport Proteins; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant; Thymidine; Tumor Necrosis Factor-alpha | 2006 |
Simple and sensitive determination of Delta(9)-tetrahydrocannabinol, cannabidiol and cannabinol in hair by combined silylation, headspace solid phase microextraction and gas chromatography-mass spectrometry.
Topics: Calibration; Cannabidiol; Cannabinol; Dronabinol; Gas Chromatography-Mass Spectrometry; Hair; Humans; Reference Standards; Sensitivity and Specificity | 2007 |
New pain management options: drugs.
Topics: Analgesics, Opioid; Cannabidiol; Cannabinoids; Carbazoles; Chronic Disease; Dronabinol; Drug Combinations; Humans; Ibuprofen; Oxycodone; Oxymorphone; Pain; Plant Extracts; Serotonin Receptor Agonists; Tryptamines | 2007 |
Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cannabidiol; Cerebral Infarction; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperazines; Piperidines; Pyrazoles; Rimonabant; Serotonin Antagonists; Time Factors | 2007 |
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells.
Topics: Animals; Benzoxazines; beta-N-Acetylhexosaminidases; Calcium; Cannabidiol; Cannabinoids; Capsaicin; Cell Degranulation; Cell Line; Cyclohexanols; Dronabinol; Intracellular Fluid; Mast Cells; Morpholines; Naphthalenes; Rats; TRPV Cation Channels | 2007 |
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.
Topics: Animals; Arachidonic Acids; Benzamides; Calcium; Cannabidiol; Cannabinoid Receptor Modulators; Carbamates; Cells, Cultured; Dronabinol; Endocannabinoids; Estrenes; Glutamic Acid; Glycerides; Hippocampus; Humans; Morpholines; Pertussis Toxin; Phosphodiesterase Inhibitors; Polyunsaturated Alkamides; Pyrazoles; Pyrrolidinones; Rats; Receptor, Cannabinoid, CB1; Signal Transduction | 2007 |
Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism.
Topics: Animals; Behavior, Animal; Cannabidiol; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Functional Laterality; Glutamic Acid; Infarction, Middle Cerebral Artery; Male; Mice; Motor Activity; Neuroprotective Agents; Perfusion; Peroxidase; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Tetrazolium Salts; Time Factors | 2007 |
Cannabis; adverse effects from an oromucosal spray.
Topics: Administration, Oral; Adult; Aerosols; Aged; Burns, Chemical; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Pain; Phytotherapy; Plant Extracts | 2007 |
Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Topics: Animals; Body Temperature; Brain; Cannabidiol; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Hypothermia; Male; Maze Learning; Memory Disorders; Mice; Motor Activity; Psychotropic Drugs; Receptor, Cannabinoid, CB1 | 2008 |
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
Topics: Animals; Cannabidiol; Cannabis; Conditioning, Psychological; Discrimination Learning; Dronabinol; Male; Mice; Mice, Inbred ICR; Spatial Behavior | 2008 |
Smoked marijuana as medicine: not much future.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Antiemetics; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Evidence-Based Medicine; Humans; Marijuana Smoking | 2008 |
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.
Topics: Adult; Analysis of Variance; Cannabidiol; Delusions; Dronabinol; Female; Hair; Humans; Male; Marijuana Abuse; Predictive Value of Tests; Psychoses, Substance-Induced | 2008 |
Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol.
Topics: Analgesics, Non-Narcotic; Animals; Calcium; Calcium Channels, T-Type; Cannabidiol; Cannabis; Cell Line; Dose-Response Relationship, Drug; Dronabinol; Gene Expression; Humans; Kinetics; Membrane Potentials; Mice; Neurons, Afferent; Receptor, Cannabinoid, CB1 | 2008 |
Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1).
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cannabidiol; Cannabinoids; Cannabinol; Cell Line, Tumor; Cell Membrane; Dronabinol; Female; Gene Expression; Humans; Insecta; Ovarian Neoplasms; Plant Extracts | 2008 |
The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus.
Topics: Animals; Antiemetics; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Motion Sickness; Receptor, Cannabinoid, CB1; Shrews; Vestibule, Labyrinth; Vomiting | 2008 |
Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro.
Topics: Cannabidiol; Cannabinoid Receptor Antagonists; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Gene Expression Regulation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Interferon-alpha; Kynurenine; Leukocytes, Mononuclear; Lipopolysaccharides; Mitogens; Morpholines; Neopterin; Pyrazoles; Statistics, Nonparametric; Tryptophan | 2009 |
Willingness to pay for a treatment for pain in multiple sclerosis.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aerosols; Aged; Aged, 80 and over; Analgesics, Opioid; Attitude to Health; Cannabidiol; Cost-Benefit Analysis; Decision Making; Dronabinol; Drug Combinations; Fees and Charges; Female; Humans; Insurance, Health; Interviews as Topic; Male; Middle Aged; Multiple Sclerosis; Pain; Patient Satisfaction; Plant Extracts; Surveys and Questionnaires | 2009 |
Evaluation of principal cannabinoids in airborne particulates.
Topics: Air Pollutants; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Particulate Matter | 2009 |
Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.
Topics: Animals; Anxiety; Cannabidiol; Dronabinol; Hallucinogens; Interpersonal Relations; Linear Models; Male; Motor Activity; Rats; Rats, Sprague-Dawley | 2009 |
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Behavior, Animal; Cannabidiol; Catalepsy; Dronabinol; Hypothermia; Interpersonal Relations; Male; Mice; Mice, Inbred C57BL; Motor Activity; Pain Measurement; Photoperiod; Psychotropic Drugs; Rats; Rats, Wistar; Schizophrenia; Schizophrenic Psychology; Sensory Gating; Time Factors | 2010 |
Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Topics: Animals; Cannabidiol; Cell Line; Cell Survival; Dronabinol; Inflammation; Intercellular Signaling Peptides and Proteins; Interferon-beta; Intracellular Space; Lipopolysaccharides; Mice; Microglia; NF-kappa B; STAT Transcription Factors | 2010 |
Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Molecular Structure; Plant Extracts; Sensitivity and Specificity | 2009 |
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
Topics: Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Cannabidiol; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dronabinol; Drug Screening Assays, Antitumor; Drug Synergism; Glioblastoma; Humans; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Proteins; Reactive Oxygen Species; Receptor, Cannabinoid, CB2 | 2010 |
Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma.
Topics: Cannabidiol; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Sensitivity and Specificity | 2010 |
Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
Topics: Animals; Antidepressive Agents; Cannabidiol; Cannabinoids; Cannabis; Catalepsy; Depression; Dose-Response Relationship, Drug; Dronabinol; Hindlimb Suspension; Hypothermia; Immobility Response, Tonic; Male; Mice; Random Allocation; Swimming | 2010 |
Lack of positive allosteric modulation of mutated alpha(1)S267I glycine receptors by cannabinoids.
Topics: Allosteric Regulation; Amino Acid Sequence; Cannabidiol; Cell Line; Dronabinol; Humans; Mutation; Patch-Clamp Techniques; Receptors, Glycine | 2010 |
Medical marijuana and the mind. More is known about the psychiatric risks than the benefits.
Topics: Administration, Inhalation; Administration, Oral; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Health Knowledge, Attitudes, Practice; Humans; Marijuana Smoking; Nausea; Pain; Phytotherapy; Plant Preparations; Psychoses, Substance-Induced; United States | 2010 |
Cannabis based drug is licensed for spasticity in patients with MS.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts | 2010 |
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
Topics: Animals; Cannabidiol; Colitis; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Therapy, Combination; Gastrointestinal Motility; In Vitro Techniques; Inflammation; Male; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid | 2010 |
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability.
Topics: Algorithms; Biological Transport, Active; Caco-2 Cells; Cannabidiol; Cannabinoids; Dronabinol; Electric Impedance; Electrophysiology; Enterocytes; Humans; Intestinal Absorption; Microvilli; Permeability; Piperidines; PPAR alpha; PPAR gamma; Pyrazoles; Receptors, Cannabinoid; RNA, Messenger; Tight Junctions; TRPV Cation Channels | 2010 |
Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans.
Topics: Adult; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Female; Humans; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Middle Aged; Motor Cortex; Multiple Sclerosis; Neuronal Plasticity; Plant Extracts; Theta Rhythm; Transcranial Magnetic Stimulation | 2009 |
Validation of an analytical method for analysis of cannabinoids in hair by headspace solid-phase microextraction and gas chromatography-ion trap tandem mass spectrometry.
Topics: Cannabidiol; Cannabinol; Chromatography, Gas; Dronabinol; Hair; Humans; Male; Sensitivity and Specificity; Solid Phase Microextraction; Tandem Mass Spectrometry; Young Adult | 2010 |
Does cannabidiol protect against the negative effects of THC?
Topics: Adolescent; Antipsychotic Agents; Cannabidiol; Dronabinol; Humans; Mental Disorders; Psychotropic Drugs | 2010 |
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].
Topics: Adolescent; Alcohol Drinking; Analysis of Variance; Cannabidiol; Cannabinoids; Dronabinol; Female; Humans; Male; Marijuana Smoking; Memory; Memory Disorders; Mental Recall; Psychiatric Status Rating Scales; Receptor, Cannabinoid, CB1; Saliva; United Kingdom; Verbal Learning; Young Adult | 2010 |
Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol.
Topics: Adult; Cannabidiol; Cannabis; Dronabinol; Hippocampus; Humans; Male; Marijuana Smoking; Neurogenesis; Neuroprotective Agents; Organ Size; Young Adult | 2011 |
Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.
Topics: Animals; Brain; Cannabidiol; Cannabinoids; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Inhalation Exposure; Limit of Detection; Male; Marijuana Smoking; Mice; Mice, Inbred C57BL; Plant Extracts; Reproducibility of Results; Tandem Mass Spectrometry; Tissue Distribution | 2010 |
Heterogeneity in the composition of marijuana seized in California.
Topics: California; Cannabidiol; Cannabis; Databases, Factual; Dronabinol; Humans; Law Enforcement; Psychotropic Drugs | 2011 |
[Cannabis medicinal drugs. "Psychedelics" by prescription?].
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Germany; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Palliative Care; Phytotherapy; Plant Extracts; Psychoses, Substance-Induced | 2010 |
Cultivation of Cannabis sativa L. in northern Morocco.
Topics: Agriculture; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Chromatography, High Pressure Liquid; Developing Countries; Dronabinol; Drug and Narcotic Control; Humans; Marijuana Abuse; Morocco; Plant Preparations; Socioeconomic Factors | 2005 |
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.
Topics: Aryl Hydrocarbon Hydroxylases; Cannabidiol; Cannabinol; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Dronabinol; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Microsomes, Liver; Middle Aged; Resorcinols | 2011 |
[Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry].
Topics: Cannabidiol; Cannabinol; Chromatography, High Pressure Liquid; Dronabinol; Food Contamination; Plant Oils; Tandem Mass Spectrometry | 2010 |
Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism.
Topics: Cannabidiol; Dronabinol; HEK293 Cells; Humans; Mutagenesis; Psychotropic Drugs; Receptors, Serotonin, 5-HT3; Transfection | 2011 |
The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.
Topics: Animals; Arachidonic Acids; beta-Cyclodextrins; Cannabidiol; Cell Death; Cell Line; Cholesterol; Culture Media, Serum-Free; Dronabinol; Endocannabinoids; Gene Expression Regulation; Interleukin-1beta; Lipid Metabolism; Lipopolysaccharides; Mice; Microglia; Oligonucleotide Array Sequence Analysis; Plants; Polyunsaturated Alkamides; RNA, Messenger; Time Factors | 2011 |
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
Topics: Animals; Cannabidiol; Cell Line; Dronabinol; Gene Expression Profiling; Glutathione; Mice; Microglia; Oxidative Stress; Transcription, Genetic | 2012 |
Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
Topics: Age Factors; Animals; Behavior, Animal; Brain; Cannabidiol; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Drug Synergism; Male; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Tissue Distribution | 2011 |
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
Topics: Animals; Cannabidiol; Cannabinoids; Caudate Nucleus; Cells, Cultured; Disease Models, Animal; Disease Progression; Dronabinol; Drug Combinations; Huntington Disease; Male; Neostriatum; Neuroprotective Agents; Phytotherapy; Plant Extracts; Putamen; Rats; Rats, Sprague-Dawley | 2011 |
Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Topics: Adult; Aged; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Humans; Male; Marijuana Abuse; Marijuana Smoking; Middle Aged; Saliva; Substance Abuse Detection; Time Factors; Young Adult | 2011 |
Evaluate symptomatic therapy in MS: can clinical trials be fine-tuned?
Topics: Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2011 |
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.
Topics: Animals; Calcium; Cannabidiol; Cannabinoids; Dronabinol; Gastrointestinal Diseases; HEK293 Cells; Humans; Inflammation; Intestine, Small; Mice; Rats; TRPV Cation Channels | 2012 |
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behavi
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoids; Compulsive Behavior; Dronabinol; Injections, Intraperitoneal; Male; Mice; Obsessive Behavior; Rats; Rats, Wistar | 2012 |
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
Topics: Adolescent; Adult; Anxiety; Cannabidiol; Cognition Disorders; Depression; Dronabinol; Female; Hair; Humans; Illicit Drugs; Male; Marijuana Smoking; Memory; Psychoses, Substance-Induced; Schizotypal Personality Disorder; Young Adult | 2012 |
Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.
Topics: Cannabidiol; Cannabinoids; Coumarins; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dronabinol; Humans; Microsomes, Liver; Oxidoreductases, O-Demethylating; Pharmacokinetics; Polycyclic Aromatic Hydrocarbons; Quaternary Ammonium Compounds; Recombinant Proteins; Steroids; Structure-Activity Relationship | 2011 |
Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Female; Glucuronides; Humans; Male; Marijuana Abuse; Middle Aged; Substance Abuse Detection; Young Adult | 2011 |
Interaction between cannabidiol (CBD) and ∆(9)-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids.
Topics: Animals; Behavior, Animal; Cannabidiol; Dronabinol; Male | 2012 |
Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity.
Topics: Aryl Hydrocarbon Hydroxylases; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; Dronabinol; Enzyme Inhibitors; Female; Humans; Hydroxylation; Kinetics; Microsomes, Liver; Middle Aged; Plant Leaves; Polycyclic Aromatic Hydrocarbons; Recombinant Proteins; Smoke; Warfarin | 2012 |
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.
Topics: Adult; Attention; Cannabidiol; Corpus Striatum; Dronabinol; Hallucinogens; Humans; Male; Prefrontal Cortex; Psychotic Disorders; Reaction Time; Space Perception; Young Adult | 2012 |
Cannabinoid disposition in oral fluid after controlled smoked cannabis.
Topics: Adolescent; Adult; Biomarkers; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Female; Humans; Male; Marijuana Smoking; Middle Aged; Saliva; Substance Abuse Detection; Young Adult | 2012 |
New pain drugs in pipeline, but challenges to usage remain.
Topics: Analgesics; Analgesics, Opioid; Antineoplastic Agents; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drugs, Investigational; Humans; Neoplasms; Neuralgia; Pain; Palliative Care; Plant Extracts | 2012 |
A survey of the potency of Japanese illicit cannabis in fiscal year 2010.
Topics: Cannabidiol; Cannabinol; Cannabis; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Japan; Plant Structures | 2012 |
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Cannabidiol; Cannabis; Cells, Cultured; Dopaminergic Neurons; Dose-Response Relationship, Drug; Dronabinol; Drug Evaluation, Preclinical; Female; Free Radical Scavengers; Mesencephalon; Mice; Neuroprotective Agents; Pregnancy; Tyrosine 3-Monooxygenase | 2012 |
Isomerization of cannabidiol and Δ9-tetrahydrocannabinol during positive electrospray ionization. In-source hydrogen/deuterium exchange experiments by flow injection hybrid quadrupole-time-of-flight mass spectrometry.
Topics: Acetonitriles; Cannabidiol; Deuterium Exchange Measurement; Deuterium Oxide; Dronabinol; Formates; Isomerism; Spectrometry, Mass, Electrospray Ionization | 2012 |
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
Topics: Androgen Antagonists; Anilides; Animals; Apoptosis; Cannabidiol; Cannabinoids; Caspase 3; Cell Cycle; Cell Survival; Docetaxel; Down-Regulation; Dronabinol; Drug Interactions; Humans; Male; Mice; Mice, Nude; Nitriles; Prostate; Prostatic Neoplasms; Reactive Oxygen Species; Receptors, Androgen; Taxoids; Tosyl Compounds; Transient Receptor Potential Channels; TRPM Cation Channels; Tumor Cells, Cultured | 2013 |
Sativex® in multiple sclerosis spasticity: a cost-effectiveness model.
Topics: Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Drug Costs; Drug Resistance; Germany; Humans; Markov Chains; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Quality-Adjusted Life Years; Severity of Illness Index; Spain | 2012 |
The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.
Topics: Animals; Animals, Newborn; Cannabidiol; Disease Models, Animal; Dronabinol; Humans; Marijuana Abuse; Mice; Psychoses, Substance-Induced; Rats; Schizophrenia | 2012 |
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report.
Topics: Administration, Mucosal; Adult; Cannabidiol; Dronabinol; Drug Combinations; Humans; Male; Plant Extracts; Quality of Life; Stiff-Person Syndrome; Surveys and Questionnaires; Treatment Outcome | 2013 |
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Cannabidiol; Caregivers; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Off-Label Use; Phytotherapy; Plant Extracts; Practice Patterns, Physicians'; Sleep; Surveys and Questionnaires; United Kingdom | 2013 |
CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cannabidiol; Cell Line, Tumor; Dronabinol; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Receptor, Cannabinoid, CB2; Rhodamine 123; RNA, Messenger; Time Factors; TRPV Cation Channels | 2012 |
Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Topics: Animals; Cannabidiol; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Combinations; Drug Therapy, Combination; Huntington Disease; Inflammation; Male; Malonates; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2012 |
On-site test for cannabinoids in oral fluid.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Reference Values; Saliva; Sensitivity and Specificity; Substance Abuse Detection; Young Adult | 2012 |
Direct analysis of cannabis samples by desorption atmospheric pressure photoionization-mass spectrometry.
Topics: Atmospheric Pressure; Cannabidiol; Cannabis; Dronabinol; Illicit Drugs; Mass Spectrometry | 2013 |
Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis.
Topics: Administration, Mucosal; Administration, Oral; Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Markov Chains; Middle Aged; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Plant Extracts; Quality-Adjusted Life Years; Severity of Illness Index; United Kingdom | 2012 |
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
Topics: Animals; Anxiety; Behavior, Animal; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Inverse Agonism; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Saccharin; Taste; Taste Perception | 2013 |
Endocannabinoids in nervous system health and disease: the big picture in a nutshell.
Topics: Arachidonic Acids; Brain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dronabinol; Electrical Synapses; Endocannabinoids; Glycerides; Humans; Inflammation; Neurodegenerative Diseases; Neurogenesis; Neuroprotective Agents; Nociceptors; Polyunsaturated Alkamides; Receptors, Cannabinoid; Synaptic Transmission | 2012 |
Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
Topics: Animals; Antipsychotic Agents; Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 2013 |
[Cannabis medicines in Norway--the basis for approval].
Topics: Cannabidiol; Dronabinol; Drug Approval; Drug Combinations; Drug Therapy, Combination; Humans; Multiple Sclerosis; Muscle Spasticity; Norway; Oral Sprays; Plant Extracts | 2012 |
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cannabidiol; Cannabis; Cell Proliferation; Dronabinol; Drug Delivery Systems; Glioblastoma; Humans; Mice; Polymers; Transplantation, Heterologous | 2013 |
Multiple sclerosis spasticity symptoms management. Endocannabinoid system modulator data beyond clinical trials. Foreword.
Topics: Anti-Dyskinesia Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Drugs, Investigational; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2013 |
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.
Topics: Amyloidosis; Animals; Behavior, Animal; Biogenic Monoamines; Cannabidiol; Disease Models, Animal; Dopamine; Dronabinol; Drug Combinations; Frontotemporal Dementia; Glutathione; Humans; Male; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Neuroprotective Agents; Phytotherapy; Plant Extracts; Synaptic Transmission; Tauopathies | 2013 |
In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.
Topics: Blood Specimen Collection; Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Drug Stability; Female; Glucuronides; Humans; Male; Marijuana Smoking; Plasma; Substance Abuse Detection | 2013 |
Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9) tetrahydrocannabinol.
Topics: Animals; Behavior, Animal; Cannabidiol; Cognition; Dronabinol; Functional Laterality; Macaca mulatta; Male; Memory; Memory Disorders; Models, Animal; Molecular Sequence Data; Motivation; Motor Activity; Time Factors | 2013 |
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cannabidiol; Cannabis; Dronabinol; Female; Humans; Incidence; Male; Middle Aged; Netherlands; Phytotherapy; Prevalence; Retrospective Studies; Time Factors | 2013 |
Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Topics: Animals; Antigen-Presenting Cells; Cannabidiol; Cell Line; Coculture Techniques; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Inflammation; Interferon-gamma; Interleukin-17; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Th17 Cells; Tumor Necrosis Factor-alpha | 2013 |
Do cannabinoids exhibit a tyramine-like effect?
Topics: Adrenergic Uptake Inhibitors; Animals; Arachidonic Acids; Benzoxazines; Cannabidiol; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Glycerides; Kidney Cortex; Male; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Time Factors; Tyramine | 2013 |
Towards a better cannabis drug.
Topics: Animals; Behavior, Animal; Cannabidiol; Cognition; Dronabinol; Male; Memory; Memory Disorders | 2013 |
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Cannabidiol; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pain; Retrospective Studies; Treatment Outcome | 2014 |
Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants.
Topics: Antioxidants; Cannabidiol; Computer Simulation; Dronabinol; Electrochemistry; Models, Chemical; Models, Molecular; Molecular Conformation; Quantum Theory | 2013 |
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Topics: Adult; Cannabidiol; Disability Evaluation; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Retrospective Studies; Treatment Outcome | 2014 |
Overview of MS spasticity.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts; Practice Guidelines as Topic | 2014 |
Who benefits most from THC:CBD spray? Learning from clinical experience.
Topics: Activities of Daily Living; Adult; Aged; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Parasympatholytics; Plant Extracts; Quality of Life; Severity of Illness Index; Spinal Cord; Treatment Outcome | 2014 |
Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.
Topics: Adult; Aged; Cannabidiol; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Plant Extracts; Prospective Studies; Severity of Illness Index; Sleep; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
Simultaneous determination of Δ9-tetrahydrocannabinol, cannabidiol, cannabinol and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in hair using liquid chromatography-tandem mass spectrometry.
Topics: Cannabidiol; Chromatography, Liquid; Dronabinol; Forensic Toxicology; Hair; Hallucinogens; Humans; Tandem Mass Spectrometry | 2014 |
[Cannabis - medicinal use].
Topics: Administration, Oral; Affect; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Germany; Humans; Marijuana Abuse; Marijuana Smoking; Medical Marijuana; Multiple Sclerosis; Pain, Intractable; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Receptors, Cannabinoid; Risk Factors; Wasting Syndrome | 2014 |
A PCR marker linked to a THCA synthase polymorphism is a reliable tool to discriminate potentially THC-rich plants of Cannabis sativa L.
Topics: Cannabidiol; Cannabis; Dronabinol; Genetic Linkage; Genetic Markers; Intramolecular Oxidoreductases; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Genetic; Sequence Analysis; Species Specificity | 2014 |
Federal red tape ties up marijuana research.
Topics: Biomedical Research; Cannabidiol; Cannabinol; Cannabis; Child; Colorado; Data Collection; Dronabinol; Federal Government; Female; Humans; Marijuana Smoking; National Institute on Drug Abuse (U.S.); Pregnancy; United States; Washington | 2014 |
[Therapeutic use of cannabis derivatives].
Topics: Antiemetics; Cannabidiol; Dronabinol; Drug Combinations; Fibromyalgia; Humans; Multiple Sclerosis; Muscle Spasticity; Pain; Plant Extracts | 2014 |
Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Cannabidiol; Dronabinol; Drug Combinations; Endocannabinoids; Female; Gene Expression Regulation; Humans; Male; Mice, Transgenic; Phospholipase D; Plant Extracts; Receptors, Cannabinoid; Sex Factors; Spinal Cord; Superoxide Dismutase | 2014 |
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Topics: Adult; Aged; Aged, 80 and over; Cannabidiol; Cannabis; Chronic Pain; Cross-Sectional Studies; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Netherlands; Patient Satisfaction; Phytotherapy; Plant Preparations; Psychometrics; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.
Topics: Animals; Arachidonic Acids; Arrestins; beta-Arrestins; Calcium; Cannabidiol; Cannabinoid Receptor Agonists; CHO Cells; Cricetulus; Cyclohexanes; Dronabinol; Glycine; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, G-Protein-Coupled; Resorcinols; Signal Transduction | 2014 |
Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
Topics: Adolescent; Cannabidiol; Cannabis; Cross-Sectional Studies; Dronabinol; Female; Humans; Male; Marijuana Smoking; United Kingdom; Young Adult | 2014 |
Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol/cannabidiol oromucosal spray) in clinical practice.
Topics: Adult; Aged; Analgesics; Cannabidiol; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Patient Satisfaction; Prospective Studies; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2014 |
Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Equipment Design; Humans; Limit of Detection; Marijuana Smoking; Middle Aged; Saliva; Specimen Handling; Substance Abuse Detection; Young Adult | 2015 |
Simultaneous quantification of delta-9-THC, THC-acid A, CBN and CBD in seized drugs using HPLC-DAD.
Topics: Cannabidiol; Cannabinol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Plant Extracts; Psychotropic Drugs | 2014 |
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.
Topics: Administration, Mucosal; Aerosols; Cannabidiol; Dronabinol; Drug Administration Schedule; Drug Combinations; Drug Interactions; Drug Packaging; Drug Storage; Evidence-Based Medicine; Humans; Multiple Sclerosis; Neuromuscular Agents; Treatment Outcome | 2014 |
Cannabinoid-induced changes in respiration of brain mitochondria.
Topics: Animals; Arachidonic Acids; Benzoxazines; Brain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cell Respiration; Dose-Response Relationship, Drug; Dronabinol; Drug Inverse Agonism; Endocannabinoids; Energy Metabolism; Mitochondria; Morpholines; Naphthalenes; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Signal Transduction; Swine | 2014 |
Drug-resistant MS spasticity treatment with Sativex(®) add-on and driving ability.
Topics: Adult; Automobile Driving; Cannabidiol; Dronabinol; Drug Combinations; Female; Germany; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pilot Projects; Plant Extracts | 2015 |
Cannabis, cannabidiol, and epilepsies: the truth is somewhere in the middle.
Topics: Animals; Cannabidiol; Dronabinol; Epilepsy; Humans; Medical Marijuana; Seizures | 2014 |
Cannabinoid modulation of functional connectivity within regions processing attentional salience.
Topics: Adult; Attention; Brain; Brain Mapping; Cannabidiol; Cannabis; Dronabinol; Humans; Magnetic Resonance Imaging; Male; Marijuana Smoking; Neural Pathways; Neuropsychological Tests; Psychotropic Drugs | 2015 |
Should patient groups be more transparent about their funding?
Topics: Analgesics; Cannabidiol; Capital Financing; Charities; Dronabinol; Drug Combinations; Drug Industry; Humans; Multiple Sclerosis; Self-Help Groups; United Kingdom | 2014 |
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
Topics: Animals; Cannabidiol; Dronabinol; Drug Combinations; Endocannabinoids; Humans; Motor Cortex; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Muscle, Skeletal; Neural Pathways; Plant Extracts; Spinal Cord | 2014 |
Advances in the management of multiple sclerosis spasticity: recent clinical trials.
Topics: Affect; Cannabidiol; Clinical Trials, Phase III as Topic; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Plant Extracts; Randomized Controlled Trials as Topic | 2014 |
Advances in the management of MS spasticity: recent observational studies.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Germany; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Plant Extracts; Registries; Spain; United Kingdom | 2014 |
Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.
Topics: Activities of Daily Living; Cannabidiol; Cost of Illness; Dronabinol; Drug Combinations; Europe; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Plant Extracts; Quality of Life | 2014 |
A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9-tetrahydrocannabinol (THC) by vaporisation.
Topics: Administration, Inhalation; Cannabidiol; Dronabinol; Humans | 2014 |
Transparency of funding of patient groups is mandatory but is not enough.
Topics: Analgesics; Cannabidiol; Capital Financing; Charities; Dronabinol; Drug Industry; Humans; Multiple Sclerosis | 2014 |
Who will support independent patient groups?
Topics: Analgesics; Cannabidiol; Capital Financing; Charities; Dronabinol; Drug Industry; Humans; Multiple Sclerosis | 2014 |
The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model.
Topics: Animals; Cannabidiol; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Female; Glioma; Humans; Mice; Radiation; Radiation Tolerance; Signal Transduction; Tumor Burden | 2014 |
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Topics: Animals; Body Temperature; Cannabidiol; Cannabinoid Receptor Antagonists; Dronabinol; Hypothermia; Male; Motor Activity; Piperidines; Pyrazoles; Rats, Sprague-Dawley; Rimonabant; Telemetry | 2015 |
Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Humans; Limit of Detection; Saliva; Solid Phase Extraction; Tandem Mass Spectrometry | 2015 |
Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Cannabidiol; Cannabinoids; Cell Line; Dronabinol; Hepatocytes; Humans; Lipid Metabolism; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Oleic Acid; Receptor, Cannabinoid, CB1; Triglycerides; TRPV Cation Channels; Zebrafish | 2015 |
Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Topics: Amino Acid Sequence; Animals; Cannabidiol; Carrier Proteins; Dronabinol; Fatty Acid-Binding Proteins; HeLa Cells; Humans; Mice; Molecular Docking Simulation; Molecular Sequence Data; Rats; Sequence Homology, Amino Acid; Signal Transduction | 2015 |
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cannabidiol; Cannabinoids; Cannabinol; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Dronabinol; Drug Combinations; Humans; Male; Melanoma; Membrane Proteins; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Plant Extracts; Proto-Oncogene Proteins B-raf; ras Proteins; Skin Neoplasms; Temozolomide | 2015 |
Sativex in the management of multiple sclerosis-related spasticity: role of the corticospinal modulation.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cerebral Cortex; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Humans; Multiple Sclerosis; Muscle Spasticity; Neural Inhibition; Plant Extracts; Pyramidal Tracts; Sensorimotor Cortex; Transcranial Magnetic Stimulation | 2015 |
[Assessment of the effectiveness and safety of Sativex® in compassionate use].
Topics: Adult; Aged; Cannabidiol; Compassionate Use Trials; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Treatment Outcome | 2015 |
High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.
Topics: Cannabidiol; Cannabis; Causality; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Schizophrenic Psychology | 2015 |
Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy.
Topics: Cannabidiol; Cost of Illness; Cost-Benefit Analysis; Delivery of Health Care; Dronabinol; Drug Combinations; Humans; Italy; Markov Chains; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Quality-Adjusted Life Years | 2015 |
Marijuana gears up for production high in US labs.
Topics: Biomedical Research; Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Smoking; Medical Marijuana; National Institute on Drug Abuse (U.S.); United States | 2015 |
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
Topics: Analysis of Variance; Animals; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Fear; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Wistar; Time Factors | 2015 |
Need for a comprehensive national survey of cannabis use.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Abuse; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 2015 |
[A breakthrough for the treatment of spasticity in multiple sclerosis].
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Parasympatholytics; Plant Extracts | 2015 |
The cannabis conundrum: Thinking outside the THC box.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Illicit Drugs; Legislation, Drug | 2015 |
A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
Topics: Animals; Cannabidiol; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Drug Therapy, Combination; Mice; Mice, Inbred Strains; Multiple Sclerosis; Plant Extracts; Theilovirus | 2015 |
Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
Topics: Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Middle Aged; Multiple Sclerosis; Self-Injurious Behavior; Suicidal Ideation | 2015 |
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Cannabidiol; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Female; Lithium Chloride; Male; Shrews; Vomiting | 2015 |
Development of a simple and sensitive HPLC-UV method for the simultaneous determination of cannabidiol and Δ(9)-tetrahydrocannabinol in rat plasma.
Topics: Animals; Cannabidiol; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Dronabinol; Drug Contamination; Green Chemistry Technology; Hydrogen-Ion Concentration; Plasma; Rats; Rifampin; Sensitivity and Specificity; Solvents; Spectrophotometry, Ultraviolet; Temperature | 2015 |
¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification.
Topics: Cannabidiol; Cannabinoids; Cannabis; Cell Survival; Chromatography, High Pressure Liquid; Dronabinol; Flavones; HeLa Cells; Humans; Plant Extracts; Proton Magnetic Resonance Spectroscopy | 2015 |
Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
Topics: Cannabidiol; Cannabinol; Cannabis; Chromatography, Gas; Dronabinol; Netherlands; Psychotropic Drugs; Time Factors | 2015 |
Walking improvements with nabiximols in patients with multiple sclerosis.
Topics: Adult; Biomechanical Phenomena; Cannabidiol; Dronabinol; Drug Combinations; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Multiple Sclerosis; Outcome Assessment, Health Care; Severity of Illness Index; Walking | 2015 |
Cannabinoid concentrations detected in fatal road traffic collision victims compared with a population of other postmortem cases.
Topics: Accidents, Traffic; Adolescent; Adult; Aged; Cannabidiol; Cannabinoids; Cannabinol; Child; Dronabinol; England; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Marijuana Smoking; Middle Aged; Substance Abuse Detection; Young Adult | 2015 |
Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
Topics: Animals; Body Temperature; Brain; Cannabidiol; Dronabinol; Drug Interactions; Exploratory Behavior; Male; Medical Marijuana; Mice; Motor Activity; Neurons | 2016 |
A potted history.
Topics: Animals; Canada; Cannabidiol; Cannabinol; Cannabis; China; Dronabinol; Drug and Narcotic Control; Drug Approval; Drug Combinations; Endocannabinoids; Herbal Medicine; History, 16th Century; History, 17th Century; History, 19th Century; History, 20th Century; History, 21st Century; History, Ancient; History, Medieval; Humans; Medical Marijuana; Multiple Sclerosis; New Orleans; Phytotherapy; Plant Extracts; Plants, Medicinal; Receptors, Cannabinoid | 2015 |
Drug development: The treasure chest.
Topics: Allosteric Site; Analgesics; Animals; Cannabidiol; Cannabinoids; Cannabis; Child; Clinical Trials as Topic; Congresses as Topic; Dronabinol; Drug Combinations; Drug Discovery; Endocannabinoids; Humans; Mice; Plant Extracts; Receptors, Cannabinoid; Seizures; Terpenes | 2015 |
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study.
Topics: Adult; Cannabidiol; Cohort Studies; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Severity of Illness Index; Treatment Outcome | 2016 |
Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells.
Topics: Apoptosis; Biomarkers, Tumor; Cannabidiol; Cell Proliferation; Dronabinol; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Hallucinogens; Heat-Shock Proteins; Humans; Immunoenzyme Techniques; Oligonucleotide Array Sequence Analysis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Burden; Tumor Cells, Cultured | 2015 |
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Prospective Studies | 2015 |
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Mice, Inbred C57BL; Neuroprotective Agents; Photomicrography; Piperidines; Plant Extracts; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Spinal Cord | 2015 |
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.
Topics: Adult; Aged; Cannabidiol; Cohort Studies; Dronabinol; Female; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Time Factors; Treatment Outcome; Young Adult | 2016 |
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis.
Topics: Adult; Cannabidiol; Cost Savings; Cost-Benefit Analysis; Dronabinol; Hospitalization; Humans; Markov Chains; Models, Economic; Multiple Sclerosis; Muscle Spasticity; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Wales | 2016 |
Hippocampal harms, protection and recovery following regular cannabis use.
Topics: Adult; Cannabidiol; Cannabis; Dronabinol; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Marijuana Abuse | 2016 |
Medical use of cannabis products: Lessons to be learned from Israel and Canada.
Topics: Canada; Cannabidiol; Cross-Cultural Comparison; Dronabinol; Drug and Narcotic Control; Drug Combinations; Germany; Humans; Insurance Coverage; Israel; Medical Marijuana; National Health Programs; Pain | 2016 |
[Cannabis as a therapeutic agent: Focal topic].
Topics: Cannabidiol; Combined Modality Therapy; Dronabinol; Germany; Insurance Coverage; Medical Marijuana; National Health Programs; Pain; Palliative Care; Prescription Drugs | 2016 |
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cannabidiol; Cognition; Disease Models, Animal; Dronabinol; Humans; Male; Medical Marijuana; Memory; Mice, Inbred C57BL; Mice, Transgenic; Nootropic Agents; Presenilin-1; Random Allocation; Receptor, Cannabinoid, CB2; tau Proteins; Treatment Outcome | 2016 |
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
Topics: Adult; Amines; Baclofen; Calcium Channel Blockers; Cannabidiol; Cohort Studies; Cyclohexanecarboxylic Acids; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Germany; Humans; Italy; Male; Medical Marijuana; Middle Aged; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Oral Sprays; Plant Extracts; Pregabalin; Prospective Studies; Treatment Outcome | 2016 |
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
Topics: Adult; Cannabidiol; Data Collection; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Medical Marijuana; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Plant Extracts; Prospective Studies; Registries; Treatment Outcome | 2016 |
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
Topics: Administration, Oral; Adult; Aged; Analgesics; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Mucosa; Multiple Sclerosis; Muscle Spasticity; Reflex, Stretch; Treatment Outcome | 2016 |
The therapeutic use of cannabinoids: Forensic aspects.
Topics: Administration, Inhalation; Analgesics, Non-Narcotic; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Female; Forensic Toxicology; Humans; Male; Middle Aged; Multiple Sclerosis; Pain, Intractable | 2016 |
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Topics: Administration, Oral; Cannabidiol; Dronabinol; Drug Combinations; Humans; Italy; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Safety | 2016 |
Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice.
Topics: Analgesics; Animals; Cannabidiol; Cisplatin; Dronabinol; Drug Combinations; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Plant Extracts | 2016 |
Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
Topics: Biomarkers; Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Glucuronides; Humans; Marijuana Smoking; Substance Abuse Detection; Tandem Mass Spectrometry | 2016 |
Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cannabidiol; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Macaca mulatta; Male; Piperidines; Pyrazoles; Reinforcement Schedule; Rimonabant | 2016 |
Automated GC-MS Determination of Δ9-Tetrahydrocannabinol, Cannabinol and Cannabidiol in Hair.
Topics: Automation, Laboratory; Cannabidiol; Cannabinol; Dronabinol; Gas Chromatography-Mass Spectrometry; Hair; Humans; Psychotropic Drugs; Substance Abuse Detection | 2016 |
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis.
Topics: Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Combinations; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Muscle Relaxants, Central; Muscle Spasticity; Trigeminal Neuralgia | 2016 |
Should we care about sativex-induced neurobehavioral effects? A 6-month follow-up study.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Follow-Up Studies; Humans; Multiple Sclerosis; Muscle Spasticity; Plant Extracts | 2016 |
Cannabis Use Surveillance by Sweat Analysis.
Topics: Adolescent; Adult; Cannabidiol; Cannabinol; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Hair; Humans; Limit of Detection; Male; Middle Aged; Substance Abuse Detection; Sweat; Urine; Young Adult | 2016 |
Cannabis and cannabinoids.
Topics: Administration, Oral; Analgesics; Anticonvulsants; Antiemetics; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Combinations; Drug Interactions; Humans; Medical Marijuana; Parasympatholytics; Plant Extracts | 2016 |
The use of medical-grade cannabis in patients non-responders to Nabiximols.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Medical Marijuana; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Retrospective Studies; Treatment Outcome | 2016 |
Long-term stability of cannabinoids in oral fluid after controlled cannabis administration.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Cannabis; Chromatography, Liquid; Dronabinol; Drug Stability; Female; Humans; Male; Marijuana Smoking; Mass Spectrometry; Middle Aged; Saliva; Substance Abuse Detection; Young Adult | 2017 |
Severe motor and vocal tics controlled with Sativex®.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Humans; Male; Psychiatric Status Rating Scales; Reproducibility of Results; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome; Videotape Recording | 2016 |
Determination of Drugs of Abuse in a Single Sample of Human Teeth by a Gas Chromatography-Mass Spectrometry Method.
Topics: Cannabidiol; Cannabinol; Cocaine; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Limit of Detection; Opiate Alkaloids; Substance Abuse Detection; Substance-Related Disorders; Tooth | 2017 |
Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.
Topics: Animals; Cannabidiol; Cognition; Dronabinol; Drug Administration Schedule; Drug Interactions; Female; Macaca mulatta; Male; Psychomotor Performance | 2016 |
Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
Topics: Activities of Daily Living; Adult; Baclofen; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Plant Extracts; Prospective Studies; Quality of Life | 2016 |
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray.
Topics: Adult; Aged; Cannabidiol; Cannabinoid Receptor Modulators; Disability Evaluation; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Female; Follow-Up Studies; H-Reflex; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Nasal Sprays; Neuromuscular Agents; Oral Sprays; Plant Extracts; Severity of Illness Index; Treatment Outcome | 2016 |
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies.
Topics: Cannabidiol; Chromatography, Liquid; Cooking; Dronabinol; Drug Stability; Food Additives; Food Analysis; Legislation, Food; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry | 2017 |
[Does stronger cannabis cause more health problems?].
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Marijuana Abuse; Marijuana Smoking; Mental Disorders | 2016 |
Country breakout session highlights.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Europe; Gait Disorders, Neurologic; Humans; Multiple Sclerosis; Muscle Spasticity | 2016 |
What is new in multiple sclerosis spasticity research? Poster session highlights.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity | 2016 |
Interactions between cannabidiol and Δ
Topics: Acetylation; Animals; Anxiety; Body Temperature; Cannabidiol; Cannabinoid Receptor Agonists; Dopamine; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Epigenesis, Genetic; Histones; Male; Mice, Inbred C57BL; Motor Activity; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Sensory Gating; Time Factors; Ventral Tegmental Area | 2017 |
Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
Topics: Calibration; Cannabidiol; Cannabinoids; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Marijuana Smoking; Substance Abuse Detection | 2017 |
Cannabinoid concentrations in Canada's regulated medical cannabis industry.
Topics: Canada; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Medical Marijuana | 2017 |
Δ
Topics: Animals; Attention; Cannabidiol; Cannabinoid Receptor Modulators; Cognition; Decision Making; Dose-Response Relationship, Drug; Dronabinol; Male; Motivation; Neuropsychological Tests; Prefrontal Cortex; Psychotropic Drugs; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reward | 2017 |
Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
Topics: Animals; Cannabidiol; Cannabinoids; Chromatography, High Pressure Liquid; Colitis; Colon; Dronabinol; Limit of Detection; Male; Mice; Mice, Inbred ICR; Pancreas; Tandem Mass Spectrometry | 2017 |
Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study.
Topics: Brain; Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Erotica; Humans; Hydrocortisone; Hypnotics and Sedatives; Libido; Magnetic Resonance Imaging; Nucleus Accumbens; Pilot Projects; Prolactin | 2017 |
Effect of prior foot shock stress and Δ
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Male; Rats; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists | 2017 |
Cannabidiol-Δ
Topics: Acute Pain; Analgesics, Non-Narcotic; Animals; Cannabidiol; Dronabinol; Drug Interactions; Female; Locomotion; Male; Rats; Sex Factors | 2017 |
THC and CBD in blood samples and seizures in Norway: Does CBD affect THC-induced impairment in apprehended subjects?
Topics: Accidents, Traffic; Adult; Cannabidiol; Driving Under the Influence; Dronabinol; Female; Humans; Male; Marijuana Abuse; Multivariate Analysis; Norway | 2017 |
Single and combined effects of Δ
Topics: Analgesics; Animals; Antineoplastic Agents, Phytogenic; Cannabidiol; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Hyperalgesia; Male; Mice, Inbred C57BL; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Vincristine | 2017 |
[Compassionate use of cannabidiol in spray form for the treatment of spastic paraparesis in a patient with adrenomyeloneuropathy].
Topics: Adrenoleukodystrophy; Adult; Aerosols; Cannabidiol; Compassionate Use Trials; Dronabinol; Drug Combinations; Humans; Male; Paraparesis, Spastic | 2017 |
The effect of antioxidants on the long-term stability of THC and related cannabinoids in sampled whole blood.
Topics: Antioxidants; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Drug Combinations; Humans; Male | 2018 |
Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior.
Topics: Brain; Cannabidiol; Cannabis; Cognition; Dronabinol; Humans; Schizophrenia | 2017 |
The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
Topics: Administration, Intravenous; Animals; Cannabidiol; Cocaine; Dose-Response Relationship, Drug; Dronabinol; Female; Male; Rats; Rats, Long-Evans; Self Administration; Sex Factors | 2017 |
The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Topics: Administration, Oral; Alkaloids; Animals; Benzodioxoles; Biological Availability; Cannabidiol; Curcumin; Dronabinol; Drug Delivery Systems; Emulsions; Excipients; Gastrointestinal Absorption; Lipids; Male; Nanoparticles; Piperidines; Polyunsaturated Alkamides; Rats, Wistar; Resveratrol; Stilbenes | 2017 |
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
Topics: Adult; Aged; Aged, 80 and over; Cannabidiol; Cost Sharing; Dronabinol; Drug Approval; Drug Combinations; Drug Costs; Drug Industry; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Sclerosis; Multivariate Analysis; Muscle Spasticity; Parasympatholytics; Plant Extracts; Proportional Hazards Models; Registries; Regression Analysis; Severity of Illness Index; Young Adult | 2017 |
[European Union regulatory and quality requirements for botanical drugs and their implications for Chinese herbal medicinal products development].
Topics: Andrographis paniculata; Cannabidiol; Catechin; Dronabinol; Drug Approval; Drug Combinations; Drugs, Chinese Herbal; European Union; Herbal Medicine; Humans; Legislation, Drug; Plant Extracts | 2017 |
Cannabis constituent synergy in a mouse neuropathic pain model.
Topics: Analgesics; Animals; Cannabidiol; Cannabis; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Hyperalgesia; Male; Mice, Inbred C57BL; Neuralgia | 2017 |
[Delta-9-tetrahydrocannabinol-cannabidiol in the treatment of spasticity in chronic spinal cord injury: a clinical experience].
Topics: Adult; Aged; Cannabidiol; Chronic Disease; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Muscle Spasticity; Spinal Cord Injuries; Treatment Outcome | 2017 |
Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series.
Topics: Adult; Antipsychotic Agents; Cannabidiol; Cannabis; Comorbidity; Dronabinol; Female; Humans; Inpatients; Male; Marijuana Abuse; Marijuana Smoking; Medical Marijuana; Middle Aged; Psychotic Disorders; Young Adult | 2018 |
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.
Topics: Administration, Mucosal; Administration, Oral; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Longitudinal Studies; Male; Middle Aged; Multiple Sclerosis; Pilot Projects; Prospective Studies; Treatment Outcome; Urinary Bladder, Overactive | 2018 |
Developmental Effects of Cannabidiol and Δ9-Tetrahydrocannabinol in Zebrafish.
Topics: Animals; Behavior, Animal; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Embryo, Nonmammalian; Embryonic Development; Lethal Dose 50; Transcriptome; Zebrafish | 2018 |
Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
Topics: Acoustic Stimulation; Administration, Inhalation; Administration, Oral; Analysis of Variance; Animals; Brain; Cannabidiol; Dronabinol; Drug Administration Routes; Drug Combinations; Exploratory Behavior; Gas Chromatography-Mass Spectrometry; Injections, Subcutaneous; Male; Prepulse Inhibition; Rats; Rats, Wistar; Time Factors; Tissue Distribution | 2017 |
Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Dronabinol; Drug Approval; Drug Combinations; Europe; Germany; Humans; Israel; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Pain Management; Palliative Care; Societies, Medical; Surveys and Questionnaires; Vomiting | 2018 |
What's new in multiple sclerosis spasticity research? Poster session highlights.
Topics: Cannabidiol; Dronabinol; Humans; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Oral Sprays | 2017 |
Pharmacological Foundations of Cannabis Chemovars.
Topics: Biomarkers; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Plant Breeding | 2018 |
Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.
Topics: Animals; Biological Assay; Cannabidiol; Dog Diseases; Dogs; Dronabinol; Drug Monitoring; Epilepsy; Gas Chromatography-Mass Spectrometry; Humans; Medical Marijuana | 2017 |
[Simultaneous Determination of Three Kinds of Effective Constituents in Cannabis Plants by Reversed-phase HPLC].
Topics: Cannabidiol; Cannabinol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol | 2016 |
Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Environmental Exposure; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hair; Humans; Infant; Limit of Detection; Marijuana Abuse; Specimen Handling; Substance Abuse Detection | 2017 |
Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Compounding; Humans; Mass Spectrometry; Medical Marijuana; Olive Oil; Plant Extracts; Reproducibility of Results | 2017 |
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ
Topics: Administration, Oral; Animals; Cannabidiol; Chromatography, Liquid; Dronabinol; Ethanol; Excipients; Male; Olive Oil; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Time Factors | 2018 |
Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of Cannabis sativa Using GC-FID.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Flame Ionization; Plant Extracts | 2018 |
Iodine-Promoted Aromatization of p-Menthane-Type Phytocannabinoids.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabinol; Cannabis; Cell Line; Dronabinol; HEK293 Cells; Humans; Iodine; TRPA1 Cation Channel; TRPV Cation Channels | 2018 |
PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
Topics: Administration, Oral; Adult; Analgesics; Biological Availability; Cannabidiol; Cannabinoids; Capsules; Dronabinol; Drug Combinations; Drug Compounding; Drug Delivery Systems; Emulsions; Excipients; Humans; Male; Young Adult | 2018 |
Occurrence of illicit drugs in two wastewater treatment plants in the South of Italy.
Topics: Amphetamine; Amphetamines; Cannabidiol; Cocaine; Dronabinol; Drug Combinations; Humans; Illicit Drugs; Methamphetamine; Pyrrolidines; Sicily; Substance Abuse Detection; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2018 |
Potency of Δ
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, Gas; Dronabinol; England; Humans; Illicit Drugs; Psychotropic Drugs; Public Health | 2018 |
Police documentation of drug use in injured drivers: Implications for monitoring and preventing drug-impaired driving.
Topics: Accidents, Traffic; Adult; Aged; Alcohol Drinking; Automobile Driving; British Columbia; Cannabidiol; Cannabis; Documentation; Driving Under the Influence; Dronabinol; Drug Combinations; Ethanol; Female; Humans; Illicit Drugs; Law Enforcement; Male; Middle Aged; Police; Prevalence; Substance-Related Disorders; Trauma Centers; United States; Young Adult | 2018 |
Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.
Topics: Adult; Cannabidiol; Down-Regulation; Dronabinol; Drug Combinations; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Multiple Sclerosis | 2018 |
Balance worsening associated with nabiximols in multiple sclerosis.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Executive Function; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuromuscular Agents; Postural Balance; Psychomotor Performance; Stroop Test | 2019 |
Police probe of Brazilian marijuana researcher sparks protests.
Topics: Alcoholism; Animals; Biomedical Research; Brazil; Cannabidiol; Cannabis; Dronabinol; Epilepsy; Freedom; Humans; Medical Marijuana; Police; Psychopharmacology; Research Personnel | 2018 |
Cannabinoids for Treatment of Dystonia in Huntington's Disease.
Topics: Adolescent; Adult; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Dystonia; Female; Humans; Huntington Disease; Male; Treatment Outcome | 2018 |
Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited.
Topics: Cannabidiol; Cannabinoids; Down-Regulation; Dronabinol; Drug Combinations; Humans; Immunomodulation; Multiple Sclerosis | 2018 |
Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae.
Topics: Animals; Behavior, Animal; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Larva; Psychotropic Drugs; Zebrafish | 2018 |
An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
Topics: Affect; Animals; Avoidance Learning; Cannabidiol; Cannabinoid Receptor Agonists; Conditioning, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Male; Rats; Rats, Wistar; Taste | 2018 |
A naturalistic examination of the perceived effects of cannabis on negative affect.
Topics: Adult; Affect; Anxiety; Cannabidiol; Depression; Dose-Response Relationship, Drug; Dronabinol; Female; Humans; Male; Perception; Stress, Psychological | 2018 |
A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dronabinol; Plant Extracts; Tandem Mass Spectrometry | 2018 |
Medical Cannabis for the Treatment of Fibromyalgia.
Topics: Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Dosage Calculations; Fibromyalgia; Humans; Medical Marijuana | 2018 |
Cannabinoid-induced alteration of motor-evoked potentials (MEPs) prior to intradural spinal tumor removal: a nasty surprise.
Topics: Analgesics; Cannabidiol; Child; Dronabinol; Drug Combinations; Evoked Potentials, Motor; Female; Humans; Intraoperative Neurophysiological Monitoring; Neurofibromatosis 1; Spinal Cord Neoplasms | 2018 |
Effect of tetrahydrocannabinol:cannabidiol oromucosal spray on activities of daily living in multiple sclerosis patients with resistant spasticity: a retrospective, observational study.
Topics: Activities of Daily Living; Adult; Cannabidiol; Dronabinol; Drug Combinations; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2018 |
A Model of Δ
Topics: Animals; Cannabidiol; Cues; Dendritic Spines; Dronabinol; Drug-Seeking Behavior; Male; Neuronal Plasticity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Self Administration | 2018 |
Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.
Topics: Administration, Inhalation; Animals; Body Temperature; Cannabidiol; Disease Models, Animal; Dronabinol; Electronic Nicotine Delivery Systems; Female; Hypothermia; Locomotion; Male; Nociception; Rats; Rats, Wistar | 2018 |
High-Resolution Ion Mobility Spectrometry for Rapid Cannabis Potency Testing.
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Humans; Ion Mobility Spectrometry; Isomerism; Marijuana Smoking; Switzerland | 2018 |
Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (∆
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Embryo, Nonmammalian; Female; Gastrulation; Heart Rate; Locomotion; Male; Models, Animal; Motor Neurons; Neurogenesis; Time Factors; Toxicity Tests, Acute; Zebrafish | 2018 |
Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report.
Topics: Adolescent; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Therapy, Combination; Female; Humans; Tourette Syndrome | 2019 |
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Carmustine; Cell Line, Tumor; Dronabinol; Glioma; Heterografts; Humans; Male; Mice, Nude; Temozolomide | 2018 |
A Survey on the Medical Use of Cannabis in Europe: A Position Paper.
Topics: Analgesics; Cannabidiol; Dronabinol; Drug Combinations; Europe; Humans; Internet; Medical Marijuana; Surveys and Questionnaires | 2018 |
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol.
Topics: Animals; Brain; Cannabidiol; Chromatography, High Pressure Liquid; Dronabinol; Metabolomics; Rats; Tandem Mass Spectrometry | 2018 |
Simultaneous quantification of THC-COOH, OH-THC, and further cannabinoids in human hair by gas chromatography-tandem mass spectrometry with electron ionization applying automated sample preparation.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Gas Chromatography-Mass Spectrometry; Hair; Humans; Limit of Detection; Robotics; Specimen Handling; Substance Abuse Detection; Tandem Mass Spectrometry | 2019 |
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Cell Line, Tumor; Dronabinol; Female; Glioblastoma; Humans; Male; Mice, Nude; Neoplastic Stem Cells; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Analysis of Contact Traces of Cannabis by In-Tube Solid-Phase Microextraction Coupled to Nanoliquid Chromatography.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Gas Chromatography-Mass Spectrometry; Nanotechnology; Plant Extracts; Solid Phase Microextraction | 2018 |
Tinkering with THC-to-CBD ratios in Marijuana.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana | 2019 |
Cannabidiol modulation of antinociceptive tolerance to Δ
Topics: Analgesics, Non-Narcotic; Animals; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Drug Therapy, Combination; Drug Tolerance; Female; Male; Motor Activity; Pain Measurement; Rats; Rats, Sprague-Dawley | 2018 |
Cannabidiol affects circadian clock core complex and its regulation in microglia cells.
Topics: Animals; ARNTL Transcription Factors; Cannabidiol; Cannabinoid Receptor Agonists; Circadian Clocks; CLOCK Proteins; Cryptochromes; Dronabinol; Gene Expression; Gene Expression Profiling; Mice; Microglia; Period Circadian Proteins; Receptor, Cannabinoid, CB1; RNA-Seq; Suprachiasmatic Nucleus | 2019 |
What legal weed in Canada means for science.
Topics: Canada; Cannabidiol; Cannabinoids; Cannabis; Desiccation; Dronabinol; Humans; Medical Marijuana; Metabolic Engineering; Research | 2018 |
Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Cannabidiol; Cannabis; Dronabinol; Drug Combinations; Drug Therapy, Combination; Epidermolysis Bullosa; Female; Humans; Male; Middle Aged; Netherlands; Pain; Pain Measurement; Plant Oils; Treatment Outcome | 2019 |
Enhancing effects of acute exposure to cannabis smoke on working memory performance.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Choice Behavior; Dronabinol; Female; Male; Marijuana Smoking; Memory, Short-Term; Rats, Long-Evans | 2019 |
Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors.
Topics: Affect; Animals; Anxiety; Behavior, Animal; Benzopyrans; Cannabidiol; Dizocilpine Maleate; Dose-Response Relationship, Drug; Dronabinol; Executive Function; Male; Microinjections; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Social Behavior | 2019 |
Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
Topics: Administration, Ophthalmic; Animals; Cannabidiol; Chromatography, Liquid; Dronabinol; Female; Gene Expression Regulation; Intraocular Pressure; Male; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Psychotropic Drugs; Real-Time Polymerase Chain Reaction; Receptor, Cannabinoid, CB1; Receptors, G-Protein-Coupled; RNA, Messenger; Sex Factors; Signal Transduction; Tandem Mass Spectrometry; Tonometry, Ocular | 2018 |
Evidence for treatment of spasticity in motor neuron disease.
Topics: Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Motor Neuron Disease; Muscle Spasticity | 2019 |
Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study.
Topics: Animals; Cannabidiol; Cross-Over Studies; Dogs; Dronabinol; Female; Food Deprivation; Plant Extracts; Random Allocation | 2019 |
Multigenerational consequences of early-life cannabinoid exposure in zebrafish.
Topics: Age Factors; Animals; Animals, Genetically Modified; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Cannabidiol; Dronabinol; Embryo, Nonmammalian; Fertility; Gene Expression Regulation, Developmental; Motor Activity; Neurotoxicity Syndromes; Proto-Oncogene Proteins c-fos; Risk Assessment; RNA-Binding Proteins; Zebrafish; Zebrafish Proteins | 2019 |
Tetrahydrocannabinol: cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity: newest evidence.
Topics: Administration, Mucosal; Cannabidiol; Cannabinoid Receptor Modulators; Congresses as Topic; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Observational Studies as Topic; Oral Sprays; Randomized Controlled Trials as Topic; Societies, Medical | 2019 |
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from randomized clinical trials.
Topics: Administration, Mucosal; Affect; Cannabidiol; Cannabinoid Receptor Modulators; Cognition; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic | 2019 |
Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studies.
Topics: Administration, Mucosal; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Drug Approval; Drug Combinations; Humans; Italy; Multiple Sclerosis; Muscle Spasticity; Observational Studies as Topic; Oral Sprays; Pragmatic Clinical Trials as Topic; Registries | 2019 |
Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation.
Topics: Animals; Bone Marrow Transplantation; Cannabidiol; Disease Models, Animal; Dronabinol; Female; Graft vs Host Disease; Inflammation; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Treatment Outcome | 2019 |
miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia-Effect of cannabinoids.
Topics: Animals; Cannabidiol; Cannabinoids; Cell Line; Dronabinol; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; High-Throughput Nucleotide Sequencing; Lipopolysaccharides; Mice; Microglia; MicroRNAs; Sequence Analysis, RNA | 2019 |
Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
Topics: Adult; Cannabidiol; Chronic Pain; Dronabinol; Drug and Narcotic Control; Female; Humans; Male; Marijuana Use; Medical Marijuana; Mental Disorders; Motivation; Prevalence; Risk Factors; Sex Factors; United States; Young Adult | 2019 |
The Association between Cannabis Product Characteristics and Symptom Relief.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Humans; Medical Marijuana; Psychotropic Drugs; Self Administration | 2019 |
Promoting cannabis products to pharmaceutical drugs.
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Discovery; Medical Marijuana | 2019 |
Development and validation of an assay to measure cannabidiol and Δ9-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS/MS.
Topics: Cannabidiol; Chromatography, High Pressure Liquid; Dronabinol; Edetic Acid; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2019 |
Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Epidermolysis Bullosa; Humans; Pain | 2019 |
THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
Topics: Adult; Behavior; Biomarkers; Cannabidiol; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Marijuana Smoking; Middle Aged; Saliva; Time Factors; Young Adult | 2020 |
Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
Topics: Adolescent; Amidohydrolases; Cannabidiol; Cannabinoid Receptor Agonists; Craving; Cross-Over Studies; Cues; Double-Blind Method; Dronabinol; Endophenotypes; Female; Humans; Male; Marijuana Abuse; Receptor, Cannabinoid, CB1; Satiation; Young Adult | 2020 |
Cannabis used in US research differs genetically to the varieties people smoke.
Topics: Biomedical Research; Cannabidiol; Cannabis; Dronabinol; Humans; Licensure; Marijuana Smoking; National Institutes of Health (U.S.); United States | 2019 |
The Terroir of Cannabis: Terpene Metabolomics as a Tool to Understand Cannabis sativa Selections.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Metabolomics; Odorants; Plant Breeding; Terpenes | 2019 |
Developments in medical cannabis.
Topics: Cannabidiol; Community Health Nursing; Dronabinol; Drug and Narcotic Control; Drug Tolerance; England; Health Services Accessibility; Humans; Medical Marijuana; Neoplasms; Pain Management; Patient Preference; State Medicine | 2019 |
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Duration of Therapy; Female; Fibromyalgia; Humans; Male; Manitoba; Medication Adherence; Middle Aged; Neoplasms; Osteoarthritis; Prescription Drugs; Retrospective Studies; Social Class; Substance-Related Disorders; Young Adult | 2019 |
Marijuana use among patients with epilepsy at a tertiary care center.
Topics: Adult; Aged; Anticonvulsants; Attitude to Health; Cannabidiol; Dronabinol; Epilepsy; Female; Health Care Surveys; Humans; Longitudinal Studies; Male; Marijuana Use; Medical Marijuana; Middle Aged; Oregon; Self Medication; Tertiary Care Centers; Treatment Outcome | 2019 |
A survey of veterinary student attitudes concerning whether marijuana could have therapeutic value for animals.
Topics: Animals; Attitude; Cannabidiol; Cannabis; Cross-Sectional Studies; Dronabinol; Education, Veterinary; Humans; Students; Surveys and Questionnaires | 2019 |
Probing the antioxidant activity of Δ
Topics: Cannabidiol; Cannabis; Dronabinol; Electrochemical Techniques; Free Radical Scavengers; Plant Extracts | 2019 |
Potential occupational and respiratory hazards in a Minnesota cannabis cultivation and processing facility.
Topics: Agriculture; Air Microbiology; Air Pollutants, Occupational; Cannabidiol; Cannabinol; Cannabis; Dronabinol; Endotoxins; Humans; Inhalation Exposure; Minnesota; Occupational Exposure; Volatile Organic Compounds | 2019 |
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study.
Topics: Allosteric Regulation; Allosteric Site; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Humans; Molecular Docking Simulation; Protein Binding; Receptor, Cannabinoid, CB1 | 2019 |
Vapor inhalation of cannabidiol (CBD) in rats.
Topics: Administration, Inhalation; Animals; Body Temperature; Cannabidiol; Cannabis; Cohort Studies; Dose-Response Relationship, Drug; Dronabinol; E-Cigarette Vapor; Electronic Nicotine Delivery Systems; Female; Hypothermia; Male; Models, Animal; Nicotine; Nociception; Plant Extracts; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Serotonin, 5-HT1A | 2019 |
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Cytokines; Disease Models, Animal; Dronabinol; Dysbiosis; Encephalomyelitis, Autoimmune, Experimental; Female; Gastrointestinal Microbiome; Inflammation; Interferon-gamma; Interleukin-17; Mice; Mice, Inbred C57BL; Multiple Sclerosis; RNA, Ribosomal, 16S | 2019 |
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
Topics: Cannabidiol; Combined Modality Therapy; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Physical Therapy Modalities; Withholding Treatment | 2019 |
Cannabis and Cannabinoid Biology in Stroke.
Topics: Cannabidiol; Cannabinoids; Cannabis; Clinical Trials as Topic; Dronabinol; Humans; Stroke | 2019 |
The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
Topics: Adult; Cannabidiol; Cannabis; Choice Behavior; Commerce; Cross-Sectional Studies; Dronabinol; Female; Flowers; Humans; Legislation, Drug; Male; Marijuana Smoking; Medical Marijuana; Middle Aged; Product Labeling; Surveys and Questionnaires; Young Adult | 2019 |
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms.
Topics: Adolescent; Adult; Aged; Anorexia; Canada; Cannabidiol; Dronabinol; Female; Humans; Male; Mental Disorders; Middle Aged; Mobile Applications; Pain; Palliative Care; Patient Portals; Patient Satisfaction; Retrospective Studies; Sleep Initiation and Maintenance Disorders | 2019 |
Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use.
Topics: Adult; Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Female; Humans; Male; Marijuana Smoking; Medical Marijuana; Middle Aged; Substance Abuse Detection; Tandem Mass Spectrometry; Young Adult | 2020 |
Cannabis's chemical synergies.
Topics: Animals; Cancer Pain; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Synergism; Humans; Medical Marijuana; Mice; Reproducibility of Results; Terpenes | 2019 |
Cannabis research round-up.
Topics: Cannabidiol; Cannabis; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Motor Neuron Disease | 2019 |
Working out with weed.
Topics: Adult; Arachidonic Acids; Athletic Performance; Cannabidiol; Cannabis; Doping in Sports; Dronabinol; Endocannabinoids; Exercise; Female; Humans; Inflammation; Male; Marijuana Use; Motivation; Performance-Enhancing Substances; Polyunsaturated Alkamides; Reproducibility of Results; Young Adult | 2019 |
Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD).
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Cannabidiol; Cohort Studies; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Muscle Spasticity; Patient Satisfaction; Retrospective Studies | 2019 |
Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cannabidiol; Cells, Cultured; Cytokines; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Female; Leukocytes, Mononuclear; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Multiple Sclerosis; Signal Transduction; Spinal Cord; Spleen | 2019 |
The effectiveness of self-directed medical cannabis treatment for pain.
Topics: Analgesics; Cannabidiol; Cannabis; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Flowers; Humans; Medical Marijuana; Pain | 2019 |
Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath.
Topics: Breath Tests; Cannabidiol; Cannabinoids; Chromatography, High Pressure Liquid; Citric Acid; Dronabinol; Glucose; Humans; Limit of Detection; Quality Control; Reference Standards; Reproducibility of Results; Smoking; Solid Phase Extraction; Tandem Mass Spectrometry; Validation Studies as Topic | 2020 |
Prospective evaluation of oral cannabis extracts in children with epilepsy.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Cannabidiol; Cannabis; Child; Child, Preschool; Dronabinol; Drug Resistant Epilepsy; Female; Humans; Male; Medical Marijuana; Plant Extracts; Prospective Studies | 2019 |
Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; C-Reactive Protein; Cannabidiol; Dronabinol; Drug Administration Routes; Employment; Female; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Israel; Male; Medical Marijuana; Mesalamine; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Prospective Studies; Serum Albumin; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Weight Gain; Young Adult | 2019 |
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Topics: Animals; Cannabidiol; Dopaminergic Neurons; Dronabinol; Hippocampus; Male; MAP Kinase Signaling System; Memory; Phosphorylation; Psychotropic Drugs; Rats, Sprague-Dawley; Reward; Ventral Tegmental Area | 2019 |
Vaping-Associated Acute Respiratory Failure Due to Acute Lipoid Pneumonia.
Topics: Administration, Inhalation; Adult; Bronchoscopy; Cannabidiol; Cannabis; Dronabinol; Electronic Nicotine Delivery Systems; Glucocorticoids; Humans; Hypoxia; Intubation, Intratracheal; Macrophages, Alveolar; Male; Methylprednisolone; Plant Oils; Pneumonia, Lipid; Respiration, Artificial; Respiratory Insufficiency; Tomography, X-Ray Computed; Vaping | 2020 |
'Standard THC units': a proposal to standardize dose across all cannabis products and methods of administration.
Topics: Cannabidiol; Cannabis; Dronabinol; Harm Reduction; Humans; Public Health; Reference Standards | 2020 |
Optimal condition of cannabis maceration to obtain the high cannabidiol and Δ9-tetrahydrocannabinol content.
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Methods; Plant Extracts; Temperature; Time Factors | 2019 |
Vaporized Cannabis differentially modulates sexual behavior of female rats according to the dose.
Topics: Animals; Cannabidiol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Female; Hallucinogens; Locomotion; Male; Motivation; Rats; Rats, Wistar; Sexual Behavior, Animal; Social Behavior; Volatilization | 2019 |
A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients.
Topics: Adult; Aged; Cannabidiol; Cannabinoid Receptor Modulators; Chronic Disease; Cohort Studies; Compassionate Use Trials; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Muscular Dystrophies; Myalgia; Myotonia; Oils; Treatment Outcome | 2020 |
Response to Casarett et al. (doi: 10.1089/jpm.2018.0658): Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms.
Topics: Cannabidiol; Dronabinol; Hospice and Palliative Care Nursing; Humans; Palliative Care | 2019 |
Cannabinoid Stability in Antemortem and Postmortem Blood.
Topics: Autopsy; Cannabidiol; Cannabinoids; Cannabinol; Chromatography, Liquid; Dronabinol; Drug Stability; Forensic Toxicology; Humans; Substance Abuse Detection; Tandem Mass Spectrometry | 2020 |
Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study.
Topics: Acute Lung Injury; Adult; Anti-Bacterial Agents; Bronchoscopy; Cannabidiol; Cohort Studies; Disease Outbreaks; Dronabinol; Electronic Nicotine Delivery Systems; Female; Glucocorticoids; Humans; Length of Stay; Male; Nicotine; Noninvasive Ventilation; Oxygen Inhalation Therapy; Prospective Studies; Respiration, Artificial; Tomography, X-Ray Computed; Utah; Vaping; Young Adult | 2019 |
The loss of NMDAR-dependent LTD following cannabinoid self-administration is restored by positive allosteric modulation of CB1 receptors.
Topics: Allosteric Regulation; Animals; Behavior, Addictive; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Glutamic Acid; Indoles; Long-Term Synaptic Depression; Male; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Self Administration; Synaptic Transmission | 2020 |
Distribution of Chemical Phenotypes (Chemotypes) in European Agricultural Hemp (Cannabis sativa L.) Cultivars.
Topics: Alleles; Cannabidiol; Cannabis; DNA, Plant; Dronabinol; Europe; Genotype; Phenotype; Polymerase Chain Reaction; Seeds | 2020 |
Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain.
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Tolerance; Female; Hyperalgesia; Male; Mice; Morphine; Neuralgia; Sciatic Nerve; Self Administration; Vocalization, Animal | 2020 |
The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study.
Topics: Adult; Aged; Cannabidiol; Cerebral Cortex; Dronabinol; Female; Glucose; Humans; Male; Middle Aged; Multiple Sclerosis; Pilot Projects | 2020 |
Lost in translation: an overinterpretation of the acute effects of cannabinoids.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Memory | 2019 |
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana; Mice; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |
Parallel Reaction Monitoring-Based Quantification of Cannabinoids in Whole Blood.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, Liquid; Dronabinol; Limit of Detection; Liquid-Liquid Extraction; Substance Abuse Detection | 2020 |
Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Marijuana Abuse | 2020 |
Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Marijuana Abuse | 2020 |
Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence-Reply.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Marijuana Abuse | 2020 |
Source of cannabinoids: what is available, what is used, and where does it come from?
Topics: Anticonvulsants; Cannabidiol; Cannabinoids; Child; Child, Preschool; Dronabinol; Drug Combinations; Epilepsies, Myoclonic; Epilepsy; Humans; Lennox Gastaut Syndrome; Plant Extracts; Seizures | 2020 |
Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population.
Topics: Adult; Aged; Aged, 80 and over; Cannabidiol; Cross-Sectional Studies; Dronabinol; Drug Administration Routes; Florida; Humans; Medical Marijuana; Middle Aged; Pain; Palliative Care; Practice Patterns, Physicians' | 2020 |
The viability of a standard THC unit.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens | 2020 |
How experimental cannabinoid studies will inform the standardized THC unit.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens | 2020 |
Synthetic route sourcing of illicit at home cannabidiol (CBD) isomerization to psychoactive cannabinoids using ion mobility-coupled-LC-MS/MS.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Ion Mobility Spectrometry; Isomerism; Law Enforcement; Psychotropic Drugs; Tandem Mass Spectrometry | 2020 |
The Clinical Assessment of Vaping Exposure.
Topics: Cannabidiol; Dronabinol; Electronic Nicotine Delivery Systems; Humans; Nicotine; Vaping | 2020 |
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Topics: A549 Cells; Adult; Aged; Aged, 80 and over; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dronabinol; Epithelial-Mesenchymal Transition; Female; Gene Expression; Humans; Lung Neoplasms; Male; Middle Aged; Psychotropic Drugs; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |
Importance of a standard unit dose for cannabis research.
Topics: Cannabidiol; Cannabis; Dronabinol; Hallucinogens | 2020 |
Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Contamination; Humans; Plant Extracts; Tandem Mass Spectrometry | 2019 |
Predictors of Nabiximols (Sativex
Topics: Adult; Analgesics, Non-Narcotic; Cannabidiol; Cognitive Dysfunction; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Patient Compliance; Patient Dropouts; Retrospective Studies; Severity of Illness Index | 2020 |
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis.
Topics: Adult; Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Female; Humans; Italy; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Quality of Life; Quality-Adjusted Life Years | 2020 |
The effect of delta-9-tetrahydrocannabinol and cannabidiol on p50 of the oxygen haemoglobin dissociation curve.
Topics: Adolescent; Adult; Cannabidiol; Dronabinol; Erythrocytes; Female; Hemoglobins; Humans; Male; Non-Smokers; Oxygen; Young Adult | 2020 |
The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats.
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Delivery Systems; Emulsifying Agents; Gastrointestinal Absorption; Male; Nanoparticles; Rats; Rats, Wistar; Triglycerides | 2020 |
Use of Tetrahydrocannabinol and Cannabidiol Products in the Perioperative Period Around Primary Unilateral Total Hip and Knee Arthroplasty.
Topics: Arthroplasty, Replacement, Knee; Cannabidiol; Dronabinol; Humans; Perioperative Period; Prospective Studies; Retrospective Studies | 2020 |
Selective Extraction of Cannabinoid Compounds from Cannabis Seed Using Pressurized Hot Water Extraction.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Hallucinogens; Hot Temperature; Plant Extracts; Seeds; Water | 2020 |
THC and CBD: is medical cannabis overhyped or under-prescribed?
Topics: Cannabidiol; Dronabinol; Humans; Medical Marijuana | 2020 |
Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland.
Topics: Cannabidiol; Commerce; Dronabinol; Electronic Nicotine Delivery Systems; Gas Chromatography-Mass Spectrometry; Humans; Spectroscopy, Fourier Transform Infrared; Switzerland; Vaping | 2020 |
Molecular Mechanism and Cannabinoid Pharmacology.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Endocannabinoids; Humans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |
Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.
Topics: Administration, Oral; Adult; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Emotions; Female; Humans; Male; Marijuana Use; Nebulizers and Vaporizers; Psychomotor Performance; Volatilization | 2020 |
Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans; Inflorescence | 2020 |
Cannabis-based medicinal products: summary of NICE guidance.
Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Decision Making, Shared; Dronabinol; Drug and Narcotic Control; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Needs Assessment; Physicians, Primary Care; Practice Guidelines as Topic; Specialization; United Kingdom; Vomiting | 2020 |
Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Psychotic Disorders; Receptors, Purinergic P2X; Receptors, Purinergic P2X7 | 2020 |
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Italy; Multiple Sclerosis; Muscle Spasticity; Plant Extracts; Retrospective Studies | 2020 |
Nabiximols plus robotic assisted gait training in improving motor performances in people with Multiple Sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Gait; Humans; Multiple Sclerosis; Robotic Surgical Procedures | 2020 |
Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
Topics: Administration, Oral; Analgesics; Animals; Biomarkers; Cannabidiol; CD4-Positive T-Lymphocytes; Dronabinol; Drug Compounding; Drug Interactions; Female; Ganglia, Spinal; Gene Expression Regulation; Male; Oils; Rats; Rats, Sprague-Dawley | 2020 |
Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study.
Topics: Adult; Aged; Cannabidiol; Cognition; Cognition Disorders; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuropsychological Tests; Oral Sprays; Parasympatholytics; Pilot Projects; Prospective Studies; Single-Blind Method; Young Adult | 2020 |
Cannabinoids as anti-ROS in aged pancreatic islet cells.
Topics: Animals; Biomarkers; Cannabidiol; Cannabinoids; Cell Survival; Cellular Senescence; Dronabinol; Homeodomain Proteins; Insulin Secretion; Islets of Langerhans; Male; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Trans-Activators | 2020 |
Efficacy of cannabinoids for treating paediatric spasticity in cerebral palsy or traumatic brain injury: what is the evidence?
Topics: Brain Injuries, Traumatic; Cannabidiol; Cannabinoids; Cerebral Palsy; Child; Dronabinol; Drug Combinations; Humans; Medicine; Muscle Spasticity; Safety | 2020 |
Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
Topics: Acyclic Monoterpenes; Animals; Animals, Genetically Modified; Anticonvulsants; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dose-Response Relationship, Drug; Dronabinol; NAV1.1 Voltage-Gated Sodium Channel; Pentylenetetrazole; Seizures; Zebrafish; Zebrafish Proteins | 2020 |
Cannabis knowledge and implications for health: Considerations regarding the legalization of non-medical cannabis.
Topics: Adolescent; Adult; Cannabidiol; Cannabis; Commerce; Dronabinol; Female; Health Status; Humans; Male; Marijuana Abuse; Marijuana Use; Prevalence; United States; Vulnerable Populations; Young Adult | 2020 |
Interactions between cannabidiol and Δ
Topics: Animals; Cannabidiol; Dronabinol; Epilepsies, Myoclonic; Mice; Mice, Inbred C57BL; NAV1.1 Voltage-Gated Sodium Channel; Seizures | 2020 |
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Patient Compliance; Prospective Studies; Time Factors; Treatment Outcome; Withholding Treatment | 2020 |
Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles.
Topics: Administration, Cutaneous; Animals; Cannabidiol; Cannabis; Dogs; Dronabinol; Female; Plant Extracts | 2020 |
Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83.
Topics: Adenocarcinoma; Apoptosis; Cannabidiol; Cannabinoids; Catalase; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dronabinol; Glutathione Peroxidase; Glutathione Reductase; HT29 Cells; Humans; Malondialdehyde; Oxidative Stress | 2020 |
Comment on Lachenmeier
Topics: Adult; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug Contamination; Humans | 2020 |
Combination of UV and MS/MS detection for the LC analysis of cannabidiol-rich products.
Topics: Cannabidiol; Cannabis; Chromatography, Liquid; Dronabinol; Tandem Mass Spectrometry | 2020 |
Data-enriched edible pharmaceuticals (DEEP) of medical cannabis by inkjet printing.
Topics: Cannabidiol; Dronabinol; Medical Marijuana; Porosity | 2020 |
Access to cannabidiol without a prescription: A cross-country comparison and analysis.
Topics: Australia; Canada; Cannabidiol; Dronabinol; Europe; Germany; Humans; Ireland; Japan; New Zealand; Prescriptions; Switzerland; United Kingdom | 2020 |
Conversion of cannabidiol (CBD) to Δ9-tetrahydrocannabinol (Δ9-THC) during protein precipitations prior to plasma samples analysis by chromatography - Troubles with reliable CBD quantitation when acidic precipitation agents are applied.
Topics: Animals; Cannabidiol; Chromatography; Dronabinol; Humans; Pharmaceutical Preparations; Plasma | 2020 |
Challenging CBD protective effect against THC-related outcomes: a call for robust clinical trials.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans | 2021 |
Energetic and thermodynamical aspects of the cyclodextrins-cannabidiol complex in aqueous solution: a molecular-dynamics study.
Topics: Algorithms; Cannabidiol; Computer Simulation; Cyclodextrins; Dronabinol; Entropy; Lactic Acid; Molecular Docking Simulation; Molecular Dynamics Simulation; Poisson Distribution; Solubility; Temperature; Thermodynamics; Water | 2020 |
Synthetic Biology of Cannabinoids and Cannabinoid Glucosides in
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Glucosides; Metabolic Engineering; Molecular Structure; Nicotiana; Plant Proteins; Saccharomyces cerevisiae; Salicylates; Synthetic Biology | 2020 |
Quantitative analysis of cannabinoids using benchtop NMR instruments.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, High Pressure Liquid; Dronabinol | 2020 |
Industrial, CBD, and Wild Hemp: How Different Are Their Essential Oil Profile and Antimicrobial Activity?
Topics: Analysis of Variance; Anti-Infective Agents; Bicyclic Monoterpenes; Candida albicans; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Fluconazole; Microbial Sensitivity Tests; Monoterpenes; Oils, Volatile; Plant Extracts; Polycyclic Sesquiterpenes; Sesquiterpenes | 2020 |
Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Breast Neoplasms; Cannabidiol; Cannabinoids; Cell Cycle; Cell Line, Tumor; Cytoplasm; Dronabinol; Endoplasmic Reticulum Chaperone BiP; Female; Humans; Lipid Droplets; MCF-7 Cells; Vacuoles | 2020 |
Evidence for adverse effects of cannabidiol (CBD) products and their non-conformity on the European food market - response to the European Industrial Hemp Association.
Topics: Adult; Cannabidiol; Cannabis; Child; Dronabinol; Food; Humans | 2020 |
Using measured cannabidiol and tetrahydrocannabinol metabolites in urine to differentiate marijuana use from consumption of commercial cannabidiol products.
Topics: Cannabidiol; Dronabinol; Humans; Marijuana Use | 2021 |
Different responses of repetitive behaviours in juvenile and young adult mice to Δ
Topics: Animals; Cannabidiol; Child; Decision Making; Dronabinol; Humans; Medical Marijuana; Mice; Tourette Syndrome | 2021 |
ToxPoint: Toxicology Studies on Δ9-tetrahydrocannabinol and Cannabidiol-containing Products Available to Consumers Are Lacking.
Topics: Cannabidiol; Consumer Product Safety; Dronabinol | 2020 |
[Nabiximols as a substitute for cannabis].
Topics: Analgesics; Cannabidiol; Cannabis; Clinical Trials as Topic; Dronabinol; Drug Combinations; Female; Humans; Male; Marijuana Abuse; Nasal Sprays; Substance Withdrawal Syndrome | 2020 |
Cannabis: are there any benefits?
Topics: Australia; Cannabidiol; Cannabinoids; Cannabis; Child; Chronic Pain; Dronabinol; Humans | 2020 |
Cannabis in Parkinson's Disease: The Patients' View.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cannabidiol; Cannabinoid Receptor Modulators; Dronabinol; Female; Health Knowledge, Attitudes, Practice; Health Surveys; Humans; Male; Medical Marijuana; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Patient Acceptance of Health Care; Patient Preference; Urban Population | 2021 |
Cannabis and Impaired Driving.
Topics: Automobile Driving; Cannabidiol; Cannabis; Driving Under the Influence; Dronabinol | 2020 |
Driving Under the Influence of CBD or THC-Is There a Difference?
Topics: Alcohol Drinking; Cannabidiol; Driving Under the Influence; Dronabinol; Humans; Vaping | 2020 |
Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS.
Topics: Cannabidiol; Cannabinoids; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dronabinol; Humans; Tandem Mass Spectrometry | 2022 |
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches.
Topics: Antiviral Agents; Cannabidiol; Cannabinoids; Computer Simulation; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Dronabinol; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Ligands; Models, Biological; Molecular Docking Simulation; Molecular Dynamics Simulation; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2021 |
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis.
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Humans; Medical Marijuana; Tandem Mass Spectrometry | 2021 |
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Chromatography, High Pressure Liquid; Dronabinol; Formaldehyde; Male; Medical Marijuana; Mice, Inbred C57BL; Stereoisomerism; Tandem Mass Spectrometry | 2020 |
Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Colitis; Colonoscopy; Dronabinol; Drug Monitoring; Enterocytes; Gastrointestinal Microbiome; Immunity, Cellular; Mice; Mice, Inbred C57BL; Mice, Knockout; Protective Agents; Receptor, Cannabinoid, CB2 | 2021 |
An Ultrafast Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for Cannabidiol Monitoring in Pediatric Refractory Epilepsy.
Topics: Cannabidiol; Child; Chromatography, High Pressure Liquid; Dronabinol; Drug Resistant Epilepsy; Humans; Limit of Detection; Tandem Mass Spectrometry | 2021 |
Role of marijuana components on the regenerative ability of stem cells.
Topics: Adipose Tissue; Animals; Bone Marrow Cells; Cannabidiol; Cannabis; Dronabinol; Humans; Stem Cells; Swine | 2021 |
Phytocannabinoid Pharmacology: Medicinal Properties of
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Phytochemicals; Signal Transduction | 2021 |
Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Electroencephalography; Epilepsy, Absence; Humans; Rats; Rats, Wistar | 2022 |
Pipette tip micro-solid phase extraction (octyl-functionalized hybrid silica monolith) and ultra-high-performance liquid chromatography-tandem mass spectrometry to determine cannabidiol and tetrahydrocannabinol in plasma samples.
Topics: Cannabidiol; Chromatography, High Pressure Liquid; Dronabinol; Humans; Particle Size; Silicon Dioxide; Solid Phase Microextraction; Surface Properties; Tandem Mass Spectrometry | 2021 |
Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Oils | 2021 |
Homegrown perceptions about the medical use and potential abuse of CBD and THC.
Topics: Adult; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Perception | 2021 |
Development and validation of a LC-HRMS method for the quantification of cannabinoids and their metabolites in human plasma.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Humans; Limit of Detection | 2021 |
Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation.
Topics: Antioxidants; Cannabidiol; Dronabinol; Humans | 2021 |
Cannabis attitudes and patterns of use among followers of the Allergy & Asthma Network.
Topics: Adolescent; Adult; Asthma; Attitude; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Female; Humans; Hypersensitivity; Male; Marijuana Smoking; Middle Aged; Quality of Life; Surveys and Questionnaires; Young Adult | 2021 |
Mid-infrared spectroscopy as process analytical technology tool for estimation of THC and CBD content in Cannabis flowers and extracts.
Topics: Cannabidiol; Cannabis; Dronabinol; Flowers; Plant Extracts; Technology | 2021 |
A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromosome Mapping; Dronabinol | 2021 |
Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Interactions; Humans; Pharmaceutical Preparations | 2021 |
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
Topics: Cannabidiol; Computer Simulation; COVID-19; Data Interpretation, Statistical; Dronabinol; Drug Combinations; Endpoint Determination; Humans; Mental Health; Physical Distancing; Randomized Controlled Trials as Topic; Research Design; Sample Size; Severity of Illness Index; Tic Disorders; Tics; Time Factors; Tourette Syndrome; Treatment Outcome | 2021 |
Origin of Δ
Topics: Cannabidiol; Chromatography, High Pressure Liquid; Dronabinol; Drug Contamination; Mass Spectrometry; Plant Extracts | 2021 |
Cannabinoids in glioblastoma multiforme-hype or hope?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Cell Proliferation; Cell Survival; Clinical Trials, Phase I as Topic; Dronabinol; Drug Combinations; Glioblastoma; Humans; Oral Sprays; Temozolomide; Treatment Outcome | 2021 |
Mechanisms of Action and Pharmacokinetics of Cannabis.
Topics: Brain; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans | 2020 |
Effects of daily Δ
Topics: Animals; Behavior, Animal; Cannabidiol; Cognition; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Hallucinogens; Models, Animal; Psychomotor Performance; Saimiri; Task Performance and Analysis | 2021 |
Effect of nabiximols on Goal Attainment Scale scores in patients with treatment-resistant multiple sclerosis spasticity.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Goals; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Pilot Projects; Plant Extracts; Proof of Concept Study; Prospective Studies; Quality of Life; Treatment Outcome | 2021 |
Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
Topics: Adolescent; Adult; Cannabidiol; Cannabis; Cohort Studies; Dronabinol; Female; Hallucinogens; Humans; Longitudinal Studies; Los Angeles; Male; Marijuana Use; Pain; Self Report; Substance-Related Disorders; Young Adult | 2021 |
Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Mice, Inbred C57BL; Neuralgia; Psychotropic Drugs; Sciatic Neuropathy; Treatment Outcome | 2021 |
Nabiximols and botulinum toxin injections for patients with multiple sclerosis: efficacy on spasticity and spasms in a single-centre experience.
Topics: Botulinum Toxins; Botulinum Toxins, Type A; Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Retrospective Studies; Spasm; Treatment Outcome | 2021 |
Simultaneous Quantification of 17 Cannabinoids by LC-MS-MS in Human Plasma.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Humans; Limit of Detection; Tandem Mass Spectrometry | 2022 |
Driving Impairment Following Vaporization of Cannabis.
Topics: Automobile Driving; Cannabidiol; Cannabis; Dronabinol; Marijuana Smoking; Volatilization | 2021 |
Driving Impairment Following Vaporization of Cannabis.
Topics: Automobile Driving; Cannabidiol; Cannabis; Dronabinol; Marijuana Smoking; Volatilization | 2021 |
Driving Impairment Following Vaporization of Cannabis.
Topics: Automobile Driving; Cannabidiol; Cannabis; Dronabinol; Marijuana Smoking; Volatilization | 2021 |
THC and CBD effects on alcohol use among alcohol and cannabis co-users.
Topics: Adult; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Ethanol; Humans | 2021 |
An approach to the evaluation of the potency of cannabis resin in Madrid: A health hazard?
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Humans | 2023 |
Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines - Identification of potential distinguishing markers.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Drug Combinations; Humans; Mass Spectrometry; Medical Marijuana; Principal Component Analysis | 2021 |
Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in Massachusetts.
Topics: Adult; Cannabidiol; Cannabinoids; Cannabis; Cohort Studies; Dronabinol; Female; Humans; Male; Marijuana Use; Massachusetts; Medical Marijuana; Middle Aged | 2021 |
Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses.
Topics: Belgium; Cannabidiol; Cost-Benefit Analysis; Dronabinol; Drug Combinations; Humans; Monte Carlo Method; Muscle Spasticity; Quality-Adjusted Life Years | 2021 |
Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice.
Topics: Animals; Anti-Anxiety Agents; Cannabidiol; Diazepam; Dronabinol; Elevated Plus Maze Test; Male; Mice | 2022 |
Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol.
Topics: Animals; Cannabidiol; Dronabinol; Humans; Peroxisome Proliferator-Activated Receptors; Receptors, Cannabinoid; Transcriptome; Zebrafish | 2021 |
CBD, a precursor of THC in e-cigarettes.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Electronic Nicotine Delivery Systems; Pyrolysis | 2021 |
CBD is not converted to THC in rats: A framework interpretation and discussion.
Topics: Animals; Cannabidiol; Dronabinol; Rats | 2021 |
Phytocannabinomics: Untargeted metabolomics as a tool for cannabis chemovar differentiation.
Topics: Cannabidiol; Cannabis; Dronabinol; Hallucinogens; Metabolomics | 2021 |
Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent.
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Humans; Signal Transduction | 2021 |
Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC-MS Analysis.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Gas Chromatography-Mass Spectrometry; Substance Abuse Detection | 2022 |
Cannabis and Its Permissibility Status.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Hallucinogens | 2021 |
Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans; United States | 2022 |
Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec.
Topics: Adult; Cannabidiol; Cannabis; Dronabinol; Female; Humans; Medical Marijuana; Middle Aged; Quebec | 2021 |
LC-MS-MS Analysis of Δ9-THC, CBN and CBD in Hair: Investigation of Artifacts.
Topics: Artifacts; Cannabidiol; Cannabinol; Chromatography, Liquid; Dronabinol; Hair; Tandem Mass Spectrometry | 2022 |
Medical cannabis and driving.
Topics: Cannabidiol; Cognition; Dronabinol; Humans; Medical Marijuana; Substance Abuse Detection | 2021 |
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans | 2022 |
Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ
Topics: Animals; Behavior, Animal; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Embryo, Nonmammalian; Embryonic Development; Locomotion; Optogenetics; Zebrafish | 2021 |
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Guinea Pigs; Respiratory System | 2021 |
Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
Topics: Administration, Oral; Adult; Analgesics; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans | 2022 |
Kinetics of CBD, Δ
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Hallucinogens; Hydrogen-Ion Concentration; Kinetics; Temperature | 2022 |
Biomechanical Effects of Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD), the Major Constituents of Cannabis, in a Sprague Dawley Rat Achilles Tendon Surgical Repair Model: A Pilot Study.
Topics: Achilles Tendon; Animals; Cannabidiol; Cannabis; Dronabinol; Pilot Projects; Rats; Rats, Sprague-Dawley | 2021 |
Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Chromatography, Liquid; Dronabinol | 2021 |
Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin and 11-nor-9-carboxy-∆9-THC in Hair.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Gas Chromatography-Mass Spectrometry; Hair | 2022 |
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience.
Topics: Belgium; Cannabidiol; Cannabinoids; Dronabinol; Drug Administration Schedule; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Oral Sprays; Patient Reported Outcome Measures; Plant Extracts; Quality of Life; Retrospective Studies; Severity of Illness Index | 2021 |
Phytochemical characterization and biological properties of two standardized extracts from a non-psychotropic Cannabis sativa L. cannabidiol (CBD)-chemotype.
Topics: Anti-Infective Agents; Antioxidants; Cannabidiol; Cannabis; Dronabinol; Phytochemicals; Plant Extracts | 2021 |
Classification of cannabis strains in the Canadian market with discriminant analysis of principal components using genome-wide single nucleotide polymorphisms.
Topics: Alleles; Canada; Cannabidiol; Cannabis; Dronabinol; Genome-Wide Association Study; Genome, Plant; Polymorphism, Single Nucleotide | 2021 |
Female but not male rats show biphasic effects of low doses of Δ
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cannabidiol; Dopamine; Dronabinol; Female; Male; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Serotonin; Sex Characteristics; Sex Factors | 2021 |
Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series.
Topics: Cannabidiol; Cannabis; Child; Dronabinol; Drug Resistant Epilepsy; Humans; Plant Extracts; Seizures | 2022 |
Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
Topics: Body Fluids; Cannabidiol; Cannabinoids; Chemistry Techniques, Analytical; Chromatography, Liquid; Dronabinol; Humans; Tandem Mass Spectrometry | 2021 |
[Design and application of special solid phase extraction column for three cannabinol compounds in hemp].
Topics: Cannabidiol; Cannabinol; Cannabis; Dronabinol; Solid Phase Extraction | 2021 |
Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?
Topics: Cannabidiol; Dronabinol; Female; Humans; Middle Aged; Neuralgia; Quality of Life; Stroke | 2021 |
HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits.
Topics: Acoustic Stimulation; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Female; Hallucinogens; HIV Infections; Male; Prepulse Inhibition; Rats; Rats, Transgenic; Reflex, Startle; Sensory Gating | 2021 |
Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group.
Topics: Australia; Cannabidiol; Cannabinoids; Cannabis; Capacity Building; Dronabinol | 2022 |
Prosocial Effects of Nonpsychotropic
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Mice; Plant Extracts | 2022 |
Medication overuse headache in patients with chronic migraine using cannabis: A case-referent study.
Topics: Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Cannabidiol; Chronic Disease; Dronabinol; Female; Headache Disorders, Secondary; Humans; Male; Medical Marijuana; Middle Aged; Migraine Disorders; Prescription Drug Overuse | 2021 |
Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion?
Topics: Cannabidiol; Cannabis; Dronabinol; European Union; Humans | 2022 |
Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray.
Topics: Adult; Cannabidiol; Dronabinol; Drug Combinations; Humans; Male; Tics; Tourette Syndrome | 2021 |
Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats.
Topics: Animals; Behavior, Animal; Cannabidiol; Cognition; Dronabinol; Female; Hallucinogens; Memory; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Synaptic Transmission | 2021 |
Chronic Cannabis Users: A New Special Population to Consider for Drug Development.
Topics: Cannabidiol; Cannabis; Dronabinol; Drug Development; Hallucinogens | 2022 |
Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry.
Topics: Adult; Analgesics; Analgesics, Opioid; Back Pain; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Neuralgia; Registries; Retrospective Studies | 2022 |
Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Cytochrome P-450 CYP2D6; Dronabinol; Humans; Molecular Dynamics Simulation; Phytochemicals; Polymorphism, Genetic | 2021 |
CBD oils on the Belgian market: A validated MRM GC-MS/MS method for routine quality control using QuEChERS sample clean up.
Topics: Belgium; Cannabidiol; Dronabinol; Gas Chromatography-Mass Spectrometry; Plant Oils; Quality Control; Tandem Mass Spectrometry | 2021 |
Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Drug Interactions; Glucuronosyltransferase; HEK293 Cells; Humans; Kidney; Liver; Microsomes; Renal Elimination | 2021 |
Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Topics: Biotransformation; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dronabinol; Drug Interactions; Glucuronosyltransferase; HEK293 Cells; Hepatobiliary Elimination; Humans | 2021 |
Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101.
Topics: Animals; Cannabidiol; Dronabinol; Exploratory Behavior; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Receptor, Adenosine A2A | 2021 |
Topics: Adolescent; Cannabidiol; Dronabinol; Humans | 2022 |
Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database.
Topics: Adult; Aged; Analgesics; Analgesics, Opioid; Cannabidiol; Databases, Factual; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Norway; Opioid-Related Disorders; Practice Patterns, Physicians' | 2022 |
Neuroprotective Effects of Cannabidiol but Not Δ
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Glucose; Hippocampus; Neurons; Neuroprotective Agents; Oxygen; Plant Extracts; Rats | 2021 |
Activity of THC, CBD, and CBN on Human ACE2 and SARS-CoV1/2 Main Protease to Understand Antiviral Defense Mechanism.
Topics: Angiotensin-Converting Enzyme 2; Angiotensins; Antiviral Agents; Cannabidiol; Cannabinoids; Cannabinol; COVID-19 Drug Treatment; Defense Mechanisms; Dronabinol; Humans; Peptide Hydrolases; Protease Inhibitors; RNA, Viral; SARS-CoV-2 | 2022 |
Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Catalepsy; Dronabinol; Female; Male; Pain; Rats; Rats, Sprague-Dawley | 2022 |
Early detection of cannabinoids in biological samples based on their affinity interaction with the growth hormone secretagogue receptor.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Gas Chromatography-Mass Spectrometry; Receptors, Ghrelin | 2022 |
Distribution of tetrahydrocannabinol and cannabidiol in several different postmortem matrices.
Topics: Autopsy; Cannabidiol; Cannabis; Dronabinol; Substance Abuse Detection | 2021 |
Optical and spectroscopic characterization of crystalline structures in cannabis extracts.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Plant Extracts; Spectrum Analysis | 2022 |
Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults.
Topics: Adult; Cannabidiol; Cannabis; Cross-Sectional Studies; Dronabinol; Humans; Marijuana Smoking; Marijuana Use; United States; Young Adult | 2022 |
The implications of the use of cannabidiol-related products in a safety-sensitive drug testing environment: A medical-legal perspective.
Topics: Advertising; Cannabidiol; Commerce; Dronabinol; Drug and Narcotic Control; Drug Contamination; Gas Chromatography-Mass Spectrometry; Humans; South Africa | 2021 |
Public interest in ∆
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Hallucinogens; Humans; United States | 2022 |
Selective Preparation and High Dynamic-Range Analysis of Cannabinoids in "CBD Oil" and Other
Topics: Analgesics; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Plant Extracts | 2022 |
Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Humans | 2022 |
Hashish seizures in Algeria over the 2019-2020 period: The rise of potent hashish hybrids.
Topics: Algeria; Cannabidiol; Cannabis; Dronabinol; Seizures | 2022 |
LC-MS/MS Assay for the Measurement of Cannabidiol Profiling in CBD Oil from Japanese Market and Application for Convertible Tetrahydrocannabinol in Acetic Acid Condition.
Topics: Acetic Acid; Cannabidiol; Chromatography, High Pressure Liquid; Dronabinol; Japan; Molecular Structure; Plant Oils; Tandem Mass Spectrometry | 2022 |
Cannabinoid use is enhanced by stress and changes conditioned stress responses.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans; Male; Rats | 2022 |
Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on-line solid phase extraction.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Gas Chromatography-Mass Spectrometry; Solid Phase Extraction; Tandem Mass Spectrometry | 2022 |
Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hair; Humans; Tandem Mass Spectrometry | 2022 |
The Effectiveness of Common Cannabis Products for Treatment of Nausea.
Topics: Analgesics; Antiemetics; Cannabidiol; Cannabis; Child; Dronabinol; Female; Humans; Medical Marijuana; Nausea; Pregnancy | 2022 |
Plant-derived cannabinoids as anticancer agents.
Topics: Antineoplastic Agents; Cannabidiol; Cannabinoids; Dronabinol; Humans; Neoplasms | 2022 |
Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens.
Topics: Cannabidiol; Cannabinoids; Carboxylic Acids; Dronabinol; Prevalence; Workplace | 2022 |
Observational study of medical marijuana as a treatment for treatment-resistant epilepsies.
Topics: Adolescent; Adult; Anticonvulsants; Cannabidiol; Child; Dronabinol; Epilepsies, Myoclonic; Epilepsy; Humans; Medical Marijuana; Middle Aged; Seizures; Young Adult | 2022 |
Development and initial psychometric properties of the Cannabidiol Outcome Expectancies Questionnaire (CBD-OEQ).
Topics: Adult; Cannabidiol; Dronabinol; Factor Analysis, Statistical; Humans; Psychometrics; Surveys and Questionnaires | 2022 |
Plasma protein binding of cannabidiol.
Topics: Cannabidiol; Dronabinol; Plasma; Protein Binding | 2022 |
[Cultivation and breeding of industrial Cannabis sativa].
Topics: Cannabidiol; Cannabis; China; Dronabinol; Plant Breeding | 2022 |
Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases.
Topics: Animals; Cannabidiol; Cannabis; Dermatitis, Atopic; Dog Diseases; Dogs; Dronabinol; Plant Extracts; Retrospective Studies | 2022 |
Beyond Δ9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis.
Topics: Analgesics; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens | 2022 |
Formation of trifluoroacetic artefacts in gas chromatograph injector during Cannabidiol analysis.
Topics: Artifacts; Cannabidiol; Cannabinol; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans | 2022 |
Terpenes and Cannabinoids Yields and Profile from Direct-Seeded and Transplanted CBD-
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Terpenes | 2022 |
Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil.
Topics: Analgesics; Brazil; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Hallucinogens; Humans; Medical Marijuana; Terpenes | 2022 |
Analysis of illicit drugs in purchased and seized electronic cigarette liquids from the United Kingdom 2014-2021.
Topics: Adolescent; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Electronic Nicotine Delivery Systems; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs | 2023 |
The effects of acute Cannabis smoke or Δ
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Male; Memory, Short-Term; Rats; Rats, Long-Evans; Reaction Time; Smoke | 2022 |
Inhibition of human androgen receptor by delta 9-tetrahydro-cannabinol and cannabidiol related to reproductive dysfunction: A computational study.
Topics: Cannabidiol; Cannabinol; Dronabinol; Humans; Ligands; Male; Receptors, Androgen | 2022 |
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
Topics: Cannabidiol; Cannabinoids; COVID-19; Cytokine Release Syndrome; Cytokines; Dronabinol; Humans; Inflammasomes; Lipopolysaccharides; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; STAT3 Transcription Factor; TYK2 Kinase | 2022 |
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome'.
Topics: Cannabidiol; Central Nervous System Diseases; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Cramp; Muscle Spasticity; Pain; Spasm; Treatment Outcome | 2022 |
Individual and combined effects of cannabidiol and Δ
Topics: Brain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Double-Blind Method; Dronabinol; Hallucinogens; Humans | 2022 |
Description and Disposition of Patients With Cancer Accessing a Novel, Pharmacist-Led Cannabis Consultation Service.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana; Middle Aged; Neoplasms; Pharmacists; Referral and Consultation; Retrospective Studies | 2022 |
Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Humans | 2023 |
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis.
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Hair; Hallucinogens; Humans; Limit of Detection; Medical Marijuana; Tandem Mass Spectrometry | 2022 |
A novel handheld FT-NIR spectroscopic approach for real-time screening of major cannabinoids content in hemp.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Spectroscopy, Near-Infrared; Tandem Mass Spectrometry | 2022 |
Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Carcinoma, Hepatocellular; Dronabinol; Extracellular Vesicles; Humans; Liver Neoplasms | 2022 |
∆8-THC, THC-O Acetates and CBD-di-O Acetate: Emerging Synthetic Cannabinoids Found in Commercially Sold Plant Material and Gummy Edibles.
Topics: Acetates; Acetic Anhydrides; Cannabidiol; Cannabinoids; Dronabinol; Humans | 2022 |
Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry.
Topics: Analgesics; Cannabidiol; Cannabis; Dronabinol; Fatigue; Female; Humans; Male; Medical Marijuana; Nausea; Neoplasms; Pain; Quebec; Registries | 2022 |
Thermal decomposition of CBD to Δ
Topics: Cannabidiol; Dronabinol; Gas Chromatography-Mass Spectrometry; Methylamines; Solvents | 2022 |
DoE-assisted development and validation of a stability-indicating HPLC-DAD method for simultaneous determination of five cannabinoids in Cannabis sativa L. based on analytical quality by design (AQbD) concept.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Chromatography, High Pressure Liquid; Cytomegalovirus Infections; Dronabinol; Plant Extracts | 2022 |
In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer.
Topics: Cancer-Associated Fibroblasts; Cannabidiol; Cannabinoid Receptor Agonists; Culture Media; Dronabinol; Humans; Lung Neoplasms; Transforming Growth Factor beta; Tumor Microenvironment | 2022 |
Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients.
Topics: Aged; Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana; Nausea; Neoplasms; Pain; Retrospective Studies; Sleep Initiation and Maintenance Disorders | 2023 |
Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.
Topics: California; Cannabidiol; Cannabis; Dronabinol; Humans | 2022 |
Analytical method validation for assay determination of cannabidiol and tetrahydrocannabinol in hemp oil infused products by RP-HPLC.
Topics: Cannabidiol; Cannabis; Capsules; Chromatography, High Pressure Liquid; Dronabinol; Plant Extracts | 2022 |
Medicinal cannabis for the treatment of anxiety disorders.
Topics: Analgesics; Anxiety Disorders; Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana | 2022 |
Cis-Δ
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol | 2022 |
Rapid quantification of cannabinoids in beef tissues and bodily fluids using direct-delivery electrospray ionization mass spectrometry.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Cattle; Chromatography, Liquid; Dronabinol; Plant Extracts; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2022 |
Discrepancies between validated GC-FID and UHPLC-DAD methods for the analysis of Δ-9-THC and CBD in dried hemp flowers.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Flowers | 2022 |
Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Disease Models, Animal; Dronabinol; Hallucinogens; Hyperalgesia; Mice; Neuralgia | 2022 |
Effect of Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Female; Hallucinogens; Humans; Lactation; Lipids; Milk Proteins; Pregnancy; RNA, Messenger | 2022 |
Chromatographic analysis of CBD and THC after their acylation with blockade of compound transformation.
Topics: Acylation; Amines; Cannabidiol; Cannabinoids; Dronabinol; Protons | 2023 |
The Determination of Cannabinoids in Urine Samples Using Microextraction by Packed Sorbent and Gas Chromatography-Mass Spectrometry.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Gas Chromatography-Mass Spectrometry; Methanol; Water | 2022 |
Neuroprotective potential of Cannabis sativa-based oils in Caenorhabditis elegans.
Topics: Acetylcholinesterase; Animals; Caenorhabditis elegans; Cannabidiol; Cannabis; Dronabinol; Humans; Plant Oils | 2022 |
Heating of consumer cannabis oils can lead to free radical initiated degradation, causing CBD and THC depletion.
Topics: Cannabidiol; Cannabis; Dronabinol; Free Radicals; Heating; Olive Oil; Peroxides; Plant Oils; Sunflower Oil; Triglycerides | 2022 |
Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Dronabinol; Female; Hyperalgesia; Male; Rats | 2023 |
Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.
Topics: Anti-Inflammatory Agents; Camphor; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Cyclooxygenase 2; Cymenes; Dronabinol; Eucalyptol; Hallucinogens; Humans; Inflammation; Interleukin-6; Plant Extracts; Terpenes; Tumor Necrosis Factor-alpha | 2022 |
Application of experimental design in HPLC method optimisation for the simultaneous determination of multiple bioactive cannabinoids.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Plant Extracts; Research Design; Tandem Mass Spectrometry | 2022 |
Differential Enantiomer-Specific Signaling of Cannabidiol at CB
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; Endocannabinoids; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2022 |
Absence of Relevant Thermal Conversion of Cannabidiol to Tetrahydrocannabinol in E-Cigarette Vapor and Low-Tetrahydrocannabinol Cannabis Smoke.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; E-Cigarette Vapor; Electronic Nicotine Delivery Systems; Hallucinogens; Psychotropic Drugs; Smoke | 2022 |
Semiquantitative Screening of THC Analogues by Silica Gel TLC with an Ag(I) Retention Zone and Chromogenic Smartphone Detection.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Chromatography, Thin Layer; Dronabinol; Hallucinogens; Plant Extracts; Silica Gel; Smartphone; Solvents | 2022 |
Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment.
Topics: Cannabidiol; Chromatography, Liquid; Dronabinol; Humans; Plant Extracts; Tandem Mass Spectrometry | 2023 |
Hemp microgreens as an innovative functional food: Variation in the organic acids, amino acids, polyphenols, and cannabinoids composition of six hemp cultivars.
Topics: Amino Acids; Amino Acids, Essential; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Functional Food; Phytochemicals; Polyphenols | 2022 |
Topics: Cannabidiol; Dronabinol; Humans | 2022 |
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers.
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Hallucinogens; Humans; Smokers; Tandem Mass Spectrometry | 2023 |
Cannabidiol pharmacotherapy for delta-9-tetrahidrocannabinol dependence
Topics: Cannabidiol; Cannabis; Dronabinol; Medical Marijuana; Retrospective Studies | 2022 |
Cannabis use for Sleep Disturbance Among Older Patients in a Geriatrics Clinic.
Topics: Aged; Cannabidiol; Cannabis; Dronabinol; Female; Geriatrics; Humans; Sleep | 2023 |
Evaluation of the anti-inflammatory effects of selected cannabinoids and terpenes from Cannabis Sativa employing human primary leukocytes.
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Dronabinol; Humans; Leukocytes, Mononuclear; Phytol; Terpenes | 2022 |
The Cytotoxic Effect of Isolated Cannabinoid Extracts on Polypoid Colorectal Tissue.
Topics: Antineoplastic Agents; Cannabidiol; Cannabinoids; Cannabis; Colonic Polyps; Colorectal Neoplasms; Dronabinol; Humans; Plant Extracts | 2022 |
Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.
Topics: Analgesics; Analgesics, Opioid; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Male; Nanoparticles; Neoplasms; Pain, Intractable; Pilot Projects; Water | 2022 |
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model.
Topics: Animals; Cannabidiol; Dronabinol; Epilepsy; Kainic Acid; Microglia; Rats; Seizures | 2022 |
Letter to the Editor: Cannabidiol is psychoactive.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans | 2022 |
Perceptions about THC and CBD effects among adults with and without prior cannabis experience.
Topics: Adult; Analgesics; Canada; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans | 2023 |
Involvement of esterases in the pulmonary metabolism of beclomethasone dipropionate and the potential influence of cannabis use.
Topics: Administration, Inhalation; Adult; Beclomethasone; Cannabidiol; Cannabis; Child; Dronabinol; Esterases; Glucocorticoids; Humans; Marijuana Smoking | 2022 |
The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Glucose; Ischemia; Microglia; Neuroprotective Agents; Oxygen; Rats; TRPV Cation Channels | 2022 |
Delta-8 Tetrahydrocannabinol Product Impurities.
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Humans; Magnetic Resonance Imaging | 2022 |
Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Ethanol; Hallucinogens; Humans | 2022 |
A 1:1 ratio of cannabidiol: tetrahydrocannabinol attenuates methamphetamine conditioned place preference in mice: A prospective study of antidopaminergic mechanism.
Topics: Animals; Bupropion; Cannabidiol; Central Nervous System Stimulants; Dronabinol; Male; Methamphetamine; Mice; Mice, Inbred ICR; Nucleus Accumbens; Prospective Studies | 2023 |
Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol.
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Hallucinogens; Humans; Metabolomics; Mice; Microsomes, Liver; Molecular Docking Simulation; Psychotropic Drugs | 2022 |
Molecular study of endo and phytocannabinoids on lipid membranes of different composition.
Topics: Cannabidiol; Dronabinol; Endocannabinoids; Endometriosis; Female; Humans; Membranes | 2023 |
Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications.
Topics: Analgesics, Opioid; Cannabidiol; Cannabis; Chronic Pain; Dronabinol; Humans; Medical Marijuana | 2023 |
Thin-layer chromatography on silver nitrate-impregnated silica gel for analysis of homemade tetrahydrocannabinol mixtures.
Topics: Cannabidiol; Chromatography, Thin Layer; Coloring Agents; Dronabinol; Silica Gel; Silver Nitrate | 2022 |
How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials.
Topics: Cannabidiol; Cannabinoids; Cannabis; Double-Blind Method; Dronabinol; Humans | 2023 |
Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Mice; Polycyclic Sesquiterpenes; Terpenes | 2022 |
Determination of cannabinoids content in light cannabis inflorescences sold in France.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabinol; Cannabis; Chromatography, Liquid; Dronabinol; France; Hallucinogens; Inflorescence; Tandem Mass Spectrometry | 2023 |
Evaluation of decarboxylation efficiency of Δ
Topics: Cannabidiol; Decarboxylation; Dronabinol; Ethanol; Solvents | 2023 |
Screening System of Cannabis sativa Extracts Based on Their Mitochondrial Safety Profile Using Cytochrome c Oxidase Activity as a Biomarker
Topics: Animals; Biomarkers; Cannabidiol; Cannabinoids; Cannabis; Cattle; Dronabinol; Electron Transport Complex IV; Mitochondria; Plant Extracts | 2023 |
On the Uncatalyzed Thermal Conversion of Cannabidiol to Delta-9-Tetrahydrocannabinol.
Topics: Cannabidiol; Cannabinoids; Dronabinol | 2023 |
Controlled human drug administration studies are necessary to define the THC-sparing effects of CBD and other cannabis constituents.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Hallucinogens; Humans | 2023 |
Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Fentanyl; Hallucinogens; Macaca mulatta | 2023 |
A Colorimetric Method for the Rapid Estimation of the Total Cannabinoid Content in Cannabis Samples.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabinol; Cannabis; Colorimetry; Dronabinol; Hallucinogens | 2023 |
Twice-daily oral administration of a cannabidiol and cannabidiolic acid-rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile.
Topics: Administration, Oral; Amazona; Animals; Cannabidiol; Cannabinoids; Cannabis; Dogs; Dronabinol; Mammals; Plant Extracts | 2023 |
Isolation and Characterization of Impurities in Commercially Marketed Δ
Topics: Cannabidiol; Cannabinoids; Cannabinol; Dronabinol; Gas Chromatography-Mass Spectrometry | 2023 |
Characterization of the Antitumor Potential of Extracts of
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Electron Transport Complex IV; Humans; Neuroblastoma; Plant Extracts | 2023 |
Absence of Age Verification for Online Purchases of Cannabidiol and Delta-8: Implications for Youth Access.
Topics: Adolescent; Adult; Cannabidiol; Consumer Behavior; Dronabinol; Humans; Self Report; United States; Young Adult | 2023 |
A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products.
Topics: Adult; Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Cross-Sectional Studies; Dronabinol; Ethanol; Hallucinogens; Humans; Oils | 2023 |
Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Chronic Pain; Dronabinol; Female; Hallucinogens; Male; Rats; Spinal Cord Injuries | 2023 |
Enantioseparation of chiral phytocannabinoids in medicinal cannabis.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Medical Marijuana | 2023 |
How Are Retailers Describing Delta-8 THC?A Mixed-Methods Study in Fort Worth, Texas.
Topics: Cannabidiol; Cannabis; Dronabinol; Hallucinogens; Humans; Texas | 2023 |
A One Health perspective on comparative cannabidiol and cannabidiolic acid pharmacokinetics and biotransformation in humans and domestic animals.
Topics: Animals; Animals, Domestic; Biotransformation; Cannabidiol; Cannabinoids; Dronabinol; Humans; One Health | 2023 |
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Humans; Male; Multiple Sclerosis; Muscle Spasticity | 2023 |
Cannabis update: Anxiety disorders and post-traumatic stress disorder.
Topics: Adult; Anxiety Disorders; Cannabidiol; Cannabis; Dronabinol; Humans; Medical Marijuana; Stress Disorders, Post-Traumatic | 2023 |
A case report of CBD and THC as analgesic therapy in a cat with chronic osteoarthritic pain.
Topics: Analgesics; Animals; Cannabidiol; Cats; Chronic Pain; Dronabinol; Male | 2023 |
Vaporized cannabis extract-induced antinociception in male vs female rats with persistent inflammatory pain.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Chronic Pain; Dronabinol; Edema; Female; Humans; Hyperalgesia; Male; Rats | 2023 |
CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Humans; Medical Marijuana | 2023 |
The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer's Disease-like Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Memory Disorders; Mice; Neuroprotective Agents | 2023 |
The analysis of cannabinoids in e-cigarette liquids using LC-HRAM-MS and LC-UV.
Topics: Cannabidiol; Cannabinoids; Cannabis; Chromatography, Liquid; Dronabinol; Electronic Nicotine Delivery Systems; Mass Spectrometry | 2023 |
Unexpected formation of dichloroacetic and trichloroacetic artefacts in gas chromatograph injector during Cannabidiol analysis.
Topics: Artifacts; Cannabidiol; Cannabinol; Dronabinol; Trichloroacetic Acid | 2023 |
Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1.
Topics: Anti-Inflammatory Agents; Cannabidiol; Dronabinol; HIV-1; Humans; Inflammasomes; Microglia | 2023 |
Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Cannabidiol; Cannabinoids; Catalepsy; Dronabinol; Male; Mice | 2023 |
Differential inflammatory profile in the lungs of mice exposed to cannabis smoke with varying THC:CBD ratio.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; CD8-Positive T-Lymphocytes; Dronabinol; Hallucinogens; Lung; Mice; Smoke | 2023 |
Argentination: A Silver Bullet for Cannabinoid Separation by Differential Mobility Spectrometry.
Topics: Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Chromatography, Liquid; Dronabinol; Hallucinogens; Limit of Detection; Spectrum Analysis | 2023 |
Δ
Topics: Cannabidiol; Cannabinoids; Dronabinol; Humans; Neuroblastoma; Transcriptome; Up-Regulation | 2023 |
CannibiSenS: an on-demand rapid screen for THC in human saliva.
Topics: Cannabidiol; Cannabis; Dronabinol; Humans; Saliva | 2023 |
Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.
Topics: Adult; Caffeine; Cannabidiol; Cannabinoids; Cannabis; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dronabinol; Drug Interactions; Hallucinogens; Humans; Losartan; Midazolam; Omeprazole; Plant Extracts | 2023 |
Cannabis sativa-based oils against aluminum-induced neurotoxicity.
Topics: Acetylcholinesterase; Aluminum; Animals; Antioxidants; Cannabidiol; Cannabis; Dronabinol; Oils; Zebrafish | 2023 |
Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products.
Topics: Animals; Biological Availability; Cannabidiol; Cannabinoids; Dronabinol; Female; Male; Rats; Rats, Sprague-Dawley | 2023 |
Chemical identification and optimization of the 4-aminophenol colorimetric test for the differentiation between hemp-type and marijuana-type cannabis plant samples.
Topics: Aminophenols; Cannabidiol; Cannabinoids; Cannabis; Colorimetry; Dronabinol; Hallucinogens | 2023 |
Quality test of cannabidiol profiling in CBD oil products and evaluation of residual THC at high temperature based on liquid chromatography coupled with tandem mass spectrometry.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Tandem Mass Spectrometry; Temperature | 2023 |
Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC).
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens; Psychotropic Drugs | 2023 |
Conversion of water-soluble CBD to ∆9-THC in synthetic gastric fluid-An unlikely cause of positive drug tests.
Topics: Cannabidiol; Dronabinol; Powders | 2023 |
Determination of phytocannabinoids in cannabis samples by ultrasound-assisted solid-liquid extraction and high-performance liquid chromatography with diode array detector analysis.
Topics: Cannabidiol; Cannabinol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Plant Extracts | 2023 |
Potency levels of regulated cannabis products in Michigan 2021-2022.
Topics: Adult; Cannabidiol; Cannabinoids; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Hallucinogens; Humans; Michigan | 2023 |
Confirmation of cannabinoids in forensic toxicology casework by isomer-selective UPLC-MS-MS analysis in urine.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Forensic Toxicology; Tandem Mass Spectrometry | 2023 |
Development and Validation of a Simple, Fast, and Accessible HPLC-UV Method for Cannabinoids Determination in
Topics: Cannabidiol; Cannabinoids; Cannabinol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Hallucinogens; Humans; Oils; Plant Extracts | 2023 |
Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Female; Humans; Placenta; Pregnancy; Trophoblasts; Vascular Endothelial Growth Factor Receptor-1 | 2023 |
Vaping of Cannabis, Cannabidiol, and Synthetic Cannabis Among US Sexual Minority Youths.
Topics: Adolescent; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Dronabinol; Hallucinogens; Humans; Vaping | 2023 |
The preanalytical stability of emerging cannabinoid analogs (delta-8 THC and its metabolites, delta-10 THC and carboxy-HHC) in urine.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Hallucinogens | 2023 |
Prevalence of ∆8-tetrahydrocannabinol carboxylic acid in workplace drug testing.
Topics: Cannabidiol; Cannabinoids; Dronabinol; Hallucinogens; Prevalence; Workplace | 2023 |
Bidimensional heart-cut achiral-chiral liquid chromatography coupled to high-resolution mass spectrometry for the separation of the main chiral phytocannabinoids and enantiomerization studies of cannabichromene and cannabichromenic acid.
Topics: Cannabidiol; Cannabis; Chromatography, Liquid; Dronabinol; Mass Spectrometry | 2024 |
Highly selective molecularly imprinted polymer nanoparticles (MIP NPs)-based microfluidic gas sensor for tetrahydrocannabinol (THC) detection.
Topics: Cannabidiol; Dronabinol; Ethanol; Methanol; Microfluidics; Molecularly Imprinted Polymers; Nanoparticles; Polymers | 2023 |
The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice.
Topics: Animals; Cannabidiol; Cannabis; Dronabinol; Endocannabinoids; Glucose; Mice; Mice, Inbred C57BL; Obesity; Weight Gain | 2023 |
Rapid electrochemical lateral flow device for the detection of Δ
Topics: Cannabidiol; Cannabis; Chromatography, High Pressure Liquid; Dronabinol; Plant Extracts | 2023 |
Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB
Topics: beta-Arrestin 1; Cannabidiol; Cannabinoid Receptor Agonists; Dronabinol; GTP-Binding Proteins; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid | 2023 |
High Specific and Rapid Detection of Cannabidiol by Gold Nanoparticle-Based Paper Sensor.
Topics: Antibodies, Monoclonal; Cannabidiol; Carbonated Water; Dronabinol; Gold; Metal Nanoparticles | 2023 |
Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure.
Topics: Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Chemokines; Cytokines; Dronabinol; Female; Hallucinogens; Humans; Maternal Health; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley; Smoke | 2023 |
11-Nor-9-Carboxy-Δ8-Tetrahydrocannabinol, 7-Carboxy Cannabidiol, and 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Urine by LC-MS/MS.
Topics: Cannabidiol; Cannabinoids; Chromatography, Liquid; Dronabinol; Tandem Mass Spectrometry | 2024 |